[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_6fc4ba12-0889-45f9-81bc-351a5d75d20f":865,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:6fc4ba12-0889-45f9-81bc-351a5d75d20f,\"}":923},{"meta":4,"data":6},{"total":5},"117",[7,56,246,295,379,474,535,646,710,744],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":25,"verifyStatus":26,"verifyTime":27,"verifyNote":28,"languages":29,"translateLanguages":28,"viewCount":32,"subjectFields":33,"manageAffiliations":34,"indexDatabases":35,"url":36,"thumbnailPath":28,"statistic":28,"gsStatistic":37,"type":55,"analyzePriority":28},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-08-27T01:57:29.562+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":14,"issn":16,"title":18,"introduce":21,"gsId":23},{"VOID":15},"VN",{"VOID":17},"08667535",{"EN":19,"VI":20},"Journal of Tropical Science and Engineering","Tạp chí Khoa học và Công nghệ nhiệt đới",{"EN":22},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":24},"MS2_GJQAAAAJ","PUBLISHER","VERIFIED","2025-10-27T06:27:25.058+00:00",null,[30,31],"VI","EN",0,[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":28,"impactFactorByYear":28,"i10Index":32,"i10IndexLast5Year":32,"totalPublication":38,"totalPublicationByYear":39,"totalCitation":43,"totalCitationByYear":44,"totalCitationPerPublication":52,"totalCitationPerPublicationByYear":53,"hindexLast5Year":42,"hindex":42},483,{"0":40,"2020":40,"2021":40,"2022":40,"2024":40,"2025":41,"2026":42},1,475,3,117,{"2017":40,"2018":40,"2019":45,"2020":46,"2021":46,"2022":47,"2023":48,"2024":49,"2025":50,"2026":51},4,5,11,6,7,53,15,0.24,{"2020":46,"2021":46,"2022":47,"2024":49,"2025":54,"2026":46},0.11,"JOURNAL",{"id":57,"createTime":58,"updateTime":10,"relativeEntities":59,"slug":60,"properties":61,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":69,"subjectFields":70,"manageAffiliations":71,"indexDatabases":84,"url":101,"thumbnailPath":28,"statistic":102,"gsStatistic":195,"type":55,"analyzePriority":28},"cc3aedc1-bd17-441e-b403-4be82349b362","2023-05-29T12:05:16.902+00:00",[],"Vietnam-Journal-of-Mechanics",{"country":62,"issn":63,"title":65,"gsId":67},{"VOID":15},{"VOID":64},"08667136",{"EN":66},"Vietnam Journal of Mechanics",{"VOID":68},"B98qpzgAAAAJ",29,[],[72],{"id":73,"createTime":28,"updateTime":28,"relativeEntities":74,"slug":28,"properties":75,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":82,"parentIds":83,"statistic":28},"5bf72910-eb8d-41eb-b358-ea294f24f765",[],{"title":76,"country":79,"abbreviation":80},{"EN":77,"VI":78},"Vietnam Academy of Science and Technology","Viện Hàn lâm Khoa học và Công nghệ Việt Nam",{"VOID":15},{"VOID":81},"VAST","https:\u002F\u002Fvast.gov.vn\u002F",[],[85],{"id":86,"indexDatabase":87,"url":97,"indexYears":98,"academicFieldIds":99,"indexDatabaseRanking":28},"61d05d3d-1119-4247-9062-3944e6a8afd5",{"id":88,"createTime":28,"updateTime":28,"relativeEntities":89,"label":90,"description":92,"key":94,"publicationTags":95,"standard":28},"7c6668cf-5dbb-472f-ac65-0e3d0d95e1c2",[],{"EN":91,"VI":91},"ACI - Asean Citation Index",{"EN":93,"VI":93},"Cơ sở dữ liệu ACI","aci",[96],"ACI","https:\u002F\u002Fasean-cites.org\u002Fjournal_info?jid=10758","2018-2022",[100],"007635a4-2624-49b8-a8f3-fec188e6a80e","http:\u002F\u002Fvjs.ac.vn\u002Findex.php\u002Fvjmech\u002Findex",{"impactFactor":32,"impactFactorByYear":103,"i10Index":122,"i10IndexLast5Year":123,"totalPublication":124,"totalPublicationByYear":125,"totalCitation":143,"totalCitationByYear":144,"totalCitationPerPublication":163,"totalCitationPerPublicationByYear":164,"hindexLast5Year":146,"hindex":146},{"1994":104,"1995":105,"1997":54,"1998":106,"1999":105,"2000":107,"2001":108,"2002":107,"2003":107,"2004":109,"2005":110,"2006":111,"2007":105,"2008":110,"2010":112,"2011":113,"2012":114,"2013":115,"2014":105,"2015":116,"2016":111,"2017":116,"2018":117,"2019":109,"2020":118,"2021":119,"2022":115,"2023":120,"2024":121},0.12,0.08,0.05,0.02,0.1,0.15,0.14,0.09,0.07,0.21,0.73,0.52,0.13,0.26,0.36,0.61,0.64,0.27,23,2,1046,{"1979":126,"1980":127,"1981":128,"1982":129,"1983":51,"1984":129,"1985":130,"1986":128,"1987":51,"1988":51,"1989":122,"1990":128,"1991":129,"1992":128,"1993":131,"1994":132,"1995":133,"1996":133,"1997":132,"1998":131,"1999":128,"2000":122,"2001":134,"2002":130,"2003":135,"2004":122,"2005":136,"2006":133,"2007":137,"2008":138,"2009":131,"2010":134,"2011":47,"2012":139,"2013":131,"2014":134,"2015":131,"2016":135,"2017":140,"2018":132,"2019":131,"2020":141,"2021":122,"2022":142,"2023":130,"2024":123},12,17,18,19,20,25,28,27,22,21,24,38,35,37,26,39,36,1403,{"1980":40,"1982":40,"1983":40,"1991":132,"1992":45,"1993":48,"1994":49,"1995":145,"1996":146,"1997":134,"1998":140,"1999":47,"2000":136,"2001":127,"2002":128,"2003":147,"2004":148,"2005":131,"2006":149,"2007":150,"2008":151,"2009":152,"2010":153,"2011":154,"2012":155,"2013":156,"2014":152,"2015":157,"2016":158,"2017":138,"2018":159,"2019":160,"2020":159,"2021":161,"2022":162,"2023":45},9,13,31,30,46,40,65,43,119,105,89,72,63,66,70,59,68,58,1.34,{"1980":165,"1982":106,"1983":112,"1991":166,"1992":167,"1993":52,"1994":168,"1995":169,"1996":170,"1997":171,"1998":172,"1999":119,"2000":172,"2001":173,"2002":174,"2003":175,"2004":176,"2005":172,"2006":177,"2007":178,"2008":179,"2009":180,"2010":181,"2011":182,"2012":183,"2013":184,"2014":185,"2015":186,"2016":187,"2017":188,"2018":189,"2019":190,"2020":191,"2021":192,"2022":193,"2023":194},0.06,1.47,0.22,0.25,0.33,0.48,0.79,1.04,0.77,0.9,1.48,1.3,1.7,1.05,1.86,1.72,5.41,9.55,2.41,2.88,1.95,2.52,3.14,1.35,2.5,2.36,1.79,2.96,1.61,0.2,{"impactFactor":28,"impactFactorByYear":28,"i10Index":196,"i10IndexLast5Year":128,"totalPublication":197,"totalPublicationByYear":198,"totalCitation":203,"totalCitationByYear":204,"totalCitationPerPublication":219,"totalCitationPerPublicationByYear":220,"hindexLast5Year":126,"hindex":199},42,1244,{"0":147,"1979":146,"1980":127,"1981":127,"1982":199,"1983":199,"1984":129,"1985":129,"1986":128,"1987":129,"1988":51,"1989":140,"1990":127,"1991":129,"1992":129,"1993":133,"1994":147,"1995":132,"1996":69,"1997":132,"1998":131,"1999":134,"2000":140,"2001":131,"2002":134,"2003":131,"2004":133,"2005":132,"2006":131,"2007":200,"2008":138,"2009":140,"2010":132,"2011":122,"2012":201,"2013":132,"2014":140,"2015":148,"2016":122,"2017":202,"2018":69,"2019":140,"2020":69,"2021":132,"2022":139,"2023":130,"2024":133,"2025":131,"2026":138},16,47,41,32,2194,{"1997":126,"1998":205,"1999":126,"2000":145,"2001":145,"2002":126,"2003":205,"2004":127,"2005":129,"2006":146,"2007":132,"2008":136,"2009":47,"2010":131,"2011":138,"2012":206,"2013":207,"2014":208,"2015":162,"2016":209,"2017":209,"2018":210,"2019":211,"2020":212,"2021":213,"2022":214,"2023":215,"2024":216,"2025":217,"2026":218},10,54,64,62,93,123,118,122,168,159,177,205,255,154,1.76,{"1997":221,"1998":222,"1999":223,"2000":224,"2001":118,"2002":223,"2003":222,"2004":225,"2005":226,"2006":115,"2007":227,"2008":228,"2009":229,"2010":230,"2011":231,"2012":232,"2013":233,"2014":234,"2015":235,"2016":236,"2017":237,"2018":238,"2019":239,"2020":240,"2021":48,"2022":241,"2023":242,"2024":243,"2025":244,"2026":245},0.43,0.4,0.55,0.35,0.63,0.68,0.6,0.69,0.42,0.89,1.52,1.32,2.29,2.38,1.93,4.04,2.91,4.24,4.54,4.21,4.3,8.85,7.59,10.2,4.4,{"id":247,"createTime":248,"updateTime":10,"relativeEntities":249,"slug":250,"properties":251,"entityType":25,"verifyStatus":26,"verifyTime":261,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":147,"subjectFields":262,"manageAffiliations":263,"indexDatabases":264,"url":273,"thumbnailPath":28,"statistic":274,"gsStatistic":290,"type":55,"analyzePriority":28},"b5209d2b-2258-40ef-8732-874e80fe24a5","2023-08-01T04:13:30.887+00:00",[],"VNU-Journal-of-Science-Medical-and-Pharmaceutical-Sciences",{"country":252,"eissn":253,"issn":255,"title":257,"gsId":259},{"VOID":15},{"VOID":254},"25881132",{"VOID":256},"26159309",{"EN":258},"VNU Journal of Science: Medical and Pharmaceutical Sciences",{"VOID":260},"nxupvWQAAAAJ","2023-08-01T04:16:22.633+00:00",[],[],[265],{"id":266,"indexDatabase":267,"url":272,"indexYears":28,"academicFieldIds":28,"indexDatabaseRanking":28},"1c684ac3-c7bf-4466-8841-3c6146083c3c",{"id":88,"createTime":28,"updateTime":28,"relativeEntities":268,"label":269,"description":270,"key":94,"publicationTags":271,"standard":28},[],{"EN":91,"VI":91},{"EN":93,"VI":93},[96],"https:\u002F\u002Fasean-cites.org\u002Fjournal_info?jid=11969","https:\u002F\u002Fjs.vnu.edu.vn\u002FMPS",{"impactFactor":32,"impactFactorByYear":275,"i10Index":32,"i10IndexLast5Year":32,"totalPublication":276,"totalPublicationByYear":277,"totalCitation":282,"totalCitationByYear":283,"totalCitationPerPublication":284,"totalCitationPerPublicationByYear":285,"hindexLast5Year":45,"hindex":45},{"2019":106,"2020":110,"2021":104,"2022":104,"2023":109,"2024":108},360,{"2016":140,"2017":278,"2018":69,"2019":148,"2020":279,"2021":200,"2022":280,"2023":281,"2024":200},34,48,49,50,163,{"2016":145,"2017":145,"2018":135,"2019":140,"2020":50,"2021":135,"2022":128,"2023":48},0.45,{"2016":224,"2017":117,"2018":286,"2019":287,"2020":288,"2021":284,"2022":289,"2023":104},0.72,0.87,1.1,0.37,{"impactFactor":28,"impactFactorByYear":28,"i10Index":32,"i10IndexLast5Year":32,"totalPublication":136,"totalPublicationByYear":291,"totalCitation":127,"totalCitationByYear":292,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":294,"hindexLast5Year":123,"hindex":42},{"0":123,"2014":40,"2015":40,"2016":130},{"2016":40,"2019":123,"2021":123,"2023":45,"2024":42,"2025":40,"2026":40},0.71,{"2016":106},{"id":296,"createTime":297,"updateTime":10,"relativeEntities":298,"slug":299,"properties":300,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":51,"subjectFields":310,"manageAffiliations":311,"indexDatabases":312,"url":313,"thumbnailPath":28,"statistic":314,"gsStatistic":349,"type":55,"analyzePriority":28},"e7ce3904-ad2d-4341-b39e-98ebe8da5908","2023-06-13T10:30:04.853+00:00",[],"Communications-in-Physics",{"country":301,"eissn":302,"issn":304,"title":306,"gsId":308},{"VOID":15},{"VOID":303},"28155947",{"VOID":305},"08863166",{"EN":307},"Communications in Physics",{"VOID":309},"FStER9AAAAAJ",[],[],[],"https:\u002F\u002Fvjs.ac.vn\u002Findex.php\u002Fcip",{"impactFactor":32,"impactFactorByYear":315,"i10Index":199,"i10IndexLast5Year":45,"totalPublication":321,"totalPublicationByYear":322,"totalCitation":326,"totalCitationByYear":327,"totalCitationPerPublication":335,"totalCitationPerPublicationByYear":336,"hindexLast5Year":126,"hindex":126},{"2008":110,"2009":316,"2010":165,"2011":317,"2012":317,"2013":112,"2014":318,"2015":105,"2016":108,"2017":116,"2018":318,"2019":52,"2020":319,"2021":284,"2022":320,"2023":116,"2024":222},0.3,0.03,0.16,0.34,0.28,738,{"2007":323,"2008":145,"2009":145,"2010":136,"2011":139,"2012":324,"2013":138,"2014":151,"2015":69,"2016":151,"2017":325,"2018":142,"2019":50,"2020":201,"2021":141,"2022":152,"2023":150,"2024":278,"2025":123},14,107,56,947,{"2007":148,"2008":49,"2009":49,"2010":127,"2011":328,"2012":155,"2013":278,"2014":329,"2015":206,"2016":330,"2017":331,"2018":332,"2019":333,"2020":334,"2021":127,"2022":132,"2023":148},52,94,86,129,76,91,106,1.28,{"2007":337,"2008":338,"2009":338,"2010":293,"2011":339,"2012":340,"2013":341,"2014":342,"2015":179,"2016":232,"2017":343,"2018":344,"2019":180,"2020":345,"2021":346,"2022":347,"2023":348},2.14,0.78,1.41,0.83,0.97,1.45,2.3,2.11,2.59,0.44,0.65,0.75,{"impactFactor":28,"impactFactorByYear":28,"i10Index":133,"i10IndexLast5Year":145,"totalPublication":350,"totalPublicationByYear":351,"totalCitation":355,"totalCitationByYear":356,"totalCitationPerPublication":363,"totalCitationPerPublicationByYear":364,"hindexLast5Year":145,"hindex":323},1117,{"0":48,"1972":40,"1991":127,"1992":51,"1993":49,"1994":47,"1995":323,"1996":42,"1997":40,"1998":146,"1999":146,"2000":205,"2001":47,"2002":128,"2003":136,"2004":132,"2005":136,"2006":148,"2007":141,"2008":149,"2009":352,"2010":353,"2011":196,"2012":208,"2013":280,"2014":354,"2015":150,"2016":328,"2017":137,"2018":142,"2019":325,"2020":152,"2021":139,"2022":139,"2023":142,"2024":148,"2025":147,"2026":132},33,44,92,1611,{"2004":46,"2005":357,"2006":47,"2007":47,"2008":126,"2009":140,"2010":69,"2011":147,"2012":147,"2013":147,"2014":208,"2015":353,"2016":201,"2017":280,"2018":161,"2019":358,"2020":212,"2021":331,"2022":212,"2023":359,"2024":360,"2025":361,"2026":362},8,85,153,178,188,132,1.44,{"2004":365,"2005":169,"2006":289,"2007":320,"2008":117,"2009":171,"2010":366,"2011":367,"2012":368,"2013":225,"2014":369,"2015":288,"2016":171,"2017":370,"2018":371,"2019":231,"2020":372,"2021":373,"2022":374,"2023":375,"2024":376,"2025":377,"2026":378},0.18,0.66,0.74,0.5,0.67,1.29,1.89,2.84,3.49,3.3,4.25,5.93,6.06,4.71,{"id":380,"createTime":381,"updateTime":382,"relativeEntities":383,"slug":384,"properties":385,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":28,"languages":394,"translateLanguages":28,"viewCount":127,"subjectFields":395,"manageAffiliations":396,"indexDatabases":404,"url":418,"thumbnailPath":28,"statistic":419,"gsStatistic":446,"type":55,"analyzePriority":28},"2300fd63-13a8-4ee9-92b0-d24d9e616c6b","2023-05-29T12:05:31.684+00:00","2026-08-27T01:57:29.561+00:00",[],"Journal-of-Computer-Science-and-Cybernetics",{"country":386,"issn":387,"title":389,"gsId":392},{"VOID":15},{"VOID":388},"18139663",{"EN":390,"VI":391},"Journal of Computer Science and Cybernetics","Tạp chí tin học và điều khiển học",{"VOID":393},"hVh9fuMAAAAJ",[30,31],[],[397],{"id":73,"createTime":28,"updateTime":28,"relativeEntities":398,"slug":28,"properties":399,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":82,"parentIds":403,"statistic":28},[],{"title":400,"country":401,"abbreviation":402},{"EN":77,"VI":78},{"VOID":15},{"VOID":81},[],[405],{"id":406,"indexDatabase":407,"url":412,"indexYears":413,"academicFieldIds":414,"indexDatabaseRanking":28},"0c897c2c-8ca4-4a7a-91b9-14955abc3043",{"id":88,"createTime":28,"updateTime":28,"relativeEntities":408,"label":409,"description":410,"key":94,"publicationTags":411,"standard":28},[],{"EN":91,"VI":91},{"EN":93,"VI":93},[96],"https:\u002F\u002Fasean-cites.org\u002Fjournal_info?jid=11305","2019-2021",[100,415,416,417],"a24a4497-b6ac-43f3-ae94-c044be819e49","b2d37900-0c9f-4074-a519-9ee0b570caa7","37da756c-1c5e-4925-87f2-a9bd3ce5859c","http:\u002F\u002Fvjs.ac.vn\u002Findex.php\u002Fjcc",{"impactFactor":32,"impactFactorByYear":420,"i10Index":129,"i10IndexLast5Year":42,"totalPublication":425,"totalPublicationByYear":426,"totalCitation":431,"totalCitationByYear":432,"totalCitationPerPublication":438,"totalCitationPerPublicationByYear":439,"hindexLast5Year":323,"hindex":323},{"2013":107,"2014":107,"2015":111,"2016":365,"2017":107,"2018":421,"2019":117,"2020":422,"2021":227,"2022":423,"2023":368,"2024":424},0.04,0.32,0.39,0.57,1184,{"2012":427,"2013":358,"2014":278,"2015":428,"2016":429,"2017":51,"2018":430,"2019":148,"2020":130,"2021":136,"2022":199,"2023":132,"2024":42},473,71,251,134,995,{"2012":433,"2013":434,"2014":434,"2015":333,"2016":435,"2017":436,"2018":437,"2019":211,"2020":281,"2021":434,"2022":126,"2023":152},149,45,114,51,232,0.84,{"2012":422,"2013":440,"2014":232,"2015":335,"2016":284,"2017":441,"2018":442,"2019":443,"2020":189,"2021":444,"2022":348,"2023":445},0.53,3.4,1.73,3.93,1.88,1.54,{"impactFactor":28,"impactFactorByYear":28,"i10Index":150,"i10IndexLast5Year":132,"totalPublication":447,"totalPublicationByYear":448,"totalCitation":449,"totalCitationByYear":450,"totalCitationPerPublication":192,"totalCitationPerPublicationByYear":460,"hindexLast5Year":51,"hindex":199},1105,{"0":47,"1981":40,"1985":199,"1986":135,"1987":136,"1988":323,"1989":126,"1990":199,"1991":127,"1992":126,"1993":47,"1994":129,"1995":130,"1996":132,"1997":142,"1998":148,"1999":201,"2000":196,"2001":353,"2002":353,"2003":352,"2004":132,"2005":131,"2006":148,"2007":147,"2008":133,"2009":131,"2010":139,"2011":201,"2012":281,"2013":142,"2014":202,"2015":69,"2016":140,"2017":136,"2018":140,"2019":134,"2020":134,"2021":133,"2022":134,"2023":134,"2024":136,"2025":49},3272,{"2007":145,"2008":323,"2009":46,"2010":48,"2011":129,"2012":148,"2013":140,"2014":69,"2015":152,"2016":160,"2017":162,"2018":451,"2019":452,"2020":453,"2021":454,"2022":455,"2023":456,"2024":457,"2025":458,"2026":459},109,173,236,318,398,469,442,440,297,{"2007":461,"2008":115,"2009":194,"2010":318,"2011":462,"2012":227,"2013":286,"2014":463,"2015":175,"2016":464,"2017":465,"2018":466,"2019":467,"2020":468,"2021":469,"2022":470,"2023":471,"2024":472,"2025":473},0.29,0.46,0.91,2.27,2.42,4.19,7.86,10.73,11.78,18.09,21.32,18.42,62.86,{"id":475,"createTime":476,"updateTime":382,"relativeEntities":477,"slug":478,"properties":479,"entityType":25,"verifyStatus":26,"verifyTime":491,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":202,"subjectFields":492,"manageAffiliations":493,"indexDatabases":509,"url":510,"thumbnailPath":28,"statistic":511,"gsStatistic":525,"type":55,"analyzePriority":28},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":480,"issn":481,"title":483,"introduce":486,"gsId":489},{"VOID":15},{"VOID":482},"23541210",{"EN":484,"VI":485},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"EN":487,"VI":488},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"VOID":490},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",[],[494],{"id":495,"createTime":28,"updateTime":28,"relativeEntities":496,"slug":28,"properties":497,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":507,"parentIds":508,"statistic":28},"6413896b-eca9-442b-a73f-182a58a0ce40",[],{"title":498,"address":501,"country":504,"abbreviation":505},{"EN":499,"VI":500},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"EN":502,"VI":503},"No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam","Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam",{"VOID":15},{"VOID":506},"ctump","http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":32,"impactFactorByYear":512,"i10Index":32,"i10IndexLast5Year":32,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":520,"totalCitationByYear":521,"totalCitationPerPublication":108,"totalCitationPerPublicationByYear":523,"hindexLast5Year":45,"hindex":45},{"2022":513,"2023":111,"2024":106},0.01,1556,{"2020":47,"2021":516,"2022":517,"2023":518,"2024":519,"2025":122},57,306,801,358,161,{"2021":146,"2022":280,"2023":522},99,{"2021":524,"2022":318,"2023":104},0.23,{"impactFactor":28,"impactFactorByYear":28,"i10Index":123,"i10IndexLast5Year":123,"totalPublication":526,"totalPublicationByYear":527,"totalCitation":526,"totalCitationByYear":528,"totalCitationPerPublication":40,"totalCitationPerPublicationByYear":531,"hindexLast5Year":49,"hindex":49},476,{"0":205,"2019":123,"2021":139,"2022":459,"2023":451,"2024":357,"2025":49,"2026":48},{"2021":42,"2022":123,"2023":161,"2024":529,"2025":360,"2026":530},136,83,{"2021":105,"2022":513,"2023":532,"2024":127,"2025":533,"2026":534},0.62,25.43,13.83,{"id":536,"createTime":537,"updateTime":382,"relativeEntities":538,"slug":539,"properties":540,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":28,"languages":552,"translateLanguages":28,"viewCount":133,"subjectFields":553,"manageAffiliations":554,"indexDatabases":555,"url":556,"thumbnailPath":557,"statistic":558,"gsStatistic":594,"type":55,"analyzePriority":28},"6984a56a-db70-403b-9cc4-4013e1ceaffa","2023-05-09T06:47:40.346+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Nghi%C3%AAn%20c%E1%BB%A9u%20n%C6%B0%E1%BB%9Bc%20ngo%C3%A0i",{"country":541,"issn":542,"title":544,"introduce":547,"gsId":550},{"VOID":15},{"VOID":543},"25252445",{"EN":545,"VI":546},"VNU Journal of Foreign Studies","Tạp chí Nghiên cứu nước ngoài",{"EN":548,"VI":549},"{\"ops\":[{\"insert\":\"\\n\\nThe \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"VNU Journal of Science\"},{\"insert\":\"\\n was established in 1985 for the publication of national and international research papers in all fields of natural sciences and technology, social sciences and humanities. Since then, the journal has grown in quality, size and scope and now comprises a dozen of serials spanning academic research. In 2002, with the rapid expansion of the field of Foreign Languages and International Studies, the \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"VNU Journal of Science\"},{\"insert\":\"\\n was delighted to announce the launch of the \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"VNU Journal of Science: Foreign Studies\"},{\"insert\":\"\\n.\\n\\n\\nSince 2017, as a natural development from its predecessor \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"VNU Journal of Science: Foreign Studies\"},{\"insert\":\"\\n, the\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\" \"},{\"attributes\":{\"italic\":true,\"bold\":true},\"insert\":\"VNU Journal of Foreign Studies \"},{\"insert\":\"\\ncontinues to be an official, independent publication of the University of Languages and International Studies (ULIS) under Vietnam National University (VNU).\\nThe\\n\"},{\"attributes\":{\"italic\":true,\"bold\":true},\"insert\":\" VNU Journal of Foreign Studies\"},{\"attributes\":{\"italic\":true},\"insert\":\" \"},{\"insert\":\"\\npublishes \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"blind\"},{\"insert\":\"\\n \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"peer-reviewed\"},{\"insert\":\"\\n research papers, discussions and reviews concerning:\\nLinguisticsForeign language educationInternational studiesRelated social sciences and humanities\\nBimonthly in 4 English editions and 2 Vietnamese editions in the current year in both print and electronic forms, the journal provides maximum exposure for published articles, making research available to all to read and share.\\n\\n\\n\"}]}","{\"ops\":[{\"attributes\":{\"italic\":true},\"insert\":\"Tạp chí Khoa học, Đại học Quốc gia Hà Nội\"},{\"insert\":\"\\n được thành lập năm 1985 với mục đích xuất bản các bài báo nghiên cứu trong nước và quốc tế về tất cả các lĩnh vực khoa học tự nhiên và công nghệ, khoa học xã hội và nhân văn. Kể từ đó, tạp chí đã phát triển về chất lượng, quy mô và phạm vi với hàng chục số báo liên quan đến nghiên cứu học thuật. Năm 2002, với sự phát triển nhanh chóng của lĩnh vực Ngoại ngữ và Quốc tế học, \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"Tạp chí Khoa học Đại học Quốc gia Hà Nội\"},{\"insert\":\"\\n đã vui mừng thông báo ra mắt Chuyên san \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"Nghiên cứu Nước ngoài.\"},{\"insert\":\"\\n\\n\\nKể từ năm 2017, như một sự kế thừa và phát triển từ tiền thân Chuyên san \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"Nghiên cứu Nước ngoài\"},{\"insert\":\"\\n của Tạp chí Khoa học, Đại học Quốc gia Hà Nội, \\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tạp chí\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\" \"},{\"insert\":\"\\n\"},{\"attributes\":{\"italic\":true,\"bold\":true},\"insert\":\"Nghiên cứu nước ngoài \"},{\"insert\":\"\\ntiếp tục là ấn phẩm khoa học chính thức và độc lập của Trường Đại học Ngoại ngữ, Đại học Quốc gia Hà Nội.\\nTạp chí \\n\"},{\"attributes\":{\"italic\":true,\"bold\":true},\"insert\":\"Nghiên cứu nước ngoài\"},{\"insert\":\"\\n xuất bản các bài báo nghiên cứu, trao đổi và đánh giá đã được phản biện kín về:\\nNgôn ngữ họcGiảng dạy ngoại ngữ\u002Fngôn ngữQuốc tế họcCác ngành khoa học xã hội và nhân văn có liên quan\\nTạp chí xuất bản định kì 06 số\u002Fnăm (gồm 04 số tiếng Anh\u002Fnăm và 2 số tiếng Việt\u002Fnăm) dưới dạng bản in và bản điện tử. Tạp chí cung cấp khả năng tiếp cận tối đa tới các bài báo đã xuất bản nhằm giúp độc giả dễ dàng đọc và chia sẻ.\\n\"}]}",{"VOID":551},"jyihv3YAAAAJ",[30,31],[],[],[],"https:\u002F\u002Fjfs.ulis.vnu.edu.vn\u002Findex.php\u002Ffs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6984a56a-db70-403b-9cc4-4013e1ceaffa\u002F92693604f5caf63c64520c5c2cd756b5.jpg",{"impactFactor":32,"impactFactorByYear":559,"i10Index":560,"i10IndexLast5Year":205,"totalPublication":561,"totalPublicationByYear":562,"totalCitation":568,"totalCitationByYear":569,"totalCitationPerPublication":579,"totalCitationPerPublicationByYear":580,"hindexLast5Year":140,"hindex":140},{"2007":317,"2010":112,"2011":109,"2012":421,"2013":165,"2014":421,"2015":421,"2016":111,"2017":116,"2018":104,"2019":109,"2020":320,"2021":284,"2022":168,"2023":116,"2024":108},67,1200,{"2002":51,"2003":51,"2004":47,"2005":352,"2006":142,"2007":131,"2008":147,"2009":139,"2010":278,"2011":138,"2012":69,"2013":206,"2014":137,"2015":69,"2016":196,"2017":563,"2018":209,"2019":564,"2020":565,"2021":566,"2022":530,"2023":567,"2024":428,"2025":281},130,78,90,80,61,3204,{"2002":42,"2003":123,"2004":123,"2005":570,"2006":47,"2007":127,"2008":571,"2009":572,"2010":196,"2011":573,"2012":130,"2013":560,"2014":574,"2015":149,"2016":325,"2017":575,"2018":576,"2019":577,"2020":578,"2021":453,"2022":206,"2023":205,"2025":51},189,223,765,246,98,171,377,355,199,2.67,{"2002":194,"2003":116,"2004":365,"2005":581,"2006":582,"2007":226,"2008":583,"2009":584,"2010":585,"2011":586,"2012":228,"2013":585,"2014":587,"2015":588,"2016":589,"2017":232,"2018":590,"2019":591,"2020":592,"2021":593,"2022":347,"2023":318,"2025":316},5.73,0.31,7.19,20.68,1.24,7.03,2.58,1.59,1.33,4.05,4.55,2.21,2.95,{"impactFactor":28,"impactFactorByYear":28,"i10Index":595,"i10IndexLast5Year":596,"totalPublication":597,"totalPublicationByYear":598,"totalCitation":609,"totalCitationByYear":610,"totalCitationPerPublication":625,"totalCitationPerPublicationByYear":626,"hindexLast5Year":142,"hindex":152},379,311,2120,{"0":361,"1960":40,"1971":40,"1975":40,"1987":40,"1988":40,"1989":40,"1990":45,"1992":40,"1993":40,"1994":46,"1995":46,"1996":45,"1997":42,"1998":49,"1999":42,"2000":123,"2001":42,"2002":48,"2003":46,"2004":145,"2005":131,"2006":51,"2007":131,"2008":135,"2009":146,"2010":127,"2011":122,"2012":148,"2013":352,"2014":201,"2015":149,"2016":599,"2017":600,"2018":601,"2019":209,"2020":602,"2021":603,"2022":604,"2023":605,"2024":606,"2025":607,"2026":608},77,75,97,143,167,156,182,231,230,128,13225,{"2003":149,"2004":150,"2005":201,"2006":196,"2007":157,"2008":436,"2009":328,"2010":611,"2011":612,"2012":333,"2013":522,"2014":613,"2015":520,"2016":614,"2017":615,"2018":616,"2019":617,"2020":618,"2021":619,"2022":620,"2023":621,"2024":622,"2025":623,"2026":624},74,88,146,228,310,347,413,636,944,1261,1400,1846,2511,1882,6.24,{"2003":627,"2004":628,"2005":629,"2006":630,"2007":186,"2008":631,"2009":45,"2010":632,"2011":633,"2012":634,"2013":42,"2014":635,"2015":636,"2016":192,"2017":637,"2018":638,"2019":628,"2020":639,"2021":640,"2022":641,"2023":642,"2024":643,"2025":644,"2026":645},9.2,4.44,1.64,2.8,2.43,4.35,3.83,3.03,3.56,3.5,4.13,3.58,4.45,5.65,8.08,7.69,7.99,10.92,14.7,{"id":647,"createTime":648,"updateTime":382,"relativeEntities":649,"slug":650,"properties":651,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":664,"languages":665,"translateLanguages":28,"viewCount":142,"subjectFields":666,"manageAffiliations":667,"indexDatabases":668,"url":677,"thumbnailPath":678,"statistic":679,"gsStatistic":699,"type":55,"analyzePriority":28},"21d239d8-ac9d-48c7-a176-9d8aadc5eba5","2023-08-21T02:43:48.721+00:00",[],"Khoa-h%E1%BB%8Dc-%C4%90HQGHN-Khoa-h%E1%BB%8Dc-T%E1%BB%B1-nhi%C3%AAn-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87",{"country":652,"eissn":653,"issn":655,"title":657,"introduce":660,"gsId":662},{"VOID":15},{"VOID":654},"25881140",{"VOID":656},"26159317",{"EN":658,"VI":659},"VNU Journal of Science: Natural Science and Technology","Khoa học ĐHQGHN: Khoa học Tự nhiên và Công nghệ",{"EN":661},"{\"ops\":[{\"insert\":\"The \"},{\"attributes\":{\"italic\":true},\"insert\":\"Journal\"},{\"insert\":\" \"},{\"attributes\":{\"italic\":true},\"insert\":\"of\"},{\"insert\":\" \"},{\"attributes\":{\"italic\":true},\"insert\":\"Science\"},{\"insert\":\" was established in 1985 for the publication of national and international research papers in all fields of natural sciences and technology, social sciences and humanities. Since then, the journal has grown in quality, size and scope and now comprises a dozen of serials spanning academic research.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"With the rapid expansion of the field of Economics, the VNU \"},{\"attributes\":{\"italic\":true},\"insert\":\"Journal\"},{\"insert\":\" \"},{\"attributes\":{\"italic\":true},\"insert\":\"of\"},{\"insert\":\" \"},{\"attributes\":{\"italic\":true},\"insert\":\"Science\"},{\"insert\":\" is delighted to announce the launch of the \"},{\"attributes\":{\"italic\":true},\"insert\":\"VNU Journal of Science: Natural Sciences and Technology (JS: NST) \"},{\"insert\":\"since 1985. This serial publication provides researchers with the opportunity to publish research covering aspects in these areas in the popular \"},{\"attributes\":{\"italic\":true},\"insert\":\"VNU Journal of Science\"},{\"insert\":\" series.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"As a fully open access publication, the journal will provide maximum exposure for published articles, making the research available to all to read and share. The journal will be published quarterly in March, June, September and December.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"JS: NST is an open access journal publishing double-blinded peer-reviewed research papers, communications and reviews dealing with Biology, Bio-technology, Chemistry, Chemical engineering, Energy, Environmental technology and Materials engineering.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Publication Ethics\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"VNUJS is committed to maintaining the highest standards of publication ethics and takes all possible measures against any publication malpractices. The journal follows the guidelines and recommendations of the Committee on Publication Ethics (C.O.P.E) to ensure ethical publishing practices.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Plagiarism is strictly prohibited and will not be tolerated. Any form of plagiarism, including but not limited to copying, paraphrasing, or reusing previously published work without proper attribution, will result in rejection of the manuscript and potential sanctions against the author. VNUJS utilizes DoIt as plagiarism detection software to verify the originality of submitted manuscripts.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"The publication ethics statement with full detail of the responsibilities of authors, reviewers and editors can be found \"},{\"attributes\":{\"bold\":true,\"color\":\"#464d50\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fjs.vnu.edu.vn\u002FNST\u002Fethics\"},\"insert\":\"here\"},{\"attributes\":{\"bold\":true},\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Peer Review Process\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Any manuscript followed the journal’s scope and author guideline will be assigned to the managing editors. All manuscripts have undergone editorial screening and anonymous double-blind peer-review by the at least one independent expert in the field. The managing editor makes an editorial decision, which is subject to endorsement by the Editor – in - Chief.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"The journal publishing process can be found in detail \"},{\"attributes\":{\"bold\":true,\"color\":\"#464d50\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fdrive.google.com\u002Ffile\u002Fd\u002F136BOGahfq9_5BB3TzSBsLBkQKfCUe5yN\u002Fview?usp=share_link\"},\"insert\":\"here\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"VOID":663},"ZfBridMAAAAJ","Admin update database",[30,31],[],[],[669],{"id":670,"indexDatabase":671,"url":676,"indexYears":28,"academicFieldIds":28,"indexDatabaseRanking":28},"6684da33-2cb9-49f9-8332-28f0bcd72e39",{"id":88,"createTime":28,"updateTime":28,"relativeEntities":672,"label":673,"description":674,"key":94,"publicationTags":675,"standard":28},[],{"EN":91,"VI":91},{"EN":93,"VI":93},[96],"https:\u002F\u002Fasean-cites.org\u002Fjournal_info?jid=11968","https:\u002F\u002Fjs.vnu.edu.vn\u002FNST","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F21d239d8-ac9d-48c7-a176-9d8aadc5eba5\u002Fb081d4211e382646c2cdc054ead551b3.jpg",{"impactFactor":32,"impactFactorByYear":680,"i10Index":130,"i10IndexLast5Year":40,"totalPublication":682,"totalPublicationByYear":683,"totalCitation":685,"totalCitationByYear":686,"totalCitationPerPublication":691,"totalCitationPerPublicationByYear":692,"hindexLast5Year":47,"hindex":47},{"2000":317,"2005":513,"2007":107,"2010":513,"2011":317,"2012":106,"2013":107,"2014":317,"2015":107,"2016":107,"2017":421,"2018":317,"2019":421,"2020":113,"2021":582,"2022":681,"2023":194,"2024":104},0.19,1700,{"1985":131,"1986":353,"1987":130,"1988":69,"1989":69,"1990":200,"1991":196,"1992":146,"1993":279,"1994":148,"1995":200,"1996":201,"1999":278,"2000":140,"2001":128,"2002":202,"2003":353,"2004":138,"2005":202,"2006":136,"2007":278,"2008":139,"2009":137,"2010":141,"2011":278,"2012":132,"2013":202,"2014":202,"2015":278,"2016":684,"2017":359,"2018":160,"2019":162,"2020":281,"2021":157,"2022":436,"2023":358,"2024":136,"2025":135},165,870,{"1995":123,"1999":123,"2001":45,"2002":130,"2003":40,"2004":123,"2005":42,"2007":69,"2008":687,"2009":352,"2010":688,"2011":137,"2012":127,"2013":47,"2014":46,"2015":146,"2016":331,"2017":689,"2018":331,"2019":690,"2020":353,"2021":567,"2022":130,"2023":357},82,60,55,102,0.51,{"1995":421,"1999":165,"2001":167,"2002":532,"2003":107,"2004":165,"2005":111,"2007":693,"2008":694,"2009":287,"2010":445,"2011":695,"2012":119,"2013":319,"2014":318,"2015":696,"2016":338,"2017":118,"2018":697,"2019":219,"2020":698,"2021":341,"2022":423,"2023":111},0.85,2.22,1.12,0.38,2.19,0.88,{"impactFactor":28,"impactFactorByYear":28,"i10Index":126,"i10IndexLast5Year":123,"totalPublication":570,"totalPublicationByYear":700,"totalCitation":701,"totalCitationByYear":702,"totalCitationPerPublication":703,"totalCitationPerPublicationByYear":704,"hindexLast5Year":46,"hindex":205},{"0":48,"1999":146,"2000":47,"2001":45,"2002":40,"2003":199,"2004":123,"2005":42,"2006":123,"2007":145,"2008":145,"2009":46,"2010":49,"2011":47,"2012":47,"2013":49,"2014":45,"2015":45,"2016":157,"2017":40},425,{"2008":42,"2009":357,"2010":47,"2011":51,"2012":199,"2013":135,"2014":323,"2015":51,"2016":278,"2017":69,"2018":69,"2019":137,"2020":142,"2021":140,"2022":148,"2023":122,"2024":202,"2025":135,"2026":126},2.25,{"2008":169,"2009":705,"2010":706,"2011":707,"2012":342,"2013":42,"2014":636,"2015":708,"2016":709,"2017":69},1.6,1.57,1.36,3.75,0.54,{"id":711,"createTime":712,"updateTime":382,"relativeEntities":713,"slug":714,"properties":715,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":664,"languages":28,"translateLanguages":28,"viewCount":150,"subjectFields":727,"manageAffiliations":728,"indexDatabases":729,"url":730,"thumbnailPath":731,"statistic":732,"gsStatistic":738,"type":55,"analyzePriority":28},"954132b5-ca74-461c-b819-45ad6e49a404","2023-08-17T03:30:52.301+00:00",[],"HPU2-Journal-of-Science-Natural-Sciences-and-Technology",{"country":716,"issn":717,"title":719,"introduce":722,"gsId":725},{"VOID":15},{"VOID":718},"28155637",{"EN":720,"VI":721},"HPU2 Journal of Science: Natural Sciences and Technology","TẠP CHÍ KHOA HỌC TRƯỜNG ĐHSP HÀ NỘI 2: CHUYÊN SAN KHOA HỌC TỰ NHIÊN VÀ CÔNG NGHỆ",{"EN":723,"VI":724},"{\"ops\":[{\"insert\":\"HPU2 journal of Science aims to provide an interdisciplinary platform for the dissemination of advances in sciences and technology. The journal publishes original papers of scientific or technological value in all areas of natural, social or educational sciences.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"The main interest of HPU2 Journal of Science: Natural sciences and technology is in papers that describe valuable findings in physics, mathematics, chemistry, biology; solving engineering or technological problems.\"},{\"attributes\":{\"align\":\"justify\",\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"insert\":\"The main interest of HPU2 Journal of Science: Social Sciences and Humanity is to facilitate the publication of high-quality papers in various areas of social sciences and studies for human development.\"},{\"attributes\":{\"align\":\"justify\",\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"insert\":\"The main interest of HPU2 Journal of Science: Educational Sciences is to publish papers in the field of educational sciences and applications of advances to education for improving and enhancing science education at all levels.\"},{\"attributes\":{\"align\":\"justify\",\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"insert\":\"Papers that are published by HPU2 Journal of Science are doubled-blind, peer-reviewed by at least two experts, are evaluated by the section editor and editor in chief.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Types of Articles\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Research articles\"},{\"attributes\":{\"align\":\"justify\",\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"insert\":\"Academic reports of original research that have never been published elsewhere in any languages. Manuscripts, where appropriate, should contain the following sections in the order: Title, Authors, Author affiliations, Email address of corresponding authors, Abstract, Keywords, Nomenclature (if any), Introduction, Experiment, Theory, Results and Discussion, Conclusions, Conflict of Interest, Acknowledgments (if any), References, Appendix (if any). Pre-published are to be formatted according to Templates (MS-Word version). \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Review articles\"},{\"attributes\":{\"align\":\"justify\",\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"insert\":\"In addition to invited reviews, literature reviews, systematic reviews, and critical reviews will be accepted for consideration. The manuscript should be composed and organized according to the required sequence: Titles, Author names, Affiliations, Email addresses, Abstract, Keywords, Main text, Conclusion, Conflict of Interest, Acknowledgments (if any), References. Although, the main text structure may vary based on the review subtopics, the articles should be formatted according to suitable Templates as research articles.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Khoa học Trường ĐHSP Hà Nội 2 nhằm mục đích cung cấp một nền tảng liên ngành của sự phổ biến những tiến bộ của khoa học và công nghệ. Tạp chí xuất bản các bài báo gốc có giá trị khoa học hoặc công nghệ trong tất cả các lĩnh vực khoa học tự nhiên, xã hội hoặc giáo dục.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Chuyên san Khoa học tự nhiên và công nghệ:\"},{\"insert\":\" Là các bài báo mô tả những phát hiện có giá trị trong vật lý, toán học, hóa học, sinh học; giải quyết các vấn đề kỹ thuật hoặc công nghệ.\"},{\"attributes\":{\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Chuyên san Khoa học Xã hội và Nhân văn:\"},{\"insert\":\" là các bài báo xuất bản chất lượng cao trong các lĩnh vực khác nhau của khoa học xã hội và nghiên cứu phát triển con người.\"},{\"attributes\":{\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Chuyên san Khoa học giáo dục:\"},{\"insert\":\" là các bài báo xuất bản trong lĩnh vực khoa học giáo dục và các ứng dụng của tiến bộ vào giáo dục để cải thiện và nâng cao giáo dục khoa học ở tất cả các cấp.\"},{\"attributes\":{\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí trường ĐHSP Hà Nội 2 xuất bản được phản biện kín, xét duyệt bởi ít nhất 02 chuyên gia, và được đánh giá, chọn lựa từ ban biên tập và Tổng biên tập.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Các loại bài báo\"},{\"insert\":\":\\nBài báo nghiên cứu:\"},{\"attributes\":{\"list\":\"ordered\"},\"insert\":\"\\n\"},{\"insert\":\"Báo cáo học thuật về nghiên cứu ban đầu chưa từng được xuất bản ở bất kỳ nơi nào, hay bằng bất kỳ ngôn ngữ nào khác. Bản thảo thích hợp, nên chứa các phần sau theo thứ tự: Tiêu đề, Tác giả, Liên kết tác giả, Địa chỉ email của tác giả tương ứng, Tóm tắt, Từ khóa, Danh pháp (nếu có), Giới thiệu, Thử nghiệm, Lý thuyết, Kết quả và thảo luận, Kết luận, Xung đột quan tâm, Lời cảm ơn (nếu có), Tài liệu tham khảo, Phụ lục (nếu có). Bản xuất bản trước phải được định dạng theo Mẫu (phiên bản MS-Word).\\n2. Bài báo tổng quan:\\nNgoài các bài phê bình được mời, các bài phê bình tài liệu, bài phê bình có hệ thống và bài phê bình sẽ được chấp nhận để xem xét. Bản thảo cần được soạn thảo và sắp xếp theo trình tự yêu cầu: Tên sách, Tên tác giả, Liên kết, Địa chỉ email, Tóm tắt, Từ khóa, Nội dung chính, Kết luận, Xung đột lợi ích, Lời cảm ơn (nếu có), Tài liệu tham khảo. Mặc dù, cấu trúc văn bản chính có thể thay đổi dựa trên các chủ đề phụ của bài đánh giá, các bài báo nên được định dạng theo các Mẫu phù hợp như các bài báo nghiên cứu.\\n\"}]}",{"VOID":726},"YPoBvsIAAAAJ",[],[],[],"https:\u002F\u002Fsj.hpu2.edu.vn\u002Findex.php\u002Fjournal","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F954132b5-ca74-461c-b819-45ad6e49a404\u002F2790ef1d0a7d7a40a504c2fc1647f670.jpg",{"impactFactor":32,"impactFactorByYear":733,"i10Index":32,"i10IndexLast5Year":32,"totalPublication":329,"totalPublicationByYear":735,"totalCitation":134,"totalCitationByYear":736,"totalCitationPerPublication":524,"totalCitationPerPublicationByYear":737,"hindexLast5Year":123,"hindex":123},{"2024":734},0.17,{"2022":136,"2023":278,"2024":142},{"2022":357,"2023":126,"2024":123},{"2022":169,"2023":224,"2024":165},{"impactFactor":28,"impactFactorByYear":28,"i10Index":45,"i10IndexLast5Year":45,"totalPublication":330,"totalPublicationByYear":739,"totalCitation":154,"totalCitationByYear":740,"totalCitationPerPublication":741,"totalCitationPerPublicationByYear":742,"hindexLast5Year":46,"hindex":46},{"0":123,"2022":134,"2023":136,"2024":69,"2025":145},{"2023":46,"2024":136,"2025":201,"2026":278},1.22,{"2023":113,"2024":340,"2025":743},4.56,{"id":745,"createTime":746,"updateTime":747,"relativeEntities":748,"slug":749,"properties":750,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":69,"subjectFields":762,"manageAffiliations":763,"indexDatabases":771,"url":817,"thumbnailPath":28,"statistic":818,"gsStatistic":850,"type":55,"analyzePriority":28},"21ccdb34-414d-420f-8a60-a592a2fa848e","2023-05-29T10:42:53.358+00:00","2026-08-27T01:57:29.560+00:00",[],"Vietnam-Journal-of-Earth-Sciences",{"country":751,"eissn":752,"issn":754,"title":756,"introduce":758,"gsId":760},{"VOID":15},{"VOID":753},"26159783",{"VOID":755},"08667187",{"EN":757},"Vietnam Journal of Earth Sciences",{"EN":759},"Science of the Earth, formerly Vietnam Journal of Earth Sciences, is a peer-reviewed journal to publish high-quality articles on the entire range of earth sciences and the environment, focused on the Asia Pacific region and their correlations and connections to the globe. The journal publishes fundamental and applied research in earth sciences and the environment, including geology, geophysics, geography, soil science, hydrology, meteorology, oceanography, petroleum, geohazards, environmental sciences, environmental engineering, sustainable development, geoinformatics, geodesy, GIS, and remote sensing.",{"VOID":761},"5htfr3YAAAAJ",[],[764],{"id":73,"createTime":28,"updateTime":28,"relativeEntities":765,"slug":28,"properties":766,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":82,"parentIds":770,"statistic":28},[],{"title":767,"country":768,"abbreviation":769},{"EN":77,"VI":78},{"VOID":15},{"VOID":81},[],[772,789,800],{"id":773,"indexDatabase":774,"url":784,"indexYears":785,"academicFieldIds":786,"indexDatabaseRanking":788},"6ace2085-a177-4a27-b309-8813b832111e",{"id":775,"createTime":28,"updateTime":28,"relativeEntities":776,"label":777,"description":779,"key":781,"publicationTags":782,"standard":28},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9",[],{"EN":778,"VI":778},"Scopus - Elsevier",{"EN":778,"VI":780},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[783],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F21101039869","2018-2024",[787],"1689391c-5702-4349-aaa7-d720ee4321fc","NONE",{"id":790,"indexDatabase":791,"url":796,"indexYears":797,"academicFieldIds":798,"indexDatabaseRanking":28},"dadb15a8-ee22-41c2-a287-49e969d9a998",{"id":88,"createTime":28,"updateTime":28,"relativeEntities":792,"label":793,"description":794,"key":94,"publicationTags":795,"standard":28},[],{"EN":91,"VI":91},{"EN":93,"VI":93},[96],"https:\u002F\u002Fasean-cites.org\u002Fjournal_info?jid=10629","2016-2022",[799],"e04f14cf-280b-4aa8-b711-b77ddd79cbaf",{"id":801,"indexDatabase":802,"url":814,"indexYears":28,"academicFieldIds":815,"indexDatabaseRanking":28},"06f278ee-37b9-41eb-a9b0-3d2d77fa502b",{"id":803,"createTime":28,"updateTime":28,"relativeEntities":804,"label":805,"description":807,"key":810,"publicationTags":811,"standard":28},"88bab0f7-443b-476c-a72a-7fa5222da393",[],{"EN":806,"VI":806},"ISI\u002FESCI  - Emerging Sources Citation Index",{"EN":808,"VI":809},"ESCI database","Cơ sở dữ liệu ESCI","esci",[812,813],"ESCI","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=0866-7187",[816],"0db73426-2364-455f-81a4-efe0f91d712e","https:\u002F\u002Fvjs.ac.vn\u002Findex.php\u002Fjse\u002F",{"impactFactor":32,"impactFactorByYear":819,"i10Index":151,"i10IndexLast5Year":132,"totalPublication":824,"totalPublicationByYear":825,"totalCitation":827,"totalCitationByYear":828,"totalCitationPerPublication":838,"totalCitationPerPublicationByYear":839,"hindexLast5Year":129,"hindex":129},{"2007":513,"2008":513,"2010":513,"2011":107,"2012":513,"2013":513,"2014":317,"2015":107,"2016":54,"2017":168,"2018":222,"2019":820,"2020":821,"2021":371,"2022":445,"2023":822,"2024":823},1.03,1.08,1.49,1.43,1180,{"2000":689,"2001":688,"2002":281,"2003":160,"2004":279,"2005":325,"2006":516,"2007":137,"2008":200,"2009":162,"2010":436,"2011":826,"2012":434,"2013":689,"2014":280,"2015":152,"2016":150,"2017":148,"2018":352,"2019":147,"2020":152,"2021":69,"2022":148,"2023":280,"2024":139,"2025":45},79,2421,{"2000":205,"2001":51,"2002":145,"2003":146,"2004":126,"2005":51,"2006":130,"2007":128,"2008":127,"2009":152,"2010":122,"2011":137,"2012":567,"2013":200,"2014":829,"2015":687,"2016":830,"2017":831,"2018":832,"2019":833,"2020":834,"2021":835,"2022":836,"2023":837,"2024":145,"2025":40},73,197,219,380,281,328,148,183,160,2.05,{"2000":365,"2001":168,"2002":365,"2003":167,"2004":168,"2005":121,"2006":224,"2007":840,"2008":118,"2009":367,"2010":284,"2011":170,"2012":707,"2013":693,"2014":822,"2015":841,"2016":842,"2017":843,"2018":844,"2019":845,"2020":846,"2021":847,"2022":848,"2023":849,"2024":52,"2025":168},0.47,1.91,4.93,7.3,11.52,9.06,7.63,5.1,6.1,3.27,{"impactFactor":28,"impactFactorByYear":28,"i10Index":435,"i10IndexLast5Year":155,"totalPublication":130,"totalPublicationByYear":851,"totalCitation":852,"totalCitationByYear":853,"totalCitationPerPublication":860,"totalCitationPerPublicationByYear":861,"hindexLast5Year":136,"hindex":133},{"1017":40,"2015":40,"2016":123,"2017":42,"2018":42,"2019":40,"2020":45,"2022":123,"2023":123,"2024":40},3528,{"2014":323,"2015":140,"2016":201,"2017":158,"2018":522,"2019":613,"2020":854,"2021":855,"2022":701,"2023":856,"2024":857,"2025":858,"2026":859},280,403,436,525,589,366,176.4,{"2015":140,"2016":862,"2017":134,"2018":352,"2019":613,"2020":159,"2022":863,"2023":864,"2024":857},20.5,212.5,218,{"code":866,"data":867,"meta":28},"SUCCESS",{"id":868,"createTime":869,"updateTime":870,"relativeEntities":871,"slug":872,"properties":873,"entityType":25,"verifyStatus":878,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":879,"manageAffiliations":886,"indexDatabases":894,"url":28,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},"6fc4ba12-0889-45f9-81bc-351a5d75d20f","2023-12-05T06:54:34.655+00:00","2025-11-21T10:05:17.336+00:00",[],"Journal-of-Controlled-Release",{"issn":874,"title":876},{"VOID":875},"01683659",{"EN":877},"Journal of Controlled Release","PENDING",[880],{"id":881,"createTime":28,"updateTime":28,"relativeEntities":882,"label":883,"description":885,"parentId":28,"standard":28,"scholarHubFieldId":28},"988aad6e-c496-4836-b969-f61991a0eed2",[],{"EN":884},"Pharmaceutical Science",{},[887],{"id":888,"createTime":28,"updateTime":28,"relativeEntities":889,"slug":28,"properties":890,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":893,"statistic":28},"c749757b-dddf-4e6f-9697-b9c441adc06c",[],{"title":891},{"EN":892},"Elsevier",[],[895,907],{"id":896,"indexDatabase":897,"url":902,"indexYears":903,"academicFieldIds":904,"indexDatabaseRanking":906},"91fff5e9-b210-4644-8fcd-792286baa1ce",{"id":775,"createTime":28,"updateTime":28,"relativeEntities":898,"label":899,"description":900,"key":781,"publicationTags":901,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],"https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F23010","1984-2025",[905],"6e740848-171b-4f21-8d03-9fed10ed0384","SCOPUS__Q1",{"id":908,"indexDatabase":909,"url":920,"indexYears":28,"academicFieldIds":921,"indexDatabaseRanking":28},"1216cb07-fb40-4e8a-8630-82aed8d753c0",{"id":910,"createTime":28,"updateTime":28,"relativeEntities":911,"label":912,"description":914,"key":917,"publicationTags":918,"standard":28},"a4921856-b128-4d9f-8f1f-e80813d3bbd4",[],{"EN":913,"VI":913},"ISI\u002FSCIE - Science Citation Index Expanded",{"EN":915,"VI":916},"SCIE database","Cơ sở dữ liệu SCIE","scie",[919,813],"SCIE","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=0168-3659",[816,922],"2b943d65-24a8-4546-9232-a1e32c12cb6c",{"meta":924,"data":926},{"total":925},"5761",[927,1067,1230,1377,1514,1565,1977,2131,2283,2410],{"id":928,"createTime":929,"updateTime":930,"relativeEntities":931,"slug":932,"properties":933,"entityType":940,"verifyStatus":26,"verifyTime":930,"verifyNote":941,"languages":28,"translateLanguages":28,"viewCount":32,"primaryUrl":942,"fullTextUrl":28,"authors":943,"publicationType":1025,"publisherRelationship":1026,"citationCount":28,"citationInfo":28,"publishDate":1063,"publishYear":1064,"citationAnalyzeStatus":878,"lastCitationAnalyze":28,"indexDatabases":1065,"openAccess":28,"references":28,"isForceReanalyzing":1066},"0005d231-ccaa-4859-8909-6b1c53fc12dd","2024-01-03T07:44:54.716+00:00","2024-12-15T07:08:45.960+00:00",[],"Glutathione-responsive-nano-vehicles-as-a-promising-platform-for-targeted-intracellular-drug-and-gene-delivery",{"title":934,"references":936,"doi":938},{"EN":935},"Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery",{"VOID":937},"Langer, 1998, Drug delivery and targeting, Nature, 392, 5\nSoppimath, 2001, Biodegradable polymeric nanoparticles as drug delivery devices, J. Control. Release, 70, 1, 10.1016\u002FS0168-3659(00)00339-4\nTorchilin, 2006, Recent approaches to intracellular delivery of drugs and DNA and organelle targeting, Annu. Rev. Biomed. Eng., 8, 343, 10.1146\u002Fannurev.bioeng.8.061505.095735\nNori, 2005, Intracellular targeting of polymer-bound drugs for cancer chemotherapy, Adv. Drug Deliv. Rev., 57, 609, 10.1016\u002Fj.addr.2004.10.006\nRijcken, 2007, Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery, J. Control. Release, 120, 131, 10.1016\u002Fj.jconrel.2007.03.023\nMeng, 2009, Stimuli-responsive polymersomes for programmed drug delivery, Biomacromolecules, 10, 197, 10.1021\u002Fbm801127d\nTorchilin, 2009, Multifunctional and stimuli-sensitive pharmaceutical nanocarriers, Eur. J. Pharm. Biopharm., 71, 431, 10.1016\u002Fj.ejpb.2008.09.026\nSchafer, 2001, Redox environment of the cell as viewed through the redox state of the glutathione disulfide\u002Fglutathione couple, Free Radic. Biol. Med., 30, 1191, 10.1016\u002FS0891-5849(01)00480-4\nWu, 2004, Glutathione metabolism and its implications for health, J. Nutr., 134, 489, 10.1093\u002Fjn\u002F134.3.489\nGo, 2008, Redox compartmentalization in eukaryotic cells, Biochim. Biophys. Acta, 1780, 1273, 10.1016\u002Fj.bbagen.2008.01.011\nArunachalam, 2000, Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT), Proc. Natl Acad. Sci. USA, 97, 745, 10.1073\u002Fpnas.97.2.745\nKurz, 2010, Redox activity within the lysosomal compartment: implications for aging and apoptosis, Antioxid. Redox. Signal., 13, 511, 10.1089\u002Fars.2009.3005\nMeng, 2009, Reduction-sensitive polymers and bioconjugates for biomedical applications, Biomaterials, 30, 2180, 10.1016\u002Fj.biomaterials.2009.01.026\nSaito, 2003, Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities, Adv. Drug Deliv. Rev., 55, 199, 10.1016\u002FS0169-409X(02)00179-5\nKataoka, 2001, Block copolymer micelles for drug delivery: design, characterization and biological significance, Adv. Drug Deliv. Rev., 47, 113, 10.1016\u002FS0169-409X(00)00124-1\nSun, 2009, Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin, Biomaterials, 30, 6358, 10.1016\u002Fj.biomaterials.2009.07.051\nSun, 2010, Shell-sheddable micelles based on dextran-SS–poly(epsilon-caprolactone) diblock copolymer for efficient intracellular release of doxorubicin, Biomacromolecules, 11, 848, 10.1021\u002Fbm1001069\nTang, 2009, Shell-detachable micelles based on disulfide-linked block copolymer as potential carrier for intracellular drug delivery, Bioconjug. Chem., 20, 1095, 10.1021\u002Fbc900144m\nRyu, 2010, Redox-sensitive disassembly of amphiphilic copolymer based micelles, Langmuir, 26, 7086, 10.1021\u002Fla904437u\nSun, 2010, Disassemblable micelles based on reduction-degradable amphiphilic graft copolymers for intracellular delivery of doxorubicin, Biomaterials, 31, 7124, 10.1016\u002Fj.biomaterials.2010.06.011\nFan, 2010, Fabrication of reduction-degradable micelle based on disulfide-linked graft copolymer–camptothecin conjugate for enhancing solubility and stability of camptothecin, Polymer, 51, 5107, 10.1016\u002Fj.polymer.2010.09.004\nKlaikherd, 2009, Multi-stimuli sensitive amphiphilic block copolymer assemblies, J. Am. Chem. Soc., 131, 4830, 10.1021\u002Fja809475a\nMa, 2010, Dual redox responsive assemblies formed from diselenide block copolymers, J. Am. Chem. Soc., 132, 442, 10.1021\u002Fja908124g\nBae, 2008, Stability issues of polymeric micelles, J. Control. Release, 131, 2, 10.1016\u002Fj.jconrel.2008.06.015\nO'Reilly, 2006, Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility, Chem. Soc. Rev., 35, 1068, 10.1039\u002Fb514858h\nKim, 2010, Polymeric micelles with ionic cores containing biodegradable cross-links for delivery of chemotherapeutic agents, Biomacromolecules, 11, 919, 10.1021\u002Fbm9013364\nZhang, 2008, Degradable disulfide core-cross-linked micelles as a drug delivery system prepared from vinyl functionalized nucleosides via the RAFT process, Biomacromolecules, 9, 3321, 10.1021\u002Fbm800867n\nZhang, 2007, Facile fabrication of reversible core cross-linked micelles possessing thermosensitive swellability, Macromolecules, 40, 9125, 10.1021\u002Fma071564r\nJiang, 2009, Degradable thermo responsive core cross-linked micelles: fabrication, surface functionalization, and biorecognition, Langmuir, 25, 13344, 10.1021\u002Fla9034276\nJia, 2008, One-pot conversion of RAFT-generated multifunctional block copolymers of HPMA to doxorubicin conjugated acid- and reductant-sensitive crosslinked micelles, Biomacromolecules, 9, 3106, 10.1021\u002Fbm800657e\nHeffernan, 2009, Disulfide-crosslinked polyion micelles for delivery of protein therapeutics, Ann. Biomed. Eng., 37, 1993, 10.1007\u002Fs10439-009-9734-x\nKoo, 2008, Disulfide-cross-linked PEG-poly(amino acid)s copolymer micelles for glutathione-mediated intracellular drug delivery, Chem. Commun., 6570, 10.1039\u002Fb815918a\nWang, 2010, Core–shell–corona micelle stabilized by reversible cross-linkage for intracellular drug delivery, Macromol. Rapid Commun., 31, 1201, 10.1002\u002Fmarc.200900863\nXu, 2009, Reduction-sensitive reversibly crosslinked biodegradable micelles for triggered release of doxorubicin, Macromol. Biosci., 9, 1254, 10.1002\u002Fmabi.200900233\nKim, 2010, Reduction-sensitive self-aggregates as a novel delivery system, Macromol. Chem. Phys., 211, 956, 10.1002\u002Fmacp.200900671\nZhang, 2010, Rapid release of entrapped contents from multi-functionalizable, surface cross-linked micelles upon different stimulation, J. Am. Chem. Soc., 132, 10642, 10.1021\u002Fja103391k\nXu, 2009, Facile ‘one-pot’ preparation of reversible, disulfide-containing shell cross-linked micelles from a RAFT-synthesized, pH-responsive triblock copolymer in water at room temperature, Aust. J. Chem., 62, 1520, 10.1071\u002FCH09255\nPanyam, 2003, Biodegradable nanoparticles for drug and gene delivery to cells and tissue, Adv. Drug Deliv. Rev., 55, 329, 10.1016\u002FS0169-409X(02)00228-4\nLi, 2009, Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells, Angew. Chem. Int. Ed., 48, 9914, 10.1002\u002Fanie.200904260\nLi, 2009, Synthesis and characterization of thermoresponsive polymers containing reduction-sensitive disulfide linkage, J. Polym. Sci. Polym. Chem., 47, 5989, 10.1002\u002Fpola.23642\nJia, 2009, Functional disulfide-stabilized polymer–protein particles, Biomacromolecules, 10, 10.1021\u002Fbm900817a\nVerheul, 2010, Tailorable thiolated trimethyl chitosans for covalently stabilized nanoparticles, Biomacromolecules, 11, 1965, 10.1021\u002Fbm1002784\nLiu, 2008, Tunable redox-responsive hybrid nanogated ensembles, J. Am. Chem. Soc., 130, 14418, 10.1021\u002Fja8060886\nLiu, 2009, Multiresponsive supramolecular nanogated ensembles, J. Am. Chem. Soc., 131, 15128, 10.1021\u002Fja905288m\nMortera, 2009, Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system, Chem. Commun., 3219, 10.1039\u002Fb900559e\nSauer, 2010, Role of endosomal escape for disulfide-based drug delivery from colloidal mesoporous silica evaluated by live-cell imaging, Nano Lett., 10, 3684, 10.1021\u002Fnl102180s\nDe Geest, 2007, Release mechanisms for polyelectrolyte capsules, Chem. Soc. Rev., 36, 636, 10.1039\u002FB600460C\nSukhorukov, 2005, Nanoengineered polymer capsules: tools for detection, controlled delivery, and site-specific manipulation, Small, 1, 194, 10.1002\u002Fsmll.200400075\nJohnston, 2006, Layer-by-layer engineered capsules and their applications, Curr. Opin. Colloid Interface Sci., 11, 203, 10.1016\u002Fj.cocis.2006.05.001\nZelikin, 2006, Disulfide cross-linked polymer capsules: en route to biodeconstructible systems, Biomacromolecules, 7, 27, 10.1021\u002Fbm050832v\nZelikin, 2008, Disulfide-stabilized poly(methacrylic acid) capsules: formation, cross-linking, and degradation behavior, Chem. Mater., 20, 2655, 10.1021\u002Fcm703403p\nChong, 2009, A paradigm for peptide vaccine delivery using viral epitopes encapsulated in degradable polymer hydrogel capsules, Biomaterials, 30, 5178, 10.1016\u002Fj.biomaterials.2009.05.078\nDe Rose, 2008, Binding, internalization, and antigen presentation of vaccine-loaded nanoengineered capsules in blood, Adv. Mater., 20, 4698, 10.1002\u002Fadma.200801826\nSexton, 2009, A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules, ACS Nano, 3, 3391, 10.1021\u002Fnn900715g\nSivakumar, 2009, Degradable, surfactant-free, monodisperse polymer-encapsulated emulsions as anticancer drug carriers, Adv. Mater., 21, 1820, 10.1002\u002Fadma.200802475\nYan, 2010, Uptake and intracellular fate of disulfide-bonded polymer hydrogel capsules for doxorubicin delivery to colorectal cancer cells, ACS Nano, 4, 2928, 10.1021\u002Fnn100173h\nChong, 2009, Stabilization of polymer-hydrogel capsules via thiol–disulfide exchange, Small, 5, 2601, 10.1002\u002Fsmll.200900906\nKim, 2010, Facile, template-free synthesis of stimuli-responsive polymer nanocapsules for targeted drug delivery, Angew. Chem. Int. Ed., 49, 4405, 10.1002\u002Fanie.201000818\nShu, 2010, Gradient cross-linked biodegradable polyelectrolyte nanocapsules for intracellular protein drug delivery, Biomaterials, 31, 6039, 10.1016\u002Fj.biomaterials.2010.04.016\nDischer, 2006, Polymersomes, Annu. Rev. Biomed. Eng., 8, 323, 10.1146\u002Fannurev.bioeng.8.061505.095838\nLoPresti, 2009, Polymersomes: nature inspired nanometer sized compartments, J. Mater. Chem., 19, 3576, 10.1039\u002Fb818869f\nLiu, 2010, The highly efficient delivery of exogenous proteins into cells mediated by biodegradable chimaeric polymersomes, Biomaterials, 31, 7575, 10.1016\u002Fj.biomaterials.2010.06.021\nLi, 2009, Stimuli-responsive polymer vesicles, Soft Matter, 5, 927, 10.1039\u002Fb815725a\nChristian, 2009, Polymersome carriers: from self-assembly to siRNA and protein therapeutics, Eur. J. Pharm. Biopharm., 71, 463, 10.1016\u002Fj.ejpb.2008.09.025\nXu, 2009, Reversibly crosslinked temperature-responsive nano-sized polymersomes: synthesis and triggered drug release, J. Mater. Chem., 19, 4183, 10.1039\u002Fb901141b\nvan Hell, 2009, Stabilization of peptide vesicles by introducing inter-peptide disulfide bonds, Pharm. Res., 26, 2186, 10.1007\u002Fs11095-009-9933-z\nvan Hell, 2010, Peptide nanocarriers for intracellular delivery of photosensitizers, J. Control. Release, 141, 347, 10.1016\u002Fj.jconrel.2009.09.012\nPark, 2010, Reduction-sensitive, robust vesicles with a non-covalently modifiable surface as a multifunctional drug-delivery platform, Small, 6, 1430, 10.1002\u002Fsmll.201000293\nOh, 2008, The development of microgels\u002Fnanogels for drug delivery applications, Prog. Polym. Sci., 33, 448, 10.1016\u002Fj.progpolymsci.2008.01.002\nKabanov, 2009, Nanogels as pharmaceutical carriers: finite networks of infinite capabilities, Angew. Chem. Int. Ed., 48, 5418, 10.1002\u002Fanie.200900441\nOh, 2006, Inverse miniemulsion ATRP: a new method for synthesis and functionalization of well-defined water-soluble\u002Fcross-linked polymeric particles, J. Am. Chem. Soc., 128, 5578, 10.1021\u002Fja060586a\nOh, 2009, Atom transfer radical polymerization in inverse miniemulsion: a versatile route toward preparation and functionalization of microgels\u002Fnanogels for targeted drug delivery applications, Polymer, 50, 4407, 10.1016\u002Fj.polymer.2009.06.045\nOh, 2007, Synthesis and biodegradation of nanogels as delivery carriers for carbohydrate drugs, Biomacromolecules, 8, 3326, 10.1021\u002Fbm070381+\nOh, 2007, Biodegradable nanogels prepared by atom transfer radical polymerization as potential drug delivery carriers: synthesis, biodegradation, in vitro release, and bioconjugation, J. Am. Chem. Soc., 129, 5939, 10.1021\u002Fja069150l\nYap, 2009, Click-engineered, bioresponsive, drug-loaded PEG spheres, Adv. Mater., 21, 4348, 10.1002\u002Fadma.200900421\nGroll, 2009, Biocompatible and degradable nanogels via oxidation reactions of synthetic thiomers in inverse miniemulsion, J. Polym. Sci. Polym. Chem., 47, 5543, 10.1002\u002Fpola.23595\nNavath, 2008, Dendrimer–drug conjugates for tailored intracellular drug release based on glutathione levels, Bioconjug. Chem., 19, 2446, 10.1021\u002Fbc800342d\nKurtoglu, 2009, Poly(amidoamine) dendrimer–drug conjugates with disulfide linkages for intracellular drug delivery, Biomaterials, 30, 2112, 10.1016\u002Fj.biomaterials.2008.12.054\nNavath, 2010, Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammation, J. Control. Release, 142, 447, 10.1016\u002Fj.jconrel.2009.10.035\nWilliams, 2009, Synthesis and characterization of poly(ethylene glycol)–glutathione conjugate self-assembled nanoparticles for antioxidant delivery, Biomacromolecules, 10, 155, 10.1021\u002Fbm801058j\nHamilton, 2009, Molecular dendritic transporter nanoparticle vectors provide efficient intracellular delivery of peptides, ACS Nano, 3, 402, 10.1021\u002Fnn800679z\nGunaseelan, 2009, Multimeric peptide-based PEG nanocarriers with programmable elimination properties, Biomaterials, 30, 5649, 10.1016\u002Fj.biomaterials.2009.05.068\nLiu, 2010, A simple methodology for the synthesis of heterotelechelic protein–polymer–biomolecule conjugates, J. Polym. Sci. Polym. Chem., 48, 1399, 10.1002\u002Fpola.23902\nLim, 2009, Design, synthesis, characterization, and biological evaluation of triazine dendrimers bearing paclitaxel using ester and ester\u002Fdisulfide linkages, Bioconjug. Chem., 20, 2154, 10.1021\u002Fbc900324z\nBauhuber, 2009, Delivery of nucleic acids via disulfide-based carrier systems, Adv. Mater., 21, 3286, 10.1002\u002Fadma.200802453\nCandiani, 2010, Bioreducible liposomes for gene delivery: from the formulation to the mechanism of action, PLoS ONE, 5, e13430, 10.1371\u002Fjournal.pone.0013430\nWon, 2010, Reducible poly(oligo-d-arginine) for enhanced gene expression in mouse lung by intratracheal injection, Mol. Ther., 18, 734, 10.1038\u002Fmt.2009.297\nLin, 2007, Novel bioreducible poly(amido amine)s for highly efficient gene delivery, Bioconjug. Chem., 18, 138, 10.1021\u002Fbc060200l\nJeong, 2007, Reducible poly(amido ethylenimine) directed to enhance RNA interference, Biomaterials, 28, 1912, 10.1016\u002Fj.biomaterials.2006.12.019\nKim, 2009, Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems, Biomaterials, 30, 658, 10.1016\u002Fj.biomaterials.2008.10.009\nChristensen, 2006, Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery, Bioconjug. Chem., 17, 1233, 10.1021\u002Fbc0602026\nLiu, 2010, Novel reduction-responsive cross-linked polyethylenimine derivatives by click chemistry for nonviral gene delivery, Bioconjug. Chem., 21, 1827, 10.1021\u002Fbc100191r\nBreunig, 2007, Breaking up the correlation between efficacy and toxicity for nonviral gene delivery, Proc. Natl Acad. Sci. USA, 104, 14454, 10.1073\u002Fpnas.0703882104\nYou, 2007, Reducible poly(2-dimethylaminoethyl methaerylate): synthesis, cytotoxicity, and gene delivery activity, J. Control. Release, 122, 217, 10.1016\u002Fj.jconrel.2007.04.020\nTakemoto, 2010, Polyion complex stability and gene silencing efficiency with a siRNA-grafted polymer delivery system, Biomaterials, 31, 8097, 10.1016\u002Fj.biomaterials.2010.07.015\nJung, 2010, Gene silencing efficiency of siRNA-PEG conjugates: effect of PEGylation site and PEG molecular weight, J. Control. Release, 144, 306, 10.1016\u002Fj.jconrel.2010.03.002\nMok, 2010, Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing, Nat. Mater., 9, 272, 10.1038\u002Fnmat2626\nLee, 2010, Stability and cellular uptake of polymerized siRNA (poly-siRNA)\u002Fpolyethylenimine (PEI) complexes for efficient gene silencing, J. Control. Release, 141, 339, 10.1016\u002Fj.jconrel.2009.10.007\nYang, 2006, Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging, Proc. Natl Acad. Sci. USA, 103, 13872, 10.1073\u002Fpnas.0601455103\nCollins, 1991, Reduction of disulfide bonds within lysosomes is a key step in antigen processing, J. Immunol., 147, 4054, 10.4049\u002Fjimmunol.147.12.4054\nAubry, 2009, Cell-surface thiols affect cell entry of disulfide-conjugated peptides, FASEB J., 23, 2956, 10.1096\u002Ffj.08-127563\nJiang, 2010, Stepwise cleavable star polymers and polymeric gels thereof, Macromolecules, 43, 7056, 10.1021\u002Fma101460n\nLiu, 2008, An approach to biodegradable star polymeric architectures using disulfide coupling, Chem. Commun., 6582, 10.1039\u002Fb817037a\nde Paz, 2010, Glutathione-mediated biodegradable polyurethanes derived from L-arabinitol, Biomacromolecules, 11, 269, 10.1021\u002Fbm9011216\nDewit, 2010, A reduction sensitive cascade biodegradable linear polymer, J. Polym. Sci. Polym. Chem., 48, 3977, 10.1002\u002Fpola.24180",{"VOID":939},"10.1016\u002Fj.jconrel.2011.01.030","PUBLICATION","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0168365911000368",[944,960,973,986,999,1012],{"id":945,"sortIndex":32,"researcher":28,"roles":946,"affiliations":948,"properties":957},"77826382-64c1-4f7f-b004-dcae808bcbe6",[947],"AUTHOR",[949],{"id":950,"sortIndex":32,"affiliation":951,"properties":28},"24f006fc-d166-45fa-9934-17b9fe4d1434",{"id":950,"createTime":28,"updateTime":28,"relativeEntities":952,"slug":28,"properties":953,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":956,"statistic":28},[],{"title":954},{"VI":955},"Biomedical Polymers Laboratory, and Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, PR China",[],{"title":958},{"VI":959},"Ru Cheng",{"id":961,"sortIndex":40,"researcher":28,"roles":962,"affiliations":963,"properties":970},"a0856cee-d290-4311-a446-01cc6f66b91e",[947],[964],{"id":950,"sortIndex":32,"affiliation":965,"properties":28},{"id":950,"createTime":28,"updateTime":28,"relativeEntities":966,"slug":28,"properties":967,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":969,"statistic":28},[],{"title":968},{"VI":955},[],{"title":971},{"VI":972},"Fang Feng",{"id":974,"sortIndex":123,"researcher":28,"roles":975,"affiliations":976,"properties":983},"62d5e111-e01a-4370-a60e-33ed3d1785ca",[947],[977],{"id":950,"sortIndex":32,"affiliation":978,"properties":28},{"id":950,"createTime":28,"updateTime":28,"relativeEntities":979,"slug":28,"properties":980,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":982,"statistic":28},[],{"title":981},{"VI":955},[],{"title":984},{"VI":985},"Fenghua Meng",{"id":987,"sortIndex":42,"researcher":28,"roles":988,"affiliations":989,"properties":996},"a2746fe8-dd99-40b6-b98a-8f3963bd97ae",[947],[990],{"id":950,"sortIndex":32,"affiliation":991,"properties":28},{"id":950,"createTime":28,"updateTime":28,"relativeEntities":992,"slug":28,"properties":993,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":995,"statistic":28},[],{"title":994},{"VI":955},[],{"title":997},{"VI":998},"Chao Deng",{"id":1000,"sortIndex":45,"researcher":28,"roles":1001,"affiliations":1002,"properties":1009},"756ec248-4ce3-465c-b1ec-59087b3742c1",[947],[1003],{"id":950,"sortIndex":32,"affiliation":1004,"properties":28},{"id":950,"createTime":28,"updateTime":28,"relativeEntities":1005,"slug":28,"properties":1006,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1008,"statistic":28},[],{"title":1007},{"VI":955},[],{"title":1010},{"VI":1011},"Jan Feijen",{"id":1013,"sortIndex":46,"researcher":28,"roles":1014,"affiliations":1015,"properties":1022},"f2b5f343-59a2-4010-9950-1c83d6ac313a",[947],[1016],{"id":950,"sortIndex":32,"affiliation":1017,"properties":28},{"id":950,"createTime":28,"updateTime":28,"relativeEntities":1018,"slug":28,"properties":1019,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1021,"statistic":28},[],{"title":1020},{"VI":955},[],{"title":1023},{"VI":1024},"Zhiyuan Zhong","ARTICLE",{"url":942,"publisher":1027,"properties":1058},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":1028,"slug":872,"properties":1029,"entityType":25,"verifyStatus":878,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":1032,"manageAffiliations":1037,"indexDatabases":1043,"url":28,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":1030,"title":1031},{"VOID":875},{"EN":877},[1033],{"id":881,"createTime":28,"updateTime":28,"relativeEntities":1034,"label":1035,"description":1036,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":884},{},[1038],{"id":888,"createTime":28,"updateTime":28,"relativeEntities":1039,"slug":28,"properties":1040,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1042,"statistic":28},[],{"title":1041},{"EN":892},[],[1044,1051],{"id":896,"indexDatabase":1045,"url":902,"indexYears":903,"academicFieldIds":1050,"indexDatabaseRanking":906},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":1046,"label":1047,"description":1048,"key":781,"publicationTags":1049,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[905],{"id":908,"indexDatabase":1052,"url":920,"indexYears":28,"academicFieldIds":1057,"indexDatabaseRanking":28},{"id":910,"createTime":28,"updateTime":28,"relativeEntities":1053,"label":1054,"description":1055,"key":917,"publicationTags":1056,"standard":28},[],{"EN":913,"VI":913},{"EN":915,"VI":916},[919,813],[816,922],{"pages":1059,"volume":1061},{"VOID":1060},"2-12",{"VOID":1062},"152","2011-05-01",2011,[919,906],false,{"id":1068,"createTime":1069,"updateTime":1070,"relativeEntities":1071,"slug":1072,"properties":1073,"entityType":940,"verifyStatus":26,"verifyTime":1070,"verifyNote":941,"languages":28,"translateLanguages":28,"viewCount":32,"primaryUrl":1080,"fullTextUrl":28,"authors":1081,"publicationType":1025,"publisherRelationship":1190,"citationCount":28,"citationInfo":28,"publishDate":1227,"publishYear":1228,"citationAnalyzeStatus":878,"lastCitationAnalyze":28,"indexDatabases":1229,"openAccess":28,"references":28,"isForceReanalyzing":1066},"000e6c18-0319-4aad-a4bd-5551c34aeb11","2024-02-13T23:14:53.731+00:00","2025-01-30T10:24:07.162+00:00",[],"-Cytokine-microfactories-recruit-DCs-and-deliver-tumor-antigens-via-gap-junctions-for-immunotherapy",{"title":1074,"references":1076,"doi":1078},{"EN":1075},"“Cytokine-microfactories” recruit DCs and deliver tumor antigens via gap junctions for immunotherapy",{"VOID":1077},"Irvine, 2020, Enhancing cancer immunotherapy with nanomedicine, Nat. Rev. Immunol., 20, 321, 10.1038\u002Fs41577-019-0269-6\nRiley, 2019, Delivery technologies for cancer immunotherapy, Nat. Rev. Drug Discov., 18, 175, 10.1038\u002Fs41573-018-0006-z\nMartin, 2020, Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges, Nat. Rev. Clin. Oncol., 17, 251, 10.1038\u002Fs41571-019-0308-z\nWagner, 2020, CAR T cell therapy for solid tumors: bright future or dark reality?, Mol. Ther., 28, 2320, 10.1016\u002Fj.ymthe.2020.09.015\nLong, 2018, CAR T cell therapy of non-hematopoietic malignancies: detours on the road to clinical success, Front. Immunol., 9, 2740, 10.3389\u002Ffimmu.2018.02740\nAnderson, 2017, Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies, Cancer Cell, 31, 311, 10.1016\u002Fj.ccell.2017.02.008\nBoks, 2012, IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction--a comparative study of human clinical-applicable DC, Clin. Immunol., 142, 332, 10.1016\u002Fj.clim.2011.11.011\nSriram, 2007, IL-4 suppresses dendritic cell response to type I interferons, J. Immunol., 179, 6446, 10.4049\u002Fjimmunol.179.10.6446\nWebb, 2007, Comparative roles of IL-4, IL-13, and IL-4Ralpha in dendritic cell maturation and CD4+ Th2 cell function, J. Immunol., 178, 219, 10.4049\u002Fjimmunol.178.1.219\nKobie, 2003, Transforming growth factor beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines, Cancer Res., 63, 1860\nDeNardo, 2019, Macrophages as regulators of tumour immunity and immunotherapy, Nat. Rev. Immunol., 19, 369, 10.1038\u002Fs41577-019-0127-6\nNoy, 2014, Tumor-associated macrophages: from mechanisms to therapy, Immunity, 41, 49, 10.1016\u002Fj.immuni.2014.06.010\nYoshimura, 2018, The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally, Cell. Mol. Immunol., 15, 335, 10.1038\u002Fcmi.2017.135\nGuo, 2019, Lipopolysaccharide-anchored macrophages hijack tumor microtube networks for selective drug transport and augmentation of antitumor effects in orthotopic lung cancer, Theranostics, 9, 6936, 10.7150\u002Fthno.37380\nGuo, 2019, Tunneling nanotubular expressways for ultrafast and accurate M1 macrophage delivery of anticancer drugs to metastatic ovarian carcinoma, ACS Nano, 13, 1078\nKlichinsky, 2020, Human chimeric antigen receptor macrophages for cancer immunotherapy, Nat. Biotechnol., 38, 947, 10.1038\u002Fs41587-020-0462-y\nGonzalez, 2018, Roles of the immune system in cancer: from tumor initiation to metastatic progression, Genes Dev., 32, 1267, 10.1101\u002Fgad.314617.118\nMpekris, 2020, Combining microenvironment normalization strategies to improve cancer immunotherapy, Proc. Natl. Acad. Sci. U. S. A., 117, 3728, 10.1073\u002Fpnas.1919764117\nShi, 2019, Combining nanomedicine and immunotherapy, Acc. Chem. Res., 52, 1543, 10.1021\u002Facs.accounts.9b00148\nZanganeh, 2016, Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues, Nat. Nanotechnol., 11, 986, 10.1038\u002Fnnano.2016.168\nGuo, 2020, Engineering microglia as intraoperative optical imaging agent vehicles potentially for fluorescence-guided surgery in gliomas, Biomater. Sci., 8, 1117, 10.1039\u002FC9BM01388A\nGonzález, 2014, Tumor cell lysates as immunogenic sources for cancer vaccine design, Hum. Vaccines Immunother., 10, 3261, 10.4161\u002F21645515.2014.982996\nHuang, 2016, Does lipopolysaccharide-mediated inflammation have a role in OA?, Nat. Rev. Rheumatol., 12, 123, 10.1038\u002Fnrrheum.2015.158\nDadfar, 2019, Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications, Adv. Drug Deliv. Rev., 138, 302, 10.1016\u002Fj.addr.2019.01.005\nSabado, 2017, Dendritic cell-based immunotherapy, Cell Res., 27, 74, 10.1038\u002Fcr.2016.157\nSchenkel, 2014, T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses, Science (New York, N.Y.), 346, 98, 10.1126\u002Fscience.1254536\nSchaller, 2017, Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3, Expert. Rev. Clin. Immunol., 13, 1049, 10.1080\u002F1744666X.2017.1384313\nGenard, 2017, Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo- and immunotherapies, Front. Immunol., 8, 828, 10.3389\u002Ffimmu.2017.00828\nDamsky, 2014, Melanoma metastasis: new concepts and evolving paradigms, Oncogene, 33, 2413, 10.1038\u002Fonc.2013.194\nDhodapkar, 2005, Recruiting dendritic cells to improve antibody therapy of cancer, Proc. Natl. Acad. Sci. U. S. A., 102, 6243, 10.1073\u002Fpnas.0502547102\nWu, 2018, Critical role of integrin CD11c in splenic dendritic cell capture of missing-self CD47 cells to induce adaptive immunity, Proc. Natl. Acad. Sci. U. S. A., 115, 6786, 10.1073\u002Fpnas.1805542115\nWculek, 2020, Dendritic cells in cancer immunology and immunotherapy, Nat. Rev. Immunol., 20, 7, 10.1038\u002Fs41577-019-0210-z\nMcCoy-Simandle, 2016, Exosomes and nanotubes: control of immune cell communication, Int. J. Biochem. Cell Biol., 71, 44, 10.1016\u002Fj.biocel.2015.12.006\nBarros, 2018, Exosomes and immune response in cancer: friends or foes?, Front. Immunol., 9, 730, 10.3389\u002Ffimmu.2018.00730\nDupont, 2018, Tunneling nanotubes: intimate communication between myeloid cells, Front. Immunol., 9, 43, 10.3389\u002Ffimmu.2018.00043\nGleisner, 2017, Mind the gaps in tumor immunity: impact of connexin-mediated intercellular connections, Front. Immunol., 8, 1067, 10.3389\u002Ffimmu.2017.01067\nShin, 2006, Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination, Nature, 444, 115, 10.1038\u002Fnature05261\nTai, 2018, Molecular mechanisms of T cells activation by dendritic cells in autoimmune diseases, Front. Pharmacol., 9, 642, 10.3389\u002Ffphar.2018.00642\nRiabov, 2014, Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis, Front. Physiol., 5, 75, 10.3389\u002Ffphys.2014.00075\nNiu, 2017, Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs, Nat. Commun., 8, 766, 10.1038\u002Fs41467-017-00523-6\nDiem, 2016, Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma, Br. J. Cancer, 114, 256, 10.1038\u002Fbjc.2015.467\nTang, 2018, Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery, Nat. Biotechnol., 36, 707, 10.1038\u002Fnbt.4181\nKreiter, 2015, Mutant MHC class II epitopes drive therapeutic immune responses to cancer, Nature, 520, 692, 10.1038\u002Fnature14426\nAlspach, 2019, MHC-II neoantigens shape tumour immunity and response to immunotherapy, Nature, 574, 696, 10.1038\u002Fs41586-019-1671-8",{"VOID":1079},"10.1016\u002Fj.jconrel.2021.07.040","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0168365921003837",[1082,1097,1110,1123,1136,1149,1164,1177],{"id":1083,"sortIndex":32,"researcher":28,"roles":1084,"affiliations":1085,"properties":1094},"4c4b8956-4102-4c03-8f92-51eb6ad22086",[947],[1086],{"id":1087,"sortIndex":32,"affiliation":1088,"properties":28},"37fad1c1-0645-4b60-a91c-38cb0a1e91bf",{"id":1087,"createTime":28,"updateTime":28,"relativeEntities":1089,"slug":28,"properties":1090,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1093,"statistic":28},[],{"title":1091},{"VI":1092},"School of Pharmaceutical Sciences, Sun Yat-sen University, University Town, Guangzhou 510006, PR China",[],{"title":1095},{"VI":1096},"Ling Guo",{"id":1098,"sortIndex":40,"researcher":28,"roles":1099,"affiliations":1100,"properties":1107},"4126aed0-afea-4ff5-9fc8-0cb1d76c874b",[947],[1101],{"id":1087,"sortIndex":32,"affiliation":1102,"properties":28},{"id":1087,"createTime":28,"updateTime":28,"relativeEntities":1103,"slug":28,"properties":1104,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1106,"statistic":28},[],{"title":1105},{"VI":1092},[],{"title":1108},{"VI":1109},"Run-Xiu Wei",{"id":1111,"sortIndex":123,"researcher":28,"roles":1112,"affiliations":1113,"properties":1120},"02345315-7a40-4864-88b4-111eeedd50d7",[947],[1114],{"id":1087,"sortIndex":32,"affiliation":1115,"properties":28},{"id":1087,"createTime":28,"updateTime":28,"relativeEntities":1116,"slug":28,"properties":1117,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1119,"statistic":28},[],{"title":1118},{"VI":1092},[],{"title":1121},{"VI":1122},"Ran Sun",{"id":1124,"sortIndex":42,"researcher":28,"roles":1125,"affiliations":1126,"properties":1133},"f75951b2-62ee-4e9f-9416-a18110161a2d",[947],[1127],{"id":1087,"sortIndex":32,"affiliation":1128,"properties":28},{"id":1087,"createTime":28,"updateTime":28,"relativeEntities":1129,"slug":28,"properties":1130,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1132,"statistic":28},[],{"title":1131},{"VI":1092},[],{"title":1134},{"VI":1135},"Qiang Yang",{"id":1137,"sortIndex":45,"researcher":28,"roles":1138,"affiliations":1139,"properties":1146},"01a83d5b-8f5e-4497-8021-e0c52957bc32",[947],[1140],{"id":1087,"sortIndex":32,"affiliation":1141,"properties":28},{"id":1087,"createTime":28,"updateTime":28,"relativeEntities":1142,"slug":28,"properties":1143,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1145,"statistic":28},[],{"title":1144},{"VI":1092},[],{"title":1147},{"VI":1148},"Gao-Jie Li",{"id":1150,"sortIndex":46,"researcher":28,"roles":1151,"affiliations":1152,"properties":1161},"55883fb4-039e-4c58-941f-bce5fea24a93",[947],[1153],{"id":1154,"sortIndex":32,"affiliation":1155,"properties":28},"c3e22ed0-414c-4897-aba7-0118c5f8a955",{"id":1154,"createTime":28,"updateTime":28,"relativeEntities":1156,"slug":28,"properties":1157,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1160,"statistic":28},[],{"title":1158},{"VI":1159},"Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, PR China",[],{"title":1162},{"VI":1163},"Ling-Yun Wang",{"id":1165,"sortIndex":48,"researcher":28,"roles":1166,"affiliations":1167,"properties":1174},"50474ae2-d40c-454c-824b-e19aca535322",[947],[1168],{"id":1087,"sortIndex":32,"affiliation":1169,"properties":28},{"id":1087,"createTime":28,"updateTime":28,"relativeEntities":1170,"slug":28,"properties":1171,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1173,"statistic":28},[],{"title":1172},{"VI":1092},[],{"title":1175},{"VI":1176},"Hai-Bin Luo",{"id":1178,"sortIndex":49,"researcher":28,"roles":1179,"affiliations":1180,"properties":1187},"c9361bb2-24bf-4b55-b332-c44ab4b4be4b",[947],[1181],{"id":1087,"sortIndex":32,"affiliation":1182,"properties":28},{"id":1087,"createTime":28,"updateTime":28,"relativeEntities":1183,"slug":28,"properties":1184,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1186,"statistic":28},[],{"title":1185},{"VI":1092},[],{"title":1188},{"VI":1189},"Min Feng",{"url":1080,"publisher":1191,"properties":1222},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":1192,"slug":872,"properties":1193,"entityType":25,"verifyStatus":878,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":1196,"manageAffiliations":1201,"indexDatabases":1207,"url":28,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":1194,"title":1195},{"VOID":875},{"EN":877},[1197],{"id":881,"createTime":28,"updateTime":28,"relativeEntities":1198,"label":1199,"description":1200,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":884},{},[1202],{"id":888,"createTime":28,"updateTime":28,"relativeEntities":1203,"slug":28,"properties":1204,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1206,"statistic":28},[],{"title":1205},{"EN":892},[],[1208,1215],{"id":896,"indexDatabase":1209,"url":902,"indexYears":903,"academicFieldIds":1214,"indexDatabaseRanking":906},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":1210,"label":1211,"description":1212,"key":781,"publicationTags":1213,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[905],{"id":908,"indexDatabase":1216,"url":920,"indexYears":28,"academicFieldIds":1221,"indexDatabaseRanking":28},{"id":910,"createTime":28,"updateTime":28,"relativeEntities":1217,"label":1218,"description":1219,"key":917,"publicationTags":1220,"standard":28},[],{"EN":913,"VI":913},{"EN":915,"VI":916},[919,813],[816,922],{"pages":1223,"volume":1225},{"VOID":1224},"417-430",{"VOID":1226},"337","2021-09-01",2021,[919,906],{"id":1231,"createTime":1232,"updateTime":1233,"relativeEntities":1234,"slug":1235,"properties":1236,"entityType":940,"verifyStatus":26,"verifyTime":1233,"verifyNote":941,"languages":28,"translateLanguages":28,"viewCount":32,"primaryUrl":1243,"fullTextUrl":28,"authors":1244,"publicationType":1025,"publisherRelationship":1338,"citationCount":28,"citationInfo":28,"publishDate":1375,"publishYear":1228,"citationAnalyzeStatus":878,"lastCitationAnalyze":28,"indexDatabases":1376,"openAccess":28,"references":28,"isForceReanalyzing":1066},"00297c74-3a1c-46da-a026-ea1a5daf7210","2023-12-29T23:46:22.650+00:00","2025-01-22T19:25:25.513+00:00",[],"Current-trends-in-smart-mesoporous-silica-based-nanovehicles-for-photoactivated-cancer-therapy",{"title":1237,"references":1239,"doi":1241},{"EN":1238},"Current trends in smart mesoporous silica-based nanovehicles for photoactivated cancer therapy",{"VOID":1240},"Buchholz, 2015, Surgical considerations after neoadjuvant chemotherapy: breast conservation therapy, J. Natl. Cancer I, 51, 11\nZajda, 2021, Methodology for characterization of platinum-based drug's targeted delivery nanosystems, J. Control. Release, 335, 178, 10.1016\u002Fj.jconrel.2021.05.022\nLi, 2020, Clinical development and potential of photothermal and photodynamic therapies for cancer, Nat. Rev. Clin. Oncol., 17, 657, 10.1038\u002Fs41571-020-0410-2\nWang, 2020, Near-infrared photoresponsive drug delivery nanosystems for cancer photo-chemotherapy, J. Nanobiotechnol., 18, 108, 10.1186\u002Fs12951-020-00668-5\nYang, 2019, Optically active nanomaterials for bioimaging and targeted therapy, Front. Bioeng. Biotech., 7, 320, 10.3389\u002Ffbioe.2019.00320\nLi, 2020, Mesoporous carbon-manganese nanocomposite for multiple imaging guided oxygen-elevated synergetic therapy, J. Control. Release, 319, 104, 10.1016\u002Fj.jconrel.2019.12.042\nLiu, 2019, Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer, Chem. Soc. Rev., 48, 2053, 10.1039\u002FC8CS00618K\nKhot, 2019, A review on the scope of photothermal therapy-based nanomedicines in preclinical models of colorectal cancer, Clin. Colorectal Cancer, 18, 200, 10.1016\u002Fj.clcc.2019.02.001\nHuo, 2021, Emerging photothermal-derived multimodal synergistic therapy in combating bacterial infections, Chem. Soc. Rev., 50, 8762, 10.1039\u002FD1CS00074H\nLi, 2020, Advanced fluorescence imaging technology in the near-infrared-II window for biomedical applications, J. Am. Chem. Soc., 142, 14789, 10.1021\u002Fjacs.0c07022\nYoo, 2012, New insights into the mechanisms for photodynamic therapy-induced cancer cell death, Int. Rev. Cell Mol. Biol., 295, 139, 10.1016\u002FB978-0-12-394306-4.00010-1\nMochizuki, 2021, Development of non-porous silica nanoparticles towards cancer photo-theranostics, Biomedicines, 9, 73, 10.3390\u002Fbiomedicines9010073\nCouleaud, 2010, Silica-based nanoparticles for photodynamic therapy applications, Nanoscale, 2, 1083, 10.1039\u002Fc0nr00096e\nStapleton, 2017, Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery, Adv. Drug Deliv. Rev., 109, 119, 10.1016\u002Fj.addr.2016.05.021\nChen, 2016, Intelligent albumin-MnO2 nanoparticles as pH-\u002FH2O2-responsive dissociable nanocarriers to modulate tumor hypoxia for effective combination therapy, Adv. Mater., 28, 7129, 10.1002\u002Fadma.201601902\nZhang, 2016, Polymeric prodrug grafted hollow mesoporous silica nanoparticles encapsulating near-infrared absorbing dye for potent combined photothermal-chemotherapy, ACS Appl. Mater. Interfaces, 8, 6869, 10.1021\u002Facsami.6b00376\nLv, 2021, Yolk-shell structured Au nanorods@mesoporous silica for gas bubble driven drug release upon near-infrared light irradiation, Nanomed. Nanotechnol., 32, 102326, 10.1016\u002Fj.nano.2020.102326\nChen, 2016, Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy, Nat. Commun., 7, 13193, 10.1038\u002Fncomms13193\nDing, 2020, Polydopamine-coated nucleic acid nanogel for siRNA-mediated low-temperature photothermal therapy, Biomaterials, 245, 119976, 10.1016\u002Fj.biomaterials.2020.119976\nWang, 2016, Biologically inspired polydopamine capped gold nanorods for drug delivery and light-mediated cancer therapy, ACS Appl. Mater. Interfaces, 8, 24368, 10.1021\u002Facsami.6b05907\nCheng, 2020, Controllable synthesis of versatile mesoporous organosilica nanoparticles as precision cancer theranostics, Biomaterials, 256, 120191, 10.1016\u002Fj.biomaterials.2020.120191\nLi, 2019, Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer, Acta Biomater., 89, 1, 10.1016\u002Fj.actbio.2019.02.031\nChen, 2020, Advances in nanomaterials for photodynamic therapy applications: status and challenges, Biomaterials, 237, 119827, 10.1016\u002Fj.biomaterials.2020.119827\nYang, 2016, Light-responsive, singlet-oxygen-triggered on-demand drug release from photosensitizer-doped mesoporous silica nanorods for cancer combination therapy, Adv. Funct. Mater., 26, 4722, 10.1002\u002Fadfm.201600722\nLiu, 2018, In situ growth of CuS\u002FSiO2-based multifunctional nanotherapeutic agents for combined photodynamic\u002Fphotothermal cancer therapy, ACS Appl. Mater. Interfaces, 10, 31008, 10.1021\u002Facsami.8b10339\nZhao, 2020, Succinylated casein functionalized mesoporous silica nanoplatforms to overcome multiple gastrointestinal barriers, J. Drug Deliv. Sci. Technol., 60, 11\nYu, 2016, Rotation-facilitated rapid transport of nanorods in mucosal tissues, Nano Lett., 16, 7176, 10.1021\u002Facs.nanolett.6b03515\nZhao, 2018, Outside-in synthesis of mesoporous silica\u002Fmolybdenum disulfide nanoparticles for antitumor application, Chem. Eng. J., 351, 157, 10.1016\u002Fj.cej.2018.06.101\nLi, 2017, An RGD-modified hollow silica@Au core\u002Fshell nanoplatform for tumor combination therapy, Acta Biomater., 62, 273, 10.1016\u002Fj.actbio.2017.08.024\nManzano, 2020, Mesoporous silica nanoparticles for drug delivery, Adv. Funct. Mater., 30, 1902634, 10.1002\u002Fadfm.201902634\nFu, 2019, Glucose oxidase-instructed multimodal synergistic cancer therapy, Adv. Mater., 31, 1808325, 10.1002\u002Fadma.201808325\nWu, 2019, A multifunctional biodegradable nanocomposite for cancer theranostics, Adv. Sci., 6, 1802001, 10.1002\u002Fadvs.201802001\nZhang, 2018, Temperature-dependent cell death patterns induced by functionalized gold nanoparticle photothermal therapy in melanoma cells, Sci. Rep., 8, 1\nMelamed, 2015, Elucidating the fundamental mechanisms of cell death triggered by photothermal therapy, ACS Nano, 9, 6, 10.1021\u002Facsnano.5b00021\nPérez-Hernández, 2015, Dissecting the molecular mechanism of apoptosis during photothermal therapy using gold nanoprisms, ACS Nano, 9, 52, 10.1021\u002Fnn505468v\nQin, 2013, Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy, J. Photochem. Photobiol. B, 120, 156, 10.1016\u002Fj.jphotobiol.2012.12.005\nKong, 2000, Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size, Cancer Res., 60, 4440\nZhang, 2011, Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide, Biomaterials, 32, 8555, 10.1016\u002Fj.biomaterials.2011.07.071\nYang, 2020, Super-assembled core-shell mesoporous silica-metal-phenolic network nanoparticles for combinatorial photothermal therapy and chemotherapy, Nano Res., 13, 1013, 10.1007\u002Fs12274-020-2736-6\nSha, 2019, \"Gate\" engineered mesoporous silica nanoparticles for a double inhibition of drug efflux and particle exocytosis to enhance antitumor activity, J. Colloid Interface Sci., 535, 380, 10.1016\u002Fj.jcis.2018.09.089\nChai, 2018, Fabricating polydopamine-coated MoSe2-wrapped hollow mesoporous silica nanoplatform for controlled drug release and chemo-photothermal therapy, Int. J. Nanomedicine, 13, 7607, 10.2147\u002FIJN.S181681\nQi, 2019, PEGylated graphene oxide-capped gold nanorods\u002Fsilica nanoparticles as multifunctional drug delivery platform with enhanced near-infrared responsiveness, Mater. Sci. Eng. C, 104, 109889, 10.1016\u002Fj.msec.2019.109889\nLei, 2017, Stimuli-responsive “cluster bomb” for programmed tumor therapy, ACS Nano, 11, 7201, 10.1021\u002Facsnano.7b03088\nYang, 2020, Supramolecular nanomaterials based on hollow mesoporous drug carriers and macrocycle-capped CuS nanogates for synergistic chemo-photothermal therapy, Theranostics, 10, 615, 10.7150\u002Fthno.40066\nZhao, 2017, Transferrin-decorated, MoS2-capped hollow mesoporous silica nanospheres as a self-guided chemo–photothermal nanoplatform for controlled drug release and thermotherapy, J. Mater. Chem. B, 5, 7403, 10.1039\u002FC7TB01648D\nWang, 2018, Gold nanorod-based multifunctional nanocarrier for synergistic chemo-photothermal therapy in tumors, RSC Adv., 8, 41454, 10.1039\u002FC8RA06176A\nChen, 2016, Functionalized graphene nanocomposites for enhancing photothermal therapy in tumor treatment, Adv. Drug Deliv. Rev., 105, 190, 10.1016\u002Fj.addr.2016.05.022\nZheng, 2016, Persistent luminescent nanocarrier as an accurate tracker in vivo for near infrared-remote selectively triggered photothermal therapy, ACS Appl. Mater. Interfaces, 8, 21603, 10.1021\u002Facsami.6b07642\nCai, 2019, Polydopamine-coated gold core\u002Fhollow mesoporous silica shell particles as a nanoplatform for multimode imaging and photothermal therapy of tumors, Chem. Eng. J., 362, 842, 10.1016\u002Fj.cej.2019.01.072\nWang, 2012, Noble metal coated single-walled carbon nanotubes for applications in surface enhanced Raman scattering imaging and photothermal therapy, J. Am. Chem. Soc., 134, 7414, 10.1021\u002Fja300140c\nChen, 2016, A high-sensitivity and low-power theranostic nanosystem for cell SERS imaging and selectively photothermal therapy using anti-EGFR-conjugated reduced graphene oxide\u002Fmesoporous silica\u002FAuNPs nanosheets, Small, 12, 1458, 10.1002\u002Fsmll.201502917\nTian, 2017, Periodic mesoporous organosilica coated prussian blue for MR\u002FPA dual-modal imaging-guided photothermal-chemotherapy of triple negative breast cancer, Adv. Sci., 4, 1600356, 10.1002\u002Fadvs.201600356\nLi, 2018, Actively targeted deep tissue imaging and photothermal-chemo therapy of breast cancer by antibody-functionalized drug-loaded X-ray-responsive bismuth sulfide@mesoporous silica core-shell nanoparticles, Adv. Funct. Mater., 28, 1704623, 10.1002\u002Fadfm.201704623\nLu, 2018, Enhancing osteosarcoma killing and CT imaging using ultrahigh drug loading and NIR-responsive bismuth sulfide@ mesoporous silica nanoparticles, Adv. Healthc. Mater., 7, 1800602, 10.1002\u002Fadhm.201800602\nLi, 2019, A near-infrared light-controlled smart nanocarrier with reversible polypeptide-engineered valve for targeted fluorescence-photoacoustic bimodal imaging-guided chemo-photothermal therapy, Theranostics, 9, 7666, 10.7150\u002Fthno.37047\nLiu, 2016, Magnetically targeted delivery of DOX loaded Cu9S5@ mSiO2@Fe3O4-PEG nanocomposites for combined MR imaging and chemo\u002Fphotothermal synergistic therapy, Nanoscale, 8, 12560, 10.1039\u002FC5NR06322A\nYang, 2011, The role of autophagy in cancer: therapeutic implications, Mol. Cancer Ther., 10, 1533, 10.1158\u002F1535-7163.MCT-11-0047\nMizushima, 2008, Autophagy fights disease through cellular self-digestion, Nature, 451, 1069, 10.1038\u002Fnature06639\nLevine, 2008, Autophagy in the pathogenesis of disease, Cell, 132, 27, 10.1016\u002Fj.cell.2007.12.018\nKroemer, 2005, Lysosomes and autophagy in cell death control, Nat. Rev. Cancer, 5, 886, 10.1038\u002Fnrc1738\nChen, 2019, Bismuth embedded silica nanoparticles loaded with autophagy suppressant to promote photothermal therapy, Biomaterials, 221, 119419, 10.1016\u002Fj.biomaterials.2019.119419\nShao, 2020, Complementary autophagy inhibition and glucose metabolism with rattle-structured polydopamine@mesoporous silica nanoparticles for augmented low-temperature photothermal therapy and in vivo photoacoustic imaging, Theranostics, 10, 7273, 10.7150\u002Fthno.44668\nQian, 2019, biodegradable mesoporous silica achieved via carbon nanodots-incorporated framework swelling for debris-mediated photothermal synergistic immunotherapy, Nano Lett., 19, 8409, 10.1021\u002Facs.nanolett.9b02448\nSeth, 2020, Polydopamine-mesoporous silica core-shell nanoparticles for combined photothermal immunotherapy, ACS Appl. Mater. Interfaces, 12, 42499, 10.1021\u002Facsami.0c10781\nHuang, 2021, Robust nanovaccine based on polydopamine-coated mesoporous silica nanoparticles for effective photothermal-immunotherapy against melanoma, Adv. Funct. Mater., 31, 2010637, 10.1002\u002Fadfm.202010637\nZhang, 2020, Light-responsive core-shell nanoplatform for bimodal imaging-guided photothermal therapy-primed cancer immunotherapy, ACS Appl. Mater. Interfaces, 12, 48420, 10.1021\u002Facsami.0c16526\nGao, 2021, Reshaping antitumor immunity with chemo-photothermal integrated nanoplatform to augment checkpoint blockade-based cancer therapy, Adv. Funct. Mater., 31, 2100437, 10.1002\u002Fadfm.202100437\nLiu, 2020, S-nitrosothiols loaded mini-sized Au@silica nanorod elicits collagen depletion and mitochondrial damage in solid tumor treatment, Theranostics, 10, 6774, 10.7150\u002Fthno.42661\nMotterlini, 2010, The therapeutic potential of carbon monoxide, Nat. Rev. Drug Discov., 9, 728, 10.1038\u002Fnrd3228\nZheng, 2017, Photocatalyzing CO2 to CO for enhanced cancer therapy, Adv. Mater., 29, 1703822, 10.1002\u002Fadma.201703822\nTang, 2018, Acidity\u002Freducibility dual-responsive hollow mesoporous organosilica nanoplatforms for tumor-specific self-assembly and synergistic therapy, ACS Nano, 12, 12269, 10.1021\u002Facsnano.8b06058\nCheng, 2017, A multifunctional nanoplatform against multidrug resistant cancer: merging the best of targeted chemo\u002Fgene\u002Fphotothermal therapy, Adv. Funct. Mater., 27, 1704135, 10.1002\u002Fadfm.201704135\nLi, 2018, In vivo imaging-guided nanoplatform for tumor targeting delivery and combined chemo-, gene- and photothermal therapy, Theranostics, 8, 5662, 10.7150\u002Fthno.28241\nChen, 2018, Rattle-structured rough nanocapsules with in-situ-formed reil gold nanorod cores for complementary gene\u002Fchemo\u002Fphotothermal therapy, ACS Nano, 12, 5646, 10.1021\u002Facsnano.8b01440\nFu, 2018, Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment, Chem. Soc. Rev., 47, 6454, 10.1039\u002FC7CS00891K\nZhou, 2021, A harmless-harmful switchable and uninterrupted laccase-instructed killer for activatable chemodynamic therapy, Adv. Mater., 33, 2100114, 10.1002\u002Fadma.202100114\nJin, 2018, Core-satellite mesoporous silica-gold nanotheranostics for biological stimuli triggered multimodal cancer therapy, Adv. Funct. Mater., 28, 9, 10.1002\u002Fadfm.201801961\nDong, 2020, Multimode imaging-guided photothermal\u002Fchemodynamic synergistic therapy nanoagent with a tumor microenvironment responded effect, ACS Appl. Mater. Interfaces, 12, 52479, 10.1021\u002Facsami.0c17923\nLi, 2019, Berberine-loaded Janus gold mesoporous silica nanocarriers for chemo\u002Fradio\u002Fphotothermal therapy of liver cancer and radiation-induced injury inhibition, Int. J. Nanomedicine, 14, 3967, 10.2147\u002FIJN.S206044\nWang, 2019, Janus gold triangle-mesoporous silica nanoplatforms for hypoxia-activated radio-chemo-photothermal therapy of liver cancer, ACS Appl. Mater. Interfaces, 11, 34755, 10.1021\u002Facsami.9b12879\nZhao, 2019, Gold nanorods based multicompartment mesoporous silica composites as bioagents for highly efficient photothermal therapy, J. Colloid Interface Sci., 549, 9, 10.1016\u002Fj.jcis.2019.04.051\nYao, 2017, Mesoporous silica nanoparticles capped with graphene quantum dots for potential chemo-photothermal synergistic cancer therapy, Langmuir, 33, 591, 10.1021\u002Facs.langmuir.6b04189\nHai, 2018, DNA-functionalized hollow mesoporous silica nanoparticles with dual cargo loading for near-infrared-responsive synergistic chemo-photothermal treatment of cancer cells, ACS Applied Nano Mater., 1, 3486, 10.1021\u002Facsanm.8b00657\nRahoui, 2018, Gold modified polydopamine coated mesoporous silica nano-structures for synergetic chemo-photothermal effect, Colloid Surf. B, 171, 176, 10.1016\u002Fj.colsurfb.2018.07.015\nCheng, 2018, Fabrication of multifunctional triple-responsive platform based on CuS-capped periodic mesoporous organosilica nanoparticles for chemo-photothermal therapy, Int. J. Nanomedicine, 13, 3661, 10.2147\u002FIJN.S167407\nPoudel, 2018, In situ fabrication of mesoporous silica-coated silver-gold hollow nanoshell for remotely controllable chemo-photothermal therapy via phase-change molecule as gatekeepers, Int. J. Pharm., 548, 92, 10.1016\u002Fj.ijpharm.2018.06.056\nZhang, 2018, A synergistically enhanced photothermal transition effect from mesoporous silica nanoparticles with gold nanorods wrapped in reduced graphene oxide, J. Mater. Sci., 53, 1810, 10.1007\u002Fs10853-017-1628-y\nWang, 2018, Gold nanorods\u002Fpolypyrrole\u002Fmsio2 core\u002Fshell hybrids as drug nanocarriers for efficient chemo-photothermal therapy, Langmuir, 34, 14661, 10.1021\u002Facs.langmuir.8b02667\nMoreira, 2018, Development of poly-2-ethyl-2-oxazoline coated gold-core silica shell nanorods for cancer chemo-photothermal therapy, Nanomed. Nanotechnol., 13, 2611\nRamasamy, 2018, Multimodal selenium nanoshell-capped Au@mSiO2 nanoplatform for NIR-responsive chemo-photothermal therapy against metastatic breast cancer, NPG Asia Mater., 10, 197, 10.1038\u002Fs41427-018-0034-5\nLiao, 2018, Fabrication of ultrasmall WS2 quantum dots-coated periodic mesoporous organosilica nanoparticles for intracellular drug delivery and synergistic chemo-photothermal therapy, Oncotargets Ther., 11, 1949, 10.2147\u002FOTT.S160748\nGautam, 2019, Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy, Acta Biomater., 88, 448, 10.1016\u002Fj.actbio.2019.02.029\nSu, 2019, Mesoporous silica-coated gold nanostars with drug payload for combined chemo-photothermal cancer therapy, J. Drug Target., 27, 201, 10.1080\u002F1061186X.2018.1499746\nLiu, 2019, Polydopamine doped reduced graphene oxide\u002Fmesoporous silica nanosheets for chemo-photothermal and enhanced photothermal therapy, Mater. Sci. Eng. C, 96, 138, 10.1016\u002Fj.msec.2018.10.093\nLei, 2019, Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy, Mater. Sci. Eng. C, 105, 110103, 10.1016\u002Fj.msec.2019.110103\nFang, 2017, Janus nanostructures formed by mesoporous silica coating Au nanorods for near-infrared chemo–photothermal therapy, J. Mater. Chem. B, 5, 8833, 10.1039\u002FC7TB02144E\nYang, 2017, Gold nanoparticle-gated mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic therapy, J. Colloid Interface Sci., 508, 323, 10.1016\u002Fj.jcis.2017.08.050\nYang, 2017, Reduced graphene oxide@mesoporous silica-doxorubicin\u002Fhydroxyapatite inorganic nanocomposites: preparation and pH-light dual-triggered synergistic chemo-photothermal therapy, Eur. J. Inorg. Chem., 2017, 2236, 10.1002\u002Fejic.201601487\nZhang, 2017, NIR-absorbing dye functionalized hollow mesoporous silica nanoparticles for combined photothermal-chemotherapy, Chem. Commun., 53, 12032, 10.1039\u002FC7CC07897H\nGao, 2019, Mesoporous silica-coated gold nanoframes as drug delivery system for remotely controllable chemo-photothermal combination therapy, Colloid Surf. B, 176, 230, 10.1016\u002Fj.colsurfb.2019.01.005\nWu, 2019, Photothermally controlled drug release system with high dose loading for synergistic chemo-photothermal therapy of multidrug resistance cancer, Colloid Surf. B, 175, 239, 10.1016\u002Fj.colsurfb.2018.11.088\nChen, 2016, Light-induced hydrogel based on tumor-targeting mesoporous silica nanoparticles as a theranostic platform for sustained cancer treatment, ACS Appl. Mater. Interfaces, 8, 15857, 10.1021\u002Facsami.6b02562\nZhou, 2017, Dual targeting hyaluronic acid-RGD mesoporous silica coated gold nanorods for chemo-photothermal cancer therapy, Mater. Sci. Eng. C, 81, 261, 10.1016\u002Fj.msec.2017.08.002\nWu, 2018, Functionalized MoS2 nanosheet-capped periodic mesoporous organosilicas as a multifunctional platform for synergistic targeted chemo-photothermal therapy, Chem. Eng. J., 342, 90, 10.1016\u002Fj.cej.2018.02.052\nZhou, 2018, Hyaluronic acid-RGD peptide conjugated mesoporous silica-coated gold nanorods for cancer dual-targeted chemo-photothermal therapy, J Wuhan Univ. Technol., 33, 512, 10.1007\u002Fs11595-018-1853-4\nVillaverde, 2018, Targeted chemo-photothermal therapy: a nanomedicine approximation to selective melanoma treatment, Part. Part. Syst. Charact., 35, 1800148, 10.1002\u002Fppsc.201800148\nZhang, 2018, One-pot synthesis of biodegradable polydopamine-doped mesoporous silica nanocomposites (PMSNs) as pH-sensitive targeting drug nanocarriers for synergistic chemo-photothermal therapy, RSC Adv., 8, 37433, 10.1039\u002FC8RA07467D\nWang, 2017, Fluorescent carbon dot gated hollow mesoporous carbon for chemo-photothermal synergistic therapy, J. Colloid Interface Sci., 507, 410, 10.1016\u002Fj.jcis.2017.08.010\nZhao, 2017, Photothermal effect enhanced cascade-targeting strategy for improved pancreatic cancer therapy by gold nanoshell@ mesoporous silica nanorod, ACS Nano, 11, 8103, 10.1021\u002Facsnano.7b02918\nChen, 2019, Hyaluronic acid conjugated polydopamine functionalized mesoporous silica nanoparticles for synergistic targeted chemo-photothermal therapy, Nanoscale, 11, 11012, 10.1039\u002FC9NR01385G\nHou, 2019, Multifunctional PEG-b-polypeptide-decorated gold nanorod for targeted combined chemo-photothermal therapy of breast cancer, Colloid Surf. B, 181, 602, 10.1016\u002Fj.colsurfb.2019.05.025\nRen, 2020, Multifunctional hierarchical mesoporous silica and black phosphorus nanohybrids as chemo-photothermal synergistic agents for enhanced cancer therapy, Nanoscale, 12, 12578, 10.1039\u002FD0NR02044C\nZhao, 2017, Upconverting and persistent luminescent nanocarriers for accurately imaging-guided photothermal therapy, Mater. Sci. Eng. C, 79, 191, 10.1016\u002Fj.msec.2017.05.046\nZeng, 2016, Cancer diagnosis and imaging-guided photothermal therapy using a dual-modality nanoparticle, ACS Appl. Mater. Interfaces, 8, 29232, 10.1021\u002Facsami.6b06883\nChen, 2017, Near-infrared persistent luminescence phosphors ZnGa2O4: Cr3+ as an accurately tracker to photothermal therapy in vivo for visual treatment, Mater. Sci. Eng. C, 79, 372, 10.1016\u002Fj.msec.2017.05.053\nWang, 2017, Construction of ICG encapsulated W18O49@ MSN as a fluorescence carrier for real-time tracked photothermal therapy, Mater. Sci. Eng. C, 80, 102, 10.1016\u002Fj.msec.2017.05.131\nLi, 2017, Formation of gold nanostar-coated hollow mesoporous silica for tumor multimodality imaging and photothermal therapy, ACS Appl. Mater. Interfaces, 9, 5817, 10.1021\u002Facsami.6b15185\nWang, 2019, Stable mesoporous silica nanoparticles incorporated with MoS2 and AIE for targeted fluorescence imaging and photothermal therapy of cancer cells, Colloid Surf. B, 174, 324, 10.1016\u002Fj.colsurfb.2018.11.030\nLiu, 2015, Gold nanorods\u002Fmesoporous silica-based nanocomposite as theranostic agents for targeting near-infrared imaging and photothermal therapy induced with laser, Int. J. Nanomedicine, 10, 4747, 10.2147\u002FIJN.S82940\nXia, 2014, Folic acid-conjugated silica-coated gold nanorods and quantum dots for dual-modality CT and fluorescence imaging and photothermal therapy, J. Mater. Chem. B, 2, 1945, 10.1039\u002Fc3tb21591a\nZhang, 2018, pH\u002Fhypoxia programmable triggered cancer photo-chemotherapy based on a semiconducting polymer dot hybridized mesoporous silica framework, Chem. Sci., 9, 7390, 10.1039\u002FC8SC02408A\nLi, 2017, AIE gen-functionalized mesoporous silica gated by cyclodextrin-modified CuS for cell imaging and chemo-photothermal cancer therapy, ACS Appl. Mater. Interfaces, 10, 12155, 10.1021\u002Facsami.7b14566\nXu, 2019, Biodegradable nanotheranostics with hyperthermia-induced bubble ability for ultrasound imaging–guided chemo-photothermal therapy, Int. J. Nanomedicine, 14, 7141, 10.2147\u002FIJN.S213518\nXu, 2018, Bacteria-like mesoporous silica-coated gold nanorods for positron emission tomography and photoacoustic imaging-guided chemo-photothermal combined therapy, Biomaterials, 165, 56, 10.1016\u002Fj.biomaterials.2018.02.043\nXu, 2018, Bioresponsive upconversion nanostructure for combinatorial bioimaging and chemo-photothermal synergistic therapy, Chem. Eng. J., 342, 446, 10.1016\u002Fj.cej.2018.02.109\nMoorthy, 2018, Prussian blue decorated mesoporous silica hybrid nanocarriers for photoacoustic imaging-guided synergistic chemo-photothermal combination therapy, J. Mater. Chem. B, 6, 5220, 10.1039\u002FC8TB01214H\nWu, 2018, Chemodrug-gated biodegradable hollow mesoporous organosilica nanotheranostics for multimodal imaging-guided low-temperature photothermal therapy\u002Fchemotherapy of cancer, ACS Appl. Mater. Interfaces, 10, 42115, 10.1021\u002Facsami.8b16448\nLi, 2018, Mesoporous silica-coated bismuth nanohybrids as a new platform for photoacoustic\u002Fcomputed tomography imaging and synergistic chemophotothermal therapy, Nanomedicine, 13, 2283, 10.2217\u002Fnnm-2018-0106\nXu, 2018, Multifunctional yolk–shell mesoporous silica obtained via selectively etching the shell: a therapeutic nanoplatform for cancer therapy, ACS Appl. Mater. Interfaces, 10, 24440, 10.1021\u002Facsami.8b08574\nFan, 2017, AIE luminogen-functionalised mesoporous silica nanoparticles as nanotheranostic agents for imaging guided synergetic chemo-\u002Fphotothermal therapy, Inorg. Chem. Front., 4, 833, 10.1039\u002FC7QI00046D\nLi, 2019, Biomimetic synthesis of Ag2Se quantum dots with enhanced photothermal properties and as “gatekeepers” to cap mesoporous silica nanoparticles for chemo-photothermal therapy, Chem. Asian J., 14, 155, 10.1002\u002Fasia.201801388\nZhu, 2018, Constructing reduction-sensitive PEGylated NIRF mesoporous silica nanoparticles via a one-pot Passerini reaction for photothermal\u002Fchemo-therapy, Chem. Commun., 54, 11921, 10.1039\u002FC8CC07106C\nLi, 2020, Biodegradable theranostic nanoplatforms of albumin-biomineralized nanocomposites modified hollow mesoporous organosilica for photoacoustic imaging guided tumor synergistic therapy, Chem. Eng. J., 388, 11, 10.1016\u002Fj.cej.2020.124253\nSun, 2019, Bone-targeted nanoplatform combining zoledronate and photothermal therapy to treat breast cancer bone metastasis, ACS Nano, 13, 7556, 10.1021\u002Facsnano.9b00097\nMao, 2019, Chylomicron-pretended nano-bio self-assembling vehicle to promote lymphatic transport and GALTs target of oral drugs, Biomaterials, 188, 173, 10.1016\u002Fj.biomaterials.2018.10.012\nAn, 2017, In vivo computed tomography\u002Fphotoacoustic imaging and nir-triggered chemo–photothermal combined therapy based on a gold nanostar-, mesoporous silica-, and thermosensitive liposome-composited nanoprobe, ACS Appl. Mater. Interfaces, 9, 41748, 10.1021\u002Facsami.7b15296\nGuo, 2021, In situ formation of metal organic framework onto gold nanorods\u002Fmesoporous silica with functional integration for targeted theranostics, Chem. Eng. J., 403, 10.1016\u002Fj.cej.2020.126432\nTran, 2020, Multimodal mesoporous silica nanocarriers for dual stimuli-responsive drug release and excellent photothermal ablation of cancer cells, Int. J. Nanomedicine, 15, 7667, 10.2147\u002FIJN.S254344\nYang, 2020, An NIR-responsive mesoporous silica nanosystem for synergetic photothermal-immunoenhancement therapy of hepatocellular carcinoma, J. Mater. Chem. B, 8, 251, 10.1039\u002FC9TB01891C\nDong, 2020, GSH-depleted nanozymes with hyperthermia-enhanced dual enzyme-mimic activities for tumor nanocatalytic therapy, Adv. Mater., 32, 2002439, 10.1002\u002Fadma.202002439\nLiu, 2020, A nanoplatform based on mesoporous silica-coated gold nanorods for cancer triplex therapy, J. Mater. Chem. B, 8, 9686, 10.1039\u002FD0TB01707H\nJia, 2020, Magnetic silica nanosystems with NIR-responsive and redox reaction capacity for drug delivery and tumor therapy, Front. Chem., 8, 567652, 10.3389\u002Ffchem.2020.567652\nCao, 2015, Gadolinium(III)-chelated silica nanospheres integrating chemotherapy and photothermal therapy for cancer treatment and magnetic resonance imaging, ACS Appl. Mater. Interfaces, 7, 25014, 10.1021\u002Facsami.5b06938\nChiaviello, 2011, Targets and mechanisms of photodynamic therapy in lung cancer cells: a brief overview, Cancers, 3, 1014, 10.3390\u002Fcancers3011014\nWong, 2017, pH-responsive dimeric Zinc(II) Phthalocyanine in mesoporous silica nanoparticles as an activatable nanophotosensitizing system for photodynamic therapy, ACS Appl. Mater. Interfaces, 9, 23487, 10.1021\u002Facsami.7b06353\nLiu, 2016, Hyperbranched polyglycerol-doped mesoporous silica nanoparticles for one-and two-photon activated photodynamic therapy, Adv. Funct. Mater., 26, 2561, 10.1002\u002Fadfm.201504939\nEr, 2018, Selective photokilling of human pancreatic cancer cells using cetuximab-targeted mesoporous silica nanoparticles for delivery of zinc phthalocyanine, Molecules, 23, 2749, 10.3390\u002Fmolecules23112749\nYang, 2017, Polyglycerol mediated covalent construction of magnetic mesoporous silica nanohybrid with aqueous dispersibility for drug delivery, Mater. Sci. Eng. C, 80, 517, 10.1016\u002Fj.msec.2017.06.022\nBouffard, 2019, Efficient photodynamic therapy of prostate cancer cells through an improved targeting of the cation-independent Mannose 6-Phosphate receptor, Int. J. Mol. Sci., 20, 2809, 10.3390\u002Fijms20112809\nLan, 2019, Photocatalysis enhancement for programmable killing of hepatocellular carcinoma through self-compensation mechanisms based on black phosphorus quantum-dot-hybridized nanocatalysts, ACS Appl. Mater. Interfaces, 11, 9804, 10.1021\u002Facsami.8b21820\nLim, 2010, In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy, J. Med. Chem., 53, 2865, 10.1021\u002Fjm901823u\nRajaputra, 2013, Synthesis and in vitro biological evaluation of lipophilic cation conjugated photosensitizers for targeting mitochondria, Bioorg. Med. Chem., 21, 379, 10.1016\u002Fj.bmc.2012.11.032\nCai, 2018, Integrating in situ formation of nanozymes with three-dimensional dendritic mesoporous silica nanospheres for hypoxia-overcoming photodynamic therapy, Nanoscale, 10, 22937, 10.1039\u002FC8NR07679K\nKalluru, 2016, Unprecedented \"all-in-one\" lanthanide-doped mesoporous silica frameworks for fluorescence\u002FMR Imaging and combination of NIR light triggered chemo-photodynamic therapy of tumors, Adv. Funct. Mater., 26, 7908, 10.1002\u002Fadfm.201603749\nTessaro, 2019, “Three-Bullets” loaded mesoporous silica nanoparticles for combined photo\u002Fchemotherapy, Nanomaterials, 9, 823, 10.3390\u002Fnano9060823\nFang, 2019, Albumin-MnO2 gated hollow mesoporous silica nanosystem for modulating tumor hypoxia and synergetic therapy of cervical carcinoma, Colloid Surf. B, 179, 250, 10.1016\u002Fj.colsurfb.2019.03.070\nTang, 2018, pH-responsive magnetic mesoporous silica-based nanoplatform for synergistic photodynamic therapy\u002Fchemotherapy, ACS Appl. Mater. Interfaces, 10, 15001, 10.1021\u002Facsami.7b19797\nDu, 2020, Confined nanoparticles growth within hollow mesoporous nanoreactors for highly efficient MRI-guided photodynamic therapy, Chem. Eng. J., 379, 122251, 10.1016\u002Fj.cej.2019.122251\nLiu, 2021, Tumor cell-activated \"Sustainable ROS Generator\" with homogeneous intratumoral distribution property for improved anti-tumor therapy, Theranostics, 11, 379, 10.7150\u002Fthno.50028\nYuan, 2017, A redox-responsive mesoporous silica based nanoplatform for in vitro tumor-specific fluorescence imaging and enhanced photodynamic therapy, Biomater. Sci., 6, 96, 10.1039\u002FC7BM00793K\nYang, 2018, Oxygen-evolving mesoporous organosilica coated prussian blue nanoplatform for highly efficient photodynamic therapy of tumors, Adv. Sci., 5, 1700847, 10.1002\u002Fadvs.201700847\nKalyanaraman, 2013, Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms, Redox Biol., 1, 244, 10.1016\u002Fj.redox.2013.01.014\nYoon, 2012, The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells, Lasers Surg. Med., 44, 76, 10.1002\u002Flsm.21154\nRao, 2018, ROS-responsive mesoporous silica nanoparticles for MR imaging-guided photodynamically maneuvered chemotherapy, Nanoscale, 10, 9616, 10.1039\u002FC8NR00888D\nCosta, 2019, The effect of low-and high-penetration light on localized cancer therapy, Adv. Drug Deliv. Rev., 138, 105, 10.1016\u002Fj.addr.2018.09.004\nBayir, 2018, Mesoporous silica nanoparticles in recent photodynamic therapy applications, Photochem. Photobiol. Sci., 17, 1651, 10.1039\u002Fc8pp00143j\nGnanasammandhan, 2016, Near-IR photoactivation using mesoporous silica-coated NaYF4:Yb,Er\u002FTm upconversion nanoparticles, Nat. Protoc., 11, 688, 10.1038\u002Fnprot.2016.035\nLiu, 2020, An all-in-one theranostic nanoplatform based on upconversion dendritic mesoporous silica nanocomposites for synergistic chemodynamic\u002Fphotodynamic\u002Fgas therapy, Nanoscale, 12, 24146, 10.1039\u002FD0NR06790C\nDing, 2018, Large-pore mesoporous-silica-coated upconversion nanoparticles as multifunctional immunoadjuvants with ultrahigh photosensitizer and antigen loading efficiency for improved cancer photodynamic immunotherapy, Adv. Mater., 30, 1802479, 10.1002\u002Fadma.201802479\nSun, 2019, Monodisperse and uniform mesoporous silicate nanosensitizers achieve low-dose X-Ray-induced deep-penetrating photodynamic therapy, Adv. Mater., 31, 8, 10.1002\u002Fadma.201808024\nZuo, 2020, Circumventing myeloid-derived suppressor cell-mediated immunosuppression using an oxygen-generated and -economized nanoplatform, ACS Appl. Mater. Interfaces, 12, 55723, 10.1021\u002Facsami.0c18180\nWu, 2021, Nano-herb medicine and PDT induced synergistic immunotherapy for colon cancer treatment, Biomaterials, 269, 11, 10.1016\u002Fj.biomaterials.2021.120654\nRizzi, 2017, Verteporfin based silica nanoparticle for in vitro selective inhibition of human highly invasive melanoma cell proliferation, J. Photochem. Photobiol. B, 167, 1, 10.1016\u002Fj.jphotobiol.2016.12.021\nCroissant, 2016, Multifunctional gold-mesoporous silica nanocomposites for enhanced two-photon imaging and therapy of cancer cells, Front. Mol. Biosci., 3, 1, 10.3389\u002Ffmolb.2016.00001\nWang, 2017, Persistent luminescent nanoparticles as energy mediators for enhanced photodynamic therapy with fractionated irradiation, J. Mater. Chem. B, 5, 5793, 10.1039\u002FC7TB00950J\nMurugan, 2017, Chemosensitive mesoporous silica nanocarriers for photodynamic therapy against breast cancer, J. Nanosci. Nanotechnol., 17, 8806, 10.1166\u002Fjnn.2017.13890\nClemente, 2019, Verteporfin-loaded mesoporous silica nanoparticles inhibit mouse melanoma proliferation in vitro and in vivo, J. Photochem. Photobiol. B, 111533, 10.1016\u002Fj.jphotobiol.2019.111533\nLin, 2019, A pH-responsive stellate mesoporous silica based nanophotosensitizer for in vivo cancer diagnosis and targeted photodynamic therapy, Biomater. Sci., 7, 211, 10.1039\u002FC8BM00386F\nXuan, 2018, Magnetic mesoporous silica nanoparticles cloaked by red blood cell membranes: applications in cancer therapy, Angew. Chem. Int. Edit., 57, 6049, 10.1002\u002Fanie.201712996\nZhan, 2017, Magnetic and pH dual-responsive mesoporous silica nanocomposites for effective and low-toxic photodynamic therapy, Int. J. Nanomedicine, 12, 2733, 10.2147\u002FIJN.S127528\nChai, 2017, Cyclodextrin-gated mesoporous silica nanoparticles as drug carriers for red light-induced drug release, Nanotechnology, 28, 145101, 10.1088\u002F1361-6528\u002Faa5e74\nLiu, 2017, Pullulan-functionalized Fe3O4 nanoparticles with mesopore silica-loaded tetraphenylporphyrin tetrasulfonic acid hydrate for targeting photodynamic therapy, J. Nanosci. Nanotechnol., 17, 3880, 10.1166\u002Fjnn.2017.13104\nYang, 2019, Boosting the photodynamic therapy efficiency with a mitochondria-targeted nanophotosensitizer, Chin. Chem. Lett., 30, 1293, 10.1016\u002Fj.cclet.2019.03.032\nWong, 2017, Encapsulating pH-responsive doxorubicin–phthalocyanine conjugates in mesoporous silica nanoparticles for combined photodynamic therapy and controlled chemotherapy, Chem. Eur. J., 23, 16505, 10.1002\u002Fchem.201703188\nLee, 2017, Doxorubicin\u002FCe6-loaded nanoparticle coated with polymer via singlet oxygen-sensitive linker for photodynamically assisted chemotherapy, Nanotheranostics, 1, 196, 10.7150\u002Fntno.18576\nAggad, 2018, Gemcitabine delivery and photodynamic therapy in cancer cells via porphyrin-ethylene-based periodic mesoporous organosilica nanoparticles, Chem. Nano Mat., 4, 46\nSun, 2018, Multifunctional mesoporous silica nanoparticles as efficient transporters of doxorubicin and chlorin e6 for chemo-photodynamic combinatorial cancer therapy, J. Biomater. Appl., 32, 1253, 10.1177\u002F0885328218758925\nGuo, 2020, Reduction-responsive Au decorated mesoporous silica-based nanoplatform for photodynamic-chemotherapy, Microporous Mesoporous Mater., 292, 7, 10.1016\u002Fj.micromeso.2019.109729\nLiu, 2017, NIR light-activated dual-modality cancer therapy mediated by photochemical internalization of porous nanocarriers with tethered lipid bilayers, J. Mater. Chem. B, 5, 8289, 10.1039\u002FC7TB02095C\nYan, 2018, pH-Sensitive mesoporous silica nanoparticles for chemo-photodynamic combination therapy, Colloid Surf. B, 161, 442, 10.1016\u002Fj.colsurfb.2017.11.006\nGary-Bobo, 2012, Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT, Int. J. Pharm., 423, 509, 10.1016\u002Fj.ijpharm.2011.11.045\nPark, 2019, Hyaluronic acid-conjugated mesoporous silica nanoparticles loaded with dual anticancer agents for chemophotodynamic cancer therapy, J. Nanomater., 2019, 3481397, 10.1155\u002F2019\u002F3481397\nSi, 2018, Shape controlled quantum dot (QD)-decorated-mesoporous SiO2 hollow particles for photodynamic therapy, J. Nanopart. Res., 20, 299, 10.1007\u002Fs11051-018-4415-z\nKim, 2017, Continuous O2-evolving MnFe2O4 nanoparticle-anchored mesoporous silica nanoparticles for efficient photodynamic therapy in hypoxic cancer, J. Am. Chem. Soc., 139, 10992, 10.1021\u002Fjacs.7b05559\nJain, 2018, Magnetic-luminescent cerium-doped gadolinium aluminum garnet nanoparticles for simultaneous imaging and photodynamic therapy of cancer cells, J. Colloid Interface Sci., 526, 220, 10.1016\u002Fj.jcis.2018.04.100\nSu, 2017, Enhanced blood suspensibility and laser-activated tumor-specific drug release of theranostic mesoporous silica nanoparticles by functionalizing with erythrocyte membranes, Theranostics, 7, 523, 10.7150\u002Fthno.17259\nLiu, 2017, A multifunctional nanoplatform based on mesoporous silica nanoparticles for imaging-guided chemo\u002Fphotodynamic synergetic therapy, RSC Adv., 7, 31133, 10.1039\u002FC7RA04549B\nChen, 2017, Mesoporous silica-based versatile theranostic nanoplatform constructed by layer-by-layer assembly for excellent photodynamic\u002Fchemo therapy, Biomaterials, 117, 54, 10.1016\u002Fj.biomaterials.2016.11.057\nLiu, 2017, Core-interlayer-shell Fe3O4@ mSiO2@ lipid-PEG-methotrexate nanoparticle for multimodal imaging and multistage targeted chemo-photodynamic therapy, Int. J. Pharm., 521, 19, 10.1016\u002Fj.ijpharm.2017.01.068\nWang, 2017, Near-infrared light activated photodynamic therapy of THP-1 macrophages based on core-shell structured upconversion nanoparticles, Microporous Mesoporous Mater., 239, 78, 10.1016\u002Fj.micromeso.2016.09.048\nZeng, 2016, 808 nm-excited upconversion nanoprobes with low heating effect for targeted magnetic resonance imaging and high-efficacy photodynamic therapy in HER2-overexpressed breast cancer, Biomaterials, 103, 116, 10.1016\u002Fj.biomaterials.2016.06.037\nHou, 2017, Controlled co-release of doxorubicin and reactive oxygen species for synergistic therapy by NIR remote-triggered nanoimpellers, Mater. Sci. Eng. C, 74, 94, 10.1016\u002Fj.msec.2017.02.016\nChen, 2017, DOX-UCNPs@ mSiO2–TiO2 nanocomposites for near-infrared photocontrolled chemo\u002Fphotodynamic therapy, New J. Chem., 41, 7292, 10.1039\u002FC7NJ01291H\nZhang, 2017, Enzyme and pH-responsive nanovehicles for intracellular drug release and photodynamic therapy, New J. Chem., 41, 2468, 10.1039\u002FC6NJ02357F\nXu, 2017, Highly emissive dye-sensitized upconversion nanostructure for dual-photosensitizer photodynamic therapy and bioimaging, ACS Nano, 11, 4133, 10.1021\u002Facsnano.7b00944\nCai, 2018, Polypyrrole-coated UCNPs@mSiO2@ZnO nanocomposite for combined photodynamic and photothermal therapy, J. Mater. Chem. B, 6, 8148, 10.1039\u002FC8TB02407C\nAbbaraju, 2017, Core-shell-structured dendritic mesoporous silica nanoparticles for combined photodynamic therapy and antibody delivery, Chem. Asian J., 12, 1465, 10.1002\u002Fasia.201700392\nYang, 2017, Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate\u002Fchitosan multilayer-modified magnetic mesoporous silica nanocomposites, Biomater. Sci., 5, 1001, 10.1039\u002FC7BM00043J\nYang, 2019, Rod-shape MSN@MoS2 nanoplatform for FL\u002FMSOT\u002FCT imaging-guided photothermal and photodynamic therapy, Theranostics, 9, 3992, 10.7150\u002Fthno.32715\nHuang, 2019, A dual-model imaging theragnostic system based on mesoporous silica nanoparticles for enhanced cancer phototherapy, Adv. Healthc. Mater., 8, 1900840, 10.1002\u002Fadhm.201900840\nLiu, 2018, Tumor acidity activating multifunctional nanoplatform for NIR-mediated multiple enhanced photodynamic and photothermal tumor therapy, Biomaterials, 157, 107, 10.1016\u002Fj.biomaterials.2017.12.003\nLiu, 2018, Functional chlorin gold nanorods enable to treat breast cancer by photothermal\u002Fphotodynamic therapy, Int. J. Nanomedicine, 13, 8119, 10.2147\u002FIJN.S186974\nGoel, 2018, Activatable hybrid nanotheranostics for tetramodal imaging and synergistic photothermal\u002Fphotodynamic therapy, Adv. Mater., 30, 1704367, 10.1002\u002Fadma.201704367\nMitchell, 2011, In Vivo Cerenkov luminescence imaging: a new tool for molecular imaging, Philos. T. R. Soc. A., 369, 4605, 10.1098\u002Frsta.2011.0271\nVoskuhl, 2013, A soft supramolecular carrier with enhanced singlet oxygen photosensitizing properties, Soft Matter, 9, 2453, 10.1039\u002Fc2sm27353e\nRoy, 2003, Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy, J. Am. Chem. Soc., 125, 7860, 10.1021\u002Fja0343095\nYang, 2019, Rodlike MSN@Au nanohybrid-modified supermolecular photosensitizer for NIRF\u002FMSOT\u002FCT\u002FMR quadmodal imaging-guided photothermal\u002Fphotodynamic cancer therapy, ACS Appl. Mater. Interfaces, 11, 6777, 10.1021\u002Facsami.8b19565\nZhang, 2019, Gold cube-in-cube based oxygen nanogenerator: a theranostic nanoplatform for modulating tumor microenvironment for precise chemo-phototherapy and multimodal imaging, ACS Nano, 13, 5306, 10.1021\u002Facsnano.8b09786\nLiu, 2017, Dacarbazine-loaded hollow mesoporous silica nanoparticles grafted with folic acid for enhancing antimetastatic melanoma response, ACS Appl. Mater. Interfaces, 9, 21673, 10.1021\u002Facsami.7b05278\nKuczynski, 2013, Drug rechallenge and treatment beyond progression-implications for drug resistance, Nat. Rev. Clin. Oncol., 10, 571, 10.1038\u002Fnrclinonc.2013.158\nYan, 2020, Chitosan capped pH-responsive hollow mesoporous silica nanoparticles for targeted chemo-photo combination therapy, Carbohydr. Polym., 231, 115706, 10.1016\u002Fj.carbpol.2019.115706\nLuo, 2016, A triple-collaborative strategy for high-performance tumor therapy by multifunctional mesoporous silica-coated gold nanorods, Adv. Funct. Mater., 26, 4339, 10.1002\u002Fadfm.201505175\nFang, 2017, Dual-stimuli responsive nanotheranostics for multimodal imaging guided trimodal synergistic therapy, Small, 13, 1602580, 10.1002\u002Fsmll.201602580\nShu, 2018, Thermo\u002FpH dual-stimuli-responsive drug delivery for chemo-\u002Fphotothermal therapy monitored by cell imaging, Talanta, 181, 278, 10.1016\u002Fj.talanta.2018.01.018\nSun, 2018, Theranostic nanoplatform: triple-modal imaging-guided synergistic cancer therapy based on liposome-conjugated mesoporous silica nanoparticles, ACS Appl. Mater. Interfaces, 10, 1963, 10.1021\u002Facsami.7b13651\nAn, 2018, The synthesis of core-shell Cu9S5@mSiO2-ICG@PEG-LA for photothermal and photodynamic therapy, New J. Chem., 42, 18318, 10.1039\u002FC8NJ03712D\nJiang, 2017, Tumor-targeting photothermal heating-responsive nanoplatform based on reduced graphene oxide\u002Fmesoporous silica\u002Fhyaluronic acid nanocomposite for enhanced photodynamic therapy, Adv. Mater. Interfaces, 4, 1700425, 10.1002\u002Fadmi.201700425\nRyplida, 2019, Zwitterionic carbon dot-encapsulating pH-responsive mesoporous silica nanoparticles for NIR light-triggered photothermal therapy through pH-controllable release, Biomater. Sci., 7, 2600, 10.1039\u002FC9BM00160C\nYou, 2017, A single-light triggered and dual-imaging guided multifunctional platform for combined photothermal and photodynamic therapy based on TD-controlled and ICG-loaded CuS@mSiO2, Nanoscale, 9, 3784, 10.1039\u002FC6NR09042G\nSun, 2017, A photoresponsive and rod-shape nanocarrier: Single wavelength of light triggered photothermal and photodynamic therapy based on AuNRs-capped & Ce6-doped mesoporous silica nanorods, Biomaterials, 122, 188, 10.1016\u002Fj.biomaterials.2017.01.021\nLi, 2019, Ultrasmall MoS2 nanodots-doped biodegradable SiO2 nanoparticles for clearable FL\u002FCT\u002FMSOT imaging-guided PTT\u002FPDT combination tumor therapy, ACS Appl. Mater. Interfaces, 11, 5771, 10.1021\u002Facsami.8b18924\nWen, 2019, In situ formation of homogeneous tellurium nanodots in paclitaxel-loaded MgAl layered double hydroxide gated mesoporous silica nanoparticles for synergistic Chemo\u002FPDT\u002FPTT trimode combinatorial therapy, Inorg. Chem., 58, 2987, 10.1021\u002Facs.inorgchem.8b02821\nAn, 2018, Synthesis of a GNRs@mSiO2-ICG-DOX@Se-Se-FA nanocomposite for controlled Chemo-\u002FPhotothermal\u002FPhotodynamic therapy, Eur. J. Inorg. Chem., 4375, 10.1002\u002Fejic.201800572\nShi, 2019, Facile formulation of near-infrared light-triggered hollow mesoporous silica nanoparticles based on mitochondria targeting for on-demand chemo\u002Fphotothermal\u002Fphotodynamic therapy, Nanotechnology, 30, 325102, 10.1088\u002F1361-6528\u002Fab1367\nYang, 2016, Imaging-guided and light-triggered chemo-\u002Fphotodynamic\u002Fphotothermal therapy based on Gd (III) chelated mesoporous silica hybrid spheres, ACS Biomater. Sci. Eng., 2, 2058, 10.1021\u002Facsbiomaterials.6b00462\nWang, 2015, A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents, Nat. Commun., 6, 10081, 10.1038\u002Fncomms10081\nWang, 2016, Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells, Biomaterials, 97, 62, 10.1016\u002Fj.biomaterials.2016.04.030\nGai, 2018, Recent advances in functional nanomaterials for light-triggered cancer therapy, Nano Today, 19, 146, 10.1016\u002Fj.nantod.2018.02.010\nSun, 2021, Near-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy, Nano Today, 37, 29, 10.1016\u002Fj.nantod.2020.101073\nHadipour Moghaddam, 2019, In Vitro and in Vivo evaluation of degradation, toxicity, biodistribution, and clearance of silica nanoparticles as a function of size, porosity, density, and composition, J. Control. Release, 311-312, 1, 10.1016\u002Fj.jconrel.2019.08.028\nChan, 2017, In Vivo toxicologic study of larger silica nanoparticles in mice, Int. J. Nanomedicine, 12, 3421, 10.2147\u002FIJN.S126823\nMohammadpour, 2020, One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility, J. Control. Release, 324, 471, 10.1016\u002Fj.jconrel.2020.05.027\nHu, 2020, Marriage of black phosphorus and Cu2+ as effective photothermal agents for PET-guided combination cancer therapy, Nat. Commun., 11, 2778, 10.1038\u002Fs41467-020-16513-0\nZou, 2017, Biological photothermal nanodots based on self-assembly of peptide-porphyrin conjugates for antitumor therapy, J. Am. Chem. Soc., 139, 1921, 10.1021\u002Fjacs.6b11382\nWicki, 2015, Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications, J. Control. Release, 200, 138, 10.1016\u002Fj.jconrel.2014.12.030\nLi, 2018, Multifunctional micelles dually responsive to hypoxia and singlet oxygen: enhanced photodynamic therapy via interactively triggered photosensitizer delivery, ACS Appl. Mater. Interfaces, 10, 17117, 10.1021\u002Facsami.8b06299\nLi, 2018, Responsive assembly of upconversion nanoparticles for pH-activated and near-infrared-triggered photodynamic therapy of deep tumors, Adv. Mater., 30, 1802808, 10.1002\u002Fadma.201802808\nLiu, 2015, Hypoxia induced by upconversion-based photodynamic therapy: towards highly effective synergistic bioreductive therapy in tumors, Angew. Chem. Int. Ed. Eng., 54, 8105, 10.1002\u002Fanie.201500478\nLee, 2016, Near-infrared-light-assisted photothermal polymerization for transdermal hydrogelation and cell delivery, Adv. Healthc. Mater., 5, 1638, 10.1002\u002Fadhm.201600048\nWang, 2020, A two-step precise targeting nanoplatform for tumor therapy via the alkyl radicals activated by the microenvironment of organelles, J. Control. Release, 318, 197, 10.1016\u002Fj.jconrel.2019.10.017\nSaito, 2020, Reaction targets of antioxidants in azo-initiator or lipid hydroperoxide induced lipid peroxidation, Free Radic. Res., 54, 301, 10.1080\u002F10715762.2020.1761020\nMeng, 2018, Near-infrared-triggered in situ gelation system for repeatedly enhanced photothermal brachytherapy with a single dose, ACS Nano, 12, 9412, 10.1021\u002Facsnano.8b04544\nCramer, 2017, Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth, Nat. Med., 23, 120, 10.1038\u002Fnm.4232\nHarris, 2015, Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression, Cancer Cell, 27, 211, 10.1016\u002Fj.ccell.2014.11.019\nEstrela, 2016, Glutathione in metastases: From mechanisms to clinical applications, Crit. Rev. Cl. Lab. Sci., 53, 253, 10.3109\u002F10408363.2015.1136259\nTraverso, 2013, Role of glutathione in cancer progression and chemoresistance, Oxidative Med. Cell. Longev., 2013, 972913, 10.1155\u002F2013\u002F972913\nXiong, 2021, Engineering nanomedicine for glutathione depletion-augmented cancer therapy, Chem. Soc. Rev., 50, 6013, 10.1039\u002FD0CS00718H\nFan, 2016, A smart photosensitizer-manganese dioxide nanosystem for enhanced photodynamic therapy by reducing glutathione levels in cancer cells, Angew. Chem. Int. Ed. Eng., 55, 5477, 10.1002\u002Fanie.201510748\nJiang, 2015, Ferroptosis as a p53-mediated activity during tumour suppression, Nature, 520, 57, 10.1038\u002Fnature14344\nHu, 2020, Recent advances in photonanomedicines for enhanced cancer photodynamic therapy, Prog. Mater. Sci., 114, 38, 10.1016\u002Fj.pmatsci.2020.100685\nZhou, 2016, Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy, Chem. Soc. Rev., 45, 6597, 10.1039\u002FC6CS00271D\nZhao, 2021, A versatile strategy for improving phototherapeutic efficacy on deep-sited tumor by tissue optical clearing technique, Nano Today, 36, 12, 10.1016\u002Fj.nantod.2020.101058\nQi, 2019, FDISCO: advanced solvent-based clearing method for imaging whole organs, Sci. Adv., 5, 8355, 10.1126\u002Fsciadv.aau8355\nSalehpour, 2019, Penetration profiles of visible and near-infrared lasers and light-emitting diode light through the head tissues in animal and human species: a review of literature, Photobiomod. Photomed., 37, 581\nOlek, 2021, Photodynamic therapy in the treatment of oral squamous cell carcinoma-the state of the art in preclinical research on the animal model, Photobiomod. Photomed., 34, 102236\nJerjes, 2010, The surgical palliation of advanced head and neck cancer using photodynamic therapy, Clin. Oncol., 22, 785, 10.1016\u002Fj.clon.2010.07.001",{"VOID":1242},"10.1016\u002Fj.jconrel.2021.10.005","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0168365921005344",[1245,1260,1273,1286,1299,1312,1325],{"id":1246,"sortIndex":32,"researcher":28,"roles":1247,"affiliations":1248,"properties":1257},"91b7ccce-875f-4f5d-928d-304ae8c457f7",[947],[1249],{"id":1250,"sortIndex":32,"affiliation":1251,"properties":28},"9a57bb1d-5de1-4dd2-8f8e-93b02042a24b",{"id":1250,"createTime":28,"updateTime":28,"relativeEntities":1252,"slug":28,"properties":1253,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1256,"statistic":28},[],{"title":1254},{"VI":1255},"Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning Province 110016, PR China",[],{"title":1258},{"VI":1259},"Kaili Wang",{"id":1261,"sortIndex":40,"researcher":28,"roles":1262,"affiliations":1263,"properties":1270},"119c6a55-f858-4261-9076-67bf9f2c9e02",[947],[1264],{"id":1250,"sortIndex":32,"affiliation":1265,"properties":28},{"id":1250,"createTime":28,"updateTime":28,"relativeEntities":1266,"slug":28,"properties":1267,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1269,"statistic":28},[],{"title":1268},{"VI":1255},[],{"title":1271},{"VI":1272},"Junya Lu",{"id":1274,"sortIndex":123,"researcher":28,"roles":1275,"affiliations":1276,"properties":1283},"5b103b36-e2f6-4238-9730-5a785eab1059",[947],[1277],{"id":1250,"sortIndex":32,"affiliation":1278,"properties":28},{"id":1250,"createTime":28,"updateTime":28,"relativeEntities":1279,"slug":28,"properties":1280,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1282,"statistic":28},[],{"title":1281},{"VI":1255},[],{"title":1284},{"VI":1285},"Jiali Li",{"id":1287,"sortIndex":42,"researcher":28,"roles":1288,"affiliations":1289,"properties":1296},"52d80e8c-ba01-4cd8-a904-7d8eb5532364",[947],[1290],{"id":1250,"sortIndex":32,"affiliation":1291,"properties":28},{"id":1250,"createTime":28,"updateTime":28,"relativeEntities":1292,"slug":28,"properties":1293,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1295,"statistic":28},[],{"title":1294},{"VI":1255},[],{"title":1297},{"VI":1298},"Yinlu Gao",{"id":1300,"sortIndex":45,"researcher":28,"roles":1301,"affiliations":1302,"properties":1309},"c46820ed-222d-459e-ba29-73504a917b42",[947],[1303],{"id":1250,"sortIndex":32,"affiliation":1304,"properties":28},{"id":1250,"createTime":28,"updateTime":28,"relativeEntities":1305,"slug":28,"properties":1306,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1308,"statistic":28},[],{"title":1307},{"VI":1255},[],{"title":1310},{"VI":1311},"Yuling Mao",{"id":1313,"sortIndex":46,"researcher":28,"roles":1314,"affiliations":1315,"properties":1322},"27967415-0400-408e-aff3-0cadd11c83b9",[947],[1316],{"id":1250,"sortIndex":32,"affiliation":1317,"properties":28},{"id":1250,"createTime":28,"updateTime":28,"relativeEntities":1318,"slug":28,"properties":1319,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1321,"statistic":28},[],{"title":1320},{"VI":1255},[],{"title":1323},{"VI":1324},"Qinfu Zhao",{"id":1326,"sortIndex":48,"researcher":28,"roles":1327,"affiliations":1328,"properties":1335},"cfe1c1e7-3653-47b8-b33f-2325c9f45e63",[947],[1329],{"id":1250,"sortIndex":32,"affiliation":1330,"properties":28},{"id":1250,"createTime":28,"updateTime":28,"relativeEntities":1331,"slug":28,"properties":1332,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1334,"statistic":28},[],{"title":1333},{"VI":1255},[],{"title":1336},{"VI":1337},"Siling Wang",{"url":1243,"publisher":1339,"properties":1370},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":1340,"slug":872,"properties":1341,"entityType":25,"verifyStatus":878,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":1344,"manageAffiliations":1349,"indexDatabases":1355,"url":28,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":1342,"title":1343},{"VOID":875},{"EN":877},[1345],{"id":881,"createTime":28,"updateTime":28,"relativeEntities":1346,"label":1347,"description":1348,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":884},{},[1350],{"id":888,"createTime":28,"updateTime":28,"relativeEntities":1351,"slug":28,"properties":1352,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1354,"statistic":28},[],{"title":1353},{"EN":892},[],[1356,1363],{"id":896,"indexDatabase":1357,"url":902,"indexYears":903,"academicFieldIds":1362,"indexDatabaseRanking":906},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":1358,"label":1359,"description":1360,"key":781,"publicationTags":1361,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[905],{"id":908,"indexDatabase":1364,"url":920,"indexYears":28,"academicFieldIds":1369,"indexDatabaseRanking":28},{"id":910,"createTime":28,"updateTime":28,"relativeEntities":1365,"label":1366,"description":1367,"key":917,"publicationTags":1368,"standard":28},[],{"EN":913,"VI":913},{"EN":915,"VI":916},[919,813],[816,922],{"pages":1371,"volume":1373},{"VOID":1372},"445-472",{"VOID":1374},"339","2021-11-01",[919,906],{"id":1378,"createTime":1379,"updateTime":1380,"relativeEntities":1381,"slug":1382,"properties":1383,"entityType":940,"verifyStatus":26,"verifyTime":1380,"verifyNote":941,"languages":28,"translateLanguages":28,"viewCount":32,"primaryUrl":1390,"fullTextUrl":28,"authors":1391,"publicationType":1025,"publisherRelationship":1474,"citationCount":28,"citationInfo":28,"publishDate":1511,"publishYear":1512,"citationAnalyzeStatus":878,"lastCitationAnalyze":28,"indexDatabases":1513,"openAccess":28,"references":28,"isForceReanalyzing":1066},"002cea63-32c6-45a4-8b64-b45e4f03bf5b","2024-01-19T00:56:24.953+00:00","2024-12-19T09:11:20.329+00:00",[],"Interactions-between-red-blood-cells-and-a-lethal-partly-quaternized-tertiary-polyamine",{"title":1384,"references":1386,"doi":1388},{"EN":1385},"Interactions between red blood cells and a lethal, partly quaternized tertiary polyamine",{"VOID":1387},"Fiume, 1986, Galactosylated poly(l-lysine) as hepatotropic carrier of 9-β-d-arabinofuranosyladenine 5′-monophosphate, FEBS Lett., 203, 203, 10.1016\u002F0014-5793(86)80742-6\nVert, 1986, Polyvalent polymeric drug carriers, CRC Crit. Rev. Ther. Drug Carrier Syst., 2, 291\nBlythman, 1981, Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells, Nature, 290, 145, 10.1038\u002F290145a0\nFiume, 1980, Selective inhibition of virus DNA synthesis in hepatocytes by ARA-A and ARA-AMP conjugated to asialofetuin, FEBS Lett., 116, 185, 10.1016\u002F0014-5793(80)80639-9\nMathé, 1958, Effet sur la leucémie 1210 de la souris d’une combinaison par diazotation d’A-méthoptérine et de γ-globulines de hamsters porteurs de cette leucémie par hétérogreffe, C.R. Acad. Sci., 246, 1626\nPastan, 1991, Recombinant toxins for cancer treatment, Science, 254, 1173, 10.1126\u002Fscience.1683495\nPincus, 1989, Treatment of HIV tissue culture infection with monoclonal antibody–ricin A chain conjugates, J. Immunol., 142, 3070, 10.4049\u002Fjimmunol.142.9.3070\nVitetta, 1987, Redesigning Nature’s poisons to create anti-tumor reagents, Science, 238, 1098, 10.1126\u002Fscience.3317828\nHuguet, 1985, Partially quaternized poly(tertiary amine) as pH-dependent drug carrier for solubilization and temporary trapping of lipophilic drugs in aqueous media, J. Contr. Rel., 1, 217, 10.1016\u002F0168-3659(85)90020-3\nVallin, 1980, Partial methylation of poly[thio-1-(N,N-dimethyl aminomethyl) ethylene] and conformational behavior of resulting dibasic polyelectrolytes, Polym. J., 12, 113, 10.1295\u002Fpolymj.12.113\nVert, 1996\nIllum, 1986, A sustained delivery system for intramuscular administration of lipophilic drugs using globular partially quaternised poly[thio-1-(N,N-diethyl aminomethyl)ethylene], J. Contr. Rel., 3, 77, 10.1016\u002F0168-3659(86)90069-6\nIllum, 1985, Accumulation in the lung of [75Se]norcholestenol administered intravenously in a globular partially quaternized poly[thio-1-(N,N-diethyl-aminomethyl)-1-ethylene] carrier system, Intern. J. Pharm., 26, 113, 10.1016\u002F0378-5173(85)90204-2\nRubini, 1951, Agglutination of red cells by synthetic lysine polypeptides, Proc. Soc. Exptl. Biol. Med., 76, 659, 10.3181\u002F00379727-76-18587\nNevo, 1955, Interactions of basic polyamino acids with the red blood cell. I: Combination of polylysine with single cells, Biochim. Biophys. Acta, 17, 536, 10.1016\u002F0006-3002(55)90416-9\nKatchalsky, 1959, Interactions of basic polyelectrolytes with the red blood cell. II: Agglutination of red blood cells by polymeric bases, Biochim. Biophys. Acta, 33, 120, 10.1016\u002F0006-3002(59)90505-0\nChoksakulnimitr, 1995, In vitro cytotoxicity of macromolecules in different cell culture systems, J. Contr. Rel., 34, 233, 10.1016\u002F0168-3659(95)00007-U\nP. Chapon, Recherche de stéréospécificité dans l’activité catalytique de polybases globulaires à base de polyamines tertiaires partiellement quaternisées, Ph.D. Thesis, Montpellier, France, 1998.\nCripps, 1968, Rapid method for the estimation of plasma haemoglobin level, J. Clin. Pathol., 21, 110, 10.1136\u002Fjcp.21.1.110\nDrochon, 1990, Determination of the red cell apparent membrane elastic modulus from viscometric measurements, J. Biomech. Eng., 112, 241, 10.1115\u002F1.2891179\nNash, 1993, Structural determinants of the rigidity of the red cell membrane, Biorheology, 30, 397, 10.3233\u002FBIR-1993-305-611\nFåhraeus, 1929, The suspension stability of blood, Physiol. Rev., 9, 241, 10.1152\u002Fphysrev.1929.9.2.241\nRampling, 1992, Albumin and rouleaux formation, Clin. Hemorheol., 12, 761\nJan, 1979, Red cell interactions in macromolecular suspension, Biorheology, 16, 137, 10.3233\u002FBIR-1979-16302\nV. Jallet, Masquage de charges cationiques d’une polybase globulaire bifonctionnelle en vue de minimiser sa toxicité vis-à-vis du sang, Ph.D. Thesis, Rouen, France, 1994.\nTsuchida, 1994, Formation of polyelectrolyte complexes and their structures, J. Mater. Sci. Pure Appl. Chem., A31, 1",{"VOID":1389},"10.1016\u002Fs0168-3659(99)00128-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0168365999001285",[1392,1407,1420,1433,1448,1461],{"id":1393,"sortIndex":32,"researcher":28,"roles":1394,"affiliations":1395,"properties":1404},"516cfae2-9201-4c36-b9c6-80243c51cc43",[947],[1396],{"id":1397,"sortIndex":32,"affiliation":1398,"properties":28},"5fb222b1-d7cf-4871-a9e9-d2d356c5916f",{"id":1397,"createTime":28,"updateTime":28,"relativeEntities":1399,"slug":28,"properties":1400,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1403,"statistic":28},[],{"title":1401},{"VI":1402},"Biomécanique et Génie Biomédical, UMR 6600 CNRS, Université de Technologie de Compiègne, BP 20529, 60205 Compiègne cedex, France",[],{"title":1405},{"VI":1406},"Élisabeth Moreau",{"id":1408,"sortIndex":40,"researcher":28,"roles":1409,"affiliations":1410,"properties":1417},"2810d0f1-3304-478c-96df-b8d19beb9823",[947],[1411],{"id":1397,"sortIndex":32,"affiliation":1412,"properties":28},{"id":1397,"createTime":28,"updateTime":28,"relativeEntities":1413,"slug":28,"properties":1414,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1416,"statistic":28},[],{"title":1415},{"VI":1402},[],{"title":1418},{"VI":1419},"Isabelle Ferrari",{"id":1421,"sortIndex":123,"researcher":28,"roles":1422,"affiliations":1423,"properties":1430},"10723278-c9f3-4bc5-b936-53a129345917",[947],[1424],{"id":1397,"sortIndex":32,"affiliation":1425,"properties":28},{"id":1397,"createTime":28,"updateTime":28,"relativeEntities":1426,"slug":28,"properties":1427,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1429,"statistic":28},[],{"title":1428},{"VI":1402},[],{"title":1431},{"VI":1432},"Agnès Drochon",{"id":1434,"sortIndex":42,"researcher":28,"roles":1435,"affiliations":1436,"properties":1445},"24e38f30-db71-49a2-89f7-6fb713c82194",[947],[1437],{"id":1438,"sortIndex":32,"affiliation":1439,"properties":28},"1c9b0a4c-6ad6-4433-a6c7-b0b8df153dbb",{"id":1438,"createTime":28,"updateTime":28,"relativeEntities":1440,"slug":28,"properties":1441,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1444,"statistic":28},[],{"title":1442},{"VI":1443},"Centre de Recherche sur les Biopolymères Artificiels, URA 1465 CNRS, Faculté de Pharmacie, Université Montpellier 1, 34060 Montpellier cedex 2, France",[],{"title":1446},{"VI":1447},"Pascal Chapon",{"id":1449,"sortIndex":45,"researcher":28,"roles":1450,"affiliations":1451,"properties":1458},"e9f915f3-ad45-4f23-b451-f3efbc314d31",[947],[1452],{"id":1438,"sortIndex":32,"affiliation":1453,"properties":28},{"id":1438,"createTime":28,"updateTime":28,"relativeEntities":1454,"slug":28,"properties":1455,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1457,"statistic":28},[],{"title":1456},{"VI":1443},[],{"title":1459},{"VI":1460},"Michel Vert",{"id":1462,"sortIndex":46,"researcher":28,"roles":1463,"affiliations":1464,"properties":1471},"b2f65555-34c8-4ee8-8a15-f1976d91c06b",[947],[1465],{"id":1438,"sortIndex":32,"affiliation":1466,"properties":28},{"id":1438,"createTime":28,"updateTime":28,"relativeEntities":1467,"slug":28,"properties":1468,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1470,"statistic":28},[],{"title":1469},{"VI":1443},[],{"title":1472},{"VI":1473},"Dominique Domurado",{"url":1390,"publisher":1475,"properties":1506},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":1476,"slug":872,"properties":1477,"entityType":25,"verifyStatus":878,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":1480,"manageAffiliations":1485,"indexDatabases":1491,"url":28,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":1478,"title":1479},{"VOID":875},{"EN":877},[1481],{"id":881,"createTime":28,"updateTime":28,"relativeEntities":1482,"label":1483,"description":1484,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":884},{},[1486],{"id":888,"createTime":28,"updateTime":28,"relativeEntities":1487,"slug":28,"properties":1488,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1490,"statistic":28},[],{"title":1489},{"EN":892},[],[1492,1499],{"id":896,"indexDatabase":1493,"url":902,"indexYears":903,"academicFieldIds":1498,"indexDatabaseRanking":906},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":1494,"label":1495,"description":1496,"key":781,"publicationTags":1497,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[905],{"id":908,"indexDatabase":1500,"url":920,"indexYears":28,"academicFieldIds":1505,"indexDatabaseRanking":28},{"id":910,"createTime":28,"updateTime":28,"relativeEntities":1501,"label":1502,"description":1503,"key":917,"publicationTags":1504,"standard":28},[],{"EN":913,"VI":913},{"EN":915,"VI":916},[919,813],[816,922],{"pages":1507,"volume":1509},{"VOID":1508},"115-128",{"VOID":1510},"64","2000-02-01",2000,[919,906],{"id":1515,"createTime":1516,"updateTime":1516,"relativeEntities":1517,"slug":28,"properties":1518,"entityType":940,"verifyStatus":878,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"primaryUrl":1523,"fullTextUrl":28,"authors":1524,"publicationType":1025,"publisherRelationship":1525,"citationCount":28,"citationInfo":28,"publishDate":1562,"publishYear":1563,"citationAnalyzeStatus":878,"lastCitationAnalyze":28,"indexDatabases":1564,"openAccess":28,"references":28,"isForceReanalyzing":1066},"002d5656-1832-49a1-b843-ea64323b545f","2024-01-29T00:11:19.036+00:00",[],{"title":1519,"doi":1521},{"EN":1520},"Validation of the IntelliCap® system as a tool to evaluate extended release profiles in human GI tract using metoprolol as model drug",{"VOID":1522},"10.1016\u002Fj.jconrel.2015.09.024","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0168365915301255",[],{"url":1523,"publisher":1526,"properties":1557},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":1527,"slug":872,"properties":1528,"entityType":25,"verifyStatus":878,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":1531,"manageAffiliations":1536,"indexDatabases":1542,"url":28,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":1529,"title":1530},{"VOID":875},{"EN":877},[1532],{"id":881,"createTime":28,"updateTime":28,"relativeEntities":1533,"label":1534,"description":1535,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":884},{},[1537],{"id":888,"createTime":28,"updateTime":28,"relativeEntities":1538,"slug":28,"properties":1539,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1541,"statistic":28},[],{"title":1540},{"EN":892},[],[1543,1550],{"id":896,"indexDatabase":1544,"url":902,"indexYears":903,"academicFieldIds":1549,"indexDatabaseRanking":906},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":1545,"label":1546,"description":1547,"key":781,"publicationTags":1548,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[905],{"id":908,"indexDatabase":1551,"url":920,"indexYears":28,"academicFieldIds":1556,"indexDatabaseRanking":28},{"id":910,"createTime":28,"updateTime":28,"relativeEntities":1552,"label":1553,"description":1554,"key":917,"publicationTags":1555,"standard":28},[],{"EN":913,"VI":913},{"EN":915,"VI":916},[919,813],[816,922],{"pages":1558,"volume":1560},{"VOID":1559},"300-307",{"VOID":1561},"217","2015-11-10",2015,[919,906],{"id":1566,"createTime":1567,"updateTime":1568,"relativeEntities":1569,"slug":1570,"properties":1571,"entityType":940,"verifyStatus":26,"verifyTime":1578,"verifyNote":941,"languages":28,"translateLanguages":28,"viewCount":32,"primaryUrl":1579,"fullTextUrl":28,"authors":1580,"publicationType":1025,"publisherRelationship":1937,"citationCount":28,"citationInfo":28,"publishDate":1974,"publishYear":1975,"citationAnalyzeStatus":878,"lastCitationAnalyze":28,"indexDatabases":1976,"openAccess":28,"references":28,"isForceReanalyzing":1066},"003c86a2-6488-4855-a333-7125fdaf35ea","2023-12-25T21:08:51.898+00:00","2025-01-27T22:13:28.414+00:00",[],"Treatment-of-cancer-micrometastasis-using-a-multicomponent-chain-like-nanoparticle",{"title":1572,"references":1574,"doi":1576},{"EN":1573},"Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle",{"VOID":1575},"American Cancer Society, 2012\nVon Hoff, 1979, Risk factors for doxorubicin-induced congestive heart failure, Ann. Intern. Med., 91, 710, 10.7326\u002F0003-4819-91-5-710\nMaeda, 2000, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J. Control. Release, 65, 271, 10.1016\u002FS0168-3659(99)00248-5\nGradishar, 2005, Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer, J. Clin. Oncol., 23, 7794, 10.1200\u002FJCO.2005.04.937\nLasic, 1996, Doxorubicin in sterically stabilized liposomes, Nature, 380, 561, 10.1038\u002F380561a0\nLasic, 1995, Liposomes revisited, Science, 267, 1275, 10.1126\u002Fscience.7871422\nSafra, 2003, Cardiac safety of liposomal anthracyclines, Oncologist, 8, 17, 10.1634\u002Ftheoncologist.8-suppl_2-17\nSchroeder, 2012, Treating metastatic cancer with nanotechnology, Nat. Rev. Cancer, 12, 39, 10.1038\u002Fnrc3180\nAdiseshaiah, 2010, Nanomaterial standards for efficacy and toxicity assessment, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 2, 99, 10.1002\u002Fwnan.66\nGay, 2011, Contribution of platelets to tumour metastasis, Nat. Rev. Cancer, 11, 123, 10.1038\u002Fnrc3004\nFelding-Habermann, 1996, Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow, J. Biol. Chem., 271, 5892, 10.1074\u002Fjbc.271.10.5892\nMcCarty, 2000, Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions, Blood, 96, 1789, 10.1182\u002Fblood.V96.5.1789\nArnaout, 2005, Integrin structure, allostery, and bidirectional signaling, Annu. Rev. Cell Dev. Biol., 21, 381, 10.1146\u002Fannurev.cellbio.21.090704.151217\nFelding-Habermann, 2001, Integrin activation controls metastasis in human breast cancer, Proc. Natl. Acad. Sci. U. S. A., 98, 1853, 10.1073\u002Fpnas.98.4.1853\nLorger, 2009, Activation of tumor cell integrin alphavbeta3 controls angiogenesis and metastatic growth in the brain, Proc. Natl. Acad. Sci. U. S. A., 106, 10666, 10.1073\u002Fpnas.0903035106\nDesgrosellier, 2010, Integrins in cancer: biological implications and therapeutic opportunities, Nat. Rev. Cancer, 10, 9, 10.1038\u002Fnrc2748\nBrooks, 1994, Requirement of vascular integrin alpha v beta 3 for angiogenesis, Science, 264, 569, 10.1126\u002Fscience.7512751\nBrooks, 1995, Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin, J. Clin. Invest., 96, 1815, 10.1172\u002FJCI118227\nPeiris, 2012, Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release, ACS Nano, 6, 4157, 10.1021\u002Fnn300652p\nZhang, 2010, The role of the intravascular microenvironment in spontaneous metastasis development, Int. J. Cancer, 126, 2534\nSteeg, 2011, Brain metastases as preventive and therapeutic targets, Nat. Rev. Cancer, 11, 352, 10.1038\u002Fnrc3053\nPeiris, 2012, Imaging metastasis using an integrin-targeting chain-shaped nanoparticle, ACS Nano, 6, 8783, 10.1021\u002Fnn303833p\nTerasaki, 1984, Nuclear binding as a determinant of tissue distribution of adriamycin, daunomycin, adriamycinol, daunorubicinol and actinomycin D, J. Pharmacobiodyn, 7, 269, 10.1248\u002Fbpb1978.7.269\nMarafino, 1981, Pharmacokinetics, covalent binding and subcellular distribution of [3H]doxorubicin after intravenous administration in the mouse, J. Pharmacol. Exp. Ther., 216, 55\nLaginha, 2005, Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors, Clin. Cancer Res., 11, 6944, 10.1158\u002F1078-0432.CCR-05-0343\nPeiris, 2011, Assembly of linear nano-chains from iron oxide nanospheres with asymmetric surface chemistry, PLoS One, 6, e15927, 10.1371\u002Fjournal.pone.0015927\nBolotin, 1994, Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomes, J. Liposome Res., 4, 455, 10.3109\u002F08982109409037057\nSloan, 2006, Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone, Breast Cancer Res., 8, R20, 10.1186\u002Fbcr1398\nPulaski, 2001, Mouse 4T1 breast tumor model, Curr. Protoc. Immunol., 20, 10.1002\u002F0471142735.im2002s39\nTao, 2008, Imagable 4T1 model for the study of late stage breast cancer, BMC Cancer, 8, 228, 10.1186\u002F1471-2407-8-228\nDykxhoorn, 2009, miR-200 enhances mouse breast cancer cell colonization to form distant metastases, PLoS One, 4, e7181, 10.1371\u002Fjournal.pone.0007181\nGao, 2011, Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymseric micelles, J Control Release, 152, 84, 10.1016\u002Fj.jconrel.2011.01.021\nWendt, 2011, In vivo dual substrate bioluminescent imaging, J Vis Exp., 56, 3245\nYori, 2011, Kruppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer, Neoplasia, 13, 601, 10.1593\u002Fneo.11260\nGabizon, 1997, Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals, Adv. Drug Deliv. Rev., 24, 337, 10.1016\u002FS0169-409X(96)00476-0\nRose, 2005, Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer, Oncologist, 10, 205, 10.1634\u002Ftheoncologist.10-3-205\nPerou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038\u002F35021093\nBertucci, 2012, Basal breast cancer: a complex and deadly molecular subtype, Curr Mol Med, 12, 96, 10.2174\u002F156652412798376134\nPerreard, 2006, Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay, Breast Cancer Res., 8, R23, 10.1186\u002Fbcr1399\nBertucci, 2009, How different are luminal A and basal breast cancers?, Int. J. Cancer, 124, 1338, 10.1002\u002Fijc.24055\nFriedl, 2009, Collective cell migration in morphogenesis, regeneration and cancer, Nat. Rev. Mol. Cell Biol., 10, 445, 10.1038\u002Fnrm2720\nBidard, 2008, A “class action” against the microenvironment: do cancer cells cooperate in metastasis?, Cancer Metastasis Rev., 27, 5, 10.1007\u002Fs10555-007-9103-x\nKirfel, 2004, Cell migration: mechanisms of rear detachment and the formation of migration tracks, Eur. J. Cell Biol., 83, 717, 10.1078\u002F0171-9335-00421\nKievit, 2012, Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs, ACS Nano, 6, 2591, 10.1021\u002Fnn205070h\nGavze, 1997, Particles in a shear flow near a solid wall: effect of nonsphericity on forces and velocities, Int. J. Multiphase Flow, 23, 155, 10.1016\u002FS0301-9322(96)00054-7\nDecuzzi, 2005, A theoretical model for the margination of particles within blood vessels, Ann. Biomed. Eng., 33, 179, 10.1007\u002Fs10439-005-8976-5\nGavze, 1998, Motion of inertial spheroidal particles in a shear flow near a solid wall with special application to aerosol transport in microgravity, J. Fluid Mech., 371, 10.1017\u002FS0022112098002109\nLee, 2009, Shaping nano-\u002Fmicro-particles for enhanced vascular interaction in laminar flows, Nanotechnology, 20\nGentile, 2008, The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows, J. Biomech., 41, 2312, 10.1016\u002Fj.jbiomech.2008.03.021\nDecuzzi, 2006, The adhesive strength of non-spherical particles mediated by specific interactions, Biomaterials, 27, 5307, 10.1016\u002Fj.biomaterials.2006.05.024\nBrazel, 2009, Magnetothermally-responsive nanomaterials: combining magnetic nanostructures and thermally-sensitive polymers for triggered drug release, Pharm. Res., 26, 644, 10.1007\u002Fs11095-008-9773-2",{"VOID":1577},"10.1016\u002Fj.jconrel.2013.10.031","2025-01-27T22:13:28.413+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0168365913008808",[1581,1614,1636,1658,1678,1698,1720,1740,1762,1784,1804,1824,1844,1859,1883,1903],{"id":1582,"sortIndex":32,"researcher":28,"roles":1583,"affiliations":1584,"properties":1611},"63a1665a-97c0-4d43-92a8-013d9ef1957f",[947],[1585,1593,1602],{"id":1586,"sortIndex":32,"affiliation":1587,"properties":28},"2be4e320-7fce-47e0-8078-c38417f3fcb4",{"id":1586,"createTime":28,"updateTime":28,"relativeEntities":1588,"slug":28,"properties":1589,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1592,"statistic":28},[],{"title":1590},{"VI":1591},"Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA",[],{"id":1594,"sortIndex":40,"affiliation":1595,"properties":1601},"a7d8487c-752f-439a-96c7-fa36a69fb3c0",{"id":1594,"createTime":28,"updateTime":28,"relativeEntities":1596,"slug":28,"properties":1597,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1600,"statistic":28},[],{"title":1598},{"VI":1599},"Department of Radiology, Case Western Reserve University, Cleveland, OH 44106, USA",[],{},{"id":1603,"sortIndex":123,"affiliation":1604,"properties":1610},"e4bec146-1790-45ef-9a61-b10b94467ca3",{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1605,"slug":28,"properties":1606,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1609,"statistic":28},[],{"title":1607},{"VI":1608},"Case Center for Imaging Research, Case Western Reserve University, Cleveland, OH 44106, USA",[],{},{"title":1612},{"VI":1613},"Pubudu M. Peiris",{"id":1615,"sortIndex":40,"researcher":28,"roles":1616,"affiliations":1617,"properties":1633},"7928741d-3251-48f1-9948-dee75c6bb541",[947],[1618,1626],{"id":1586,"sortIndex":32,"affiliation":1619,"properties":1624},{"id":1586,"createTime":28,"updateTime":28,"relativeEntities":1620,"slug":28,"properties":1621,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1623,"statistic":28},[],{"title":1622},{"VI":1591},[],{"title":1625},{"VI":1591},{"id":1603,"sortIndex":40,"affiliation":1627,"properties":1632},{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1628,"slug":28,"properties":1629,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1631,"statistic":28},[],{"title":1630},{"VI":1608},[],{},{"title":1634},{"VI":1635},"Randall Toy",{"id":1637,"sortIndex":123,"researcher":28,"roles":1638,"affiliations":1639,"properties":1655},"46664853-1716-42b9-b463-424bf37776a7",[947],[1640,1646],{"id":1603,"sortIndex":32,"affiliation":1641,"properties":28},{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1642,"slug":28,"properties":1643,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1645,"statistic":28},[],{"title":1644},{"VI":1608},[],{"id":1647,"sortIndex":40,"affiliation":1648,"properties":1654},"1304f735-ad83-4c04-99da-f3cdf48d4921",{"id":1647,"createTime":28,"updateTime":28,"relativeEntities":1649,"slug":28,"properties":1650,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1653,"statistic":28},[],{"title":1651},{"VI":1652},"Department of Biochemistry, Case Western Reserve University, Cleveland, OH, 44106, USA",[],{},{"title":1656},{"VI":1657},"Aaron Abramowski",{"id":1659,"sortIndex":42,"researcher":28,"roles":1660,"affiliations":1661,"properties":1675},"24799b39-e9bb-449c-a3d4-f6e3ecd2e430",[947],[1662,1668],{"id":1586,"sortIndex":32,"affiliation":1663,"properties":28},{"id":1586,"createTime":28,"updateTime":28,"relativeEntities":1664,"slug":28,"properties":1665,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1667,"statistic":28},[],{"title":1666},{"VI":1591},[],{"id":1603,"sortIndex":40,"affiliation":1669,"properties":1674},{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1670,"slug":28,"properties":1671,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1673,"statistic":28},[],{"title":1672},{"VI":1608},[],{},{"title":1676},{"VI":1677},"Pete Vicente",{"id":1679,"sortIndex":45,"researcher":28,"roles":1680,"affiliations":1681,"properties":1695},"e99ef446-2691-403d-a9e7-56b2d544dc88",[947],[1682,1688],{"id":1586,"sortIndex":32,"affiliation":1683,"properties":28},{"id":1586,"createTime":28,"updateTime":28,"relativeEntities":1684,"slug":28,"properties":1685,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1687,"statistic":28},[],{"title":1686},{"VI":1591},[],{"id":1603,"sortIndex":40,"affiliation":1689,"properties":1694},{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1690,"slug":28,"properties":1691,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1693,"statistic":28},[],{"title":1692},{"VI":1608},[],{},{"title":1696},{"VI":1697},"Samantha Tucci",{"id":1699,"sortIndex":46,"researcher":28,"roles":1700,"affiliations":1701,"properties":1717},"a543feba-5acc-4e07-8d76-58a26f9e7178",[947],[1702,1708],{"id":1603,"sortIndex":32,"affiliation":1703,"properties":28},{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1704,"slug":28,"properties":1705,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1707,"statistic":28},[],{"title":1706},{"VI":1608},[],{"id":1709,"sortIndex":40,"affiliation":1710,"properties":1716},"029f65ad-0ecb-4c03-8676-5fe04f062a74",{"id":1709,"createTime":28,"updateTime":28,"relativeEntities":1711,"slug":28,"properties":1712,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1715,"statistic":28},[],{"title":1713},{"VI":1714},"Department of Physics, Case Western Reserve University, Cleveland, OH 44106, USA",[],{},{"title":1718},{"VI":1719},"Lisa Bauer",{"id":1721,"sortIndex":48,"researcher":28,"roles":1722,"affiliations":1723,"properties":1737},"801d0c16-684c-4f00-95f0-28eda28dd0d3",[947],[1724,1730],{"id":1586,"sortIndex":32,"affiliation":1725,"properties":28},{"id":1586,"createTime":28,"updateTime":28,"relativeEntities":1726,"slug":28,"properties":1727,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1729,"statistic":28},[],{"title":1728},{"VI":1591},[],{"id":1603,"sortIndex":40,"affiliation":1731,"properties":1736},{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1732,"slug":28,"properties":1733,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1735,"statistic":28},[],{"title":1734},{"VI":1608},[],{},{"title":1738},{"VI":1739},"Aaron Mayer",{"id":1741,"sortIndex":49,"researcher":28,"roles":1742,"affiliations":1743,"properties":1759},"1f786d06-3316-4bf3-ab9e-aa9303087d89",[947],[1744,1752],{"id":1586,"sortIndex":32,"affiliation":1745,"properties":1750},{"id":1586,"createTime":28,"updateTime":28,"relativeEntities":1746,"slug":28,"properties":1747,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1749,"statistic":28},[],{"title":1748},{"VI":1591},[],{"title":1751},{"VI":1591},{"id":1603,"sortIndex":40,"affiliation":1753,"properties":1758},{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1754,"slug":28,"properties":1755,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1757,"statistic":28},[],{"title":1756},{"VI":1608},[],{},{"title":1760},{"VI":1761},"Morgan Tam",{"id":1763,"sortIndex":357,"researcher":28,"roles":1764,"affiliations":1765,"properties":1781},"5b7203e7-581e-462b-ab6f-af7ead8efa6d",[947],[1766,1774],{"id":1586,"sortIndex":32,"affiliation":1767,"properties":1772},{"id":1586,"createTime":28,"updateTime":28,"relativeEntities":1768,"slug":28,"properties":1769,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1771,"statistic":28},[],{"title":1770},{"VI":1591},[],{"title":1773},{"VI":1591},{"id":1603,"sortIndex":40,"affiliation":1775,"properties":1780},{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1776,"slug":28,"properties":1777,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1779,"statistic":28},[],{"title":1778},{"VI":1608},[],{},{"title":1782},{"VI":1783},"Elizabeth Doolittle",{"id":1785,"sortIndex":145,"researcher":28,"roles":1786,"affiliations":1787,"properties":1801},"5ea6c5c0-59dd-4449-b1fd-f2a8bd9e7251",[947],[1788,1794],{"id":1603,"sortIndex":32,"affiliation":1789,"properties":28},{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1790,"slug":28,"properties":1791,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1793,"statistic":28},[],{"title":1792},{"VI":1608},[],{"id":1647,"sortIndex":40,"affiliation":1795,"properties":1800},{"id":1647,"createTime":28,"updateTime":28,"relativeEntities":1796,"slug":28,"properties":1797,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1799,"statistic":28},[],{"title":1798},{"VI":1652},[],{},{"title":1802},{"VI":1803},"Jenna Pansky",{"id":1805,"sortIndex":205,"researcher":28,"roles":1806,"affiliations":1807,"properties":1821},"2d0fd166-84b3-49db-a609-01a6080802ba",[947],[1808,1814],{"id":1586,"sortIndex":32,"affiliation":1809,"properties":28},{"id":1586,"createTime":28,"updateTime":28,"relativeEntities":1810,"slug":28,"properties":1811,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1813,"statistic":28},[],{"title":1812},{"VI":1591},[],{"id":1603,"sortIndex":40,"affiliation":1815,"properties":1820},{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1816,"slug":28,"properties":1817,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1819,"statistic":28},[],{"title":1818},{"VI":1608},[],{},{"title":1822},{"VI":1823},"Emily Tran",{"id":1825,"sortIndex":47,"researcher":28,"roles":1826,"affiliations":1827,"properties":1841},"0cc40a1a-206f-4cea-8a96-89087805ae8c",[947],[1828,1834],{"id":1586,"sortIndex":32,"affiliation":1829,"properties":28},{"id":1586,"createTime":28,"updateTime":28,"relativeEntities":1830,"slug":28,"properties":1831,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1833,"statistic":28},[],{"title":1832},{"VI":1591},[],{"id":1603,"sortIndex":40,"affiliation":1835,"properties":1840},{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1836,"slug":28,"properties":1837,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1839,"statistic":28},[],{"title":1838},{"VI":1608},[],{},{"title":1842},{"VI":1843},"Dishen Lin",{"id":1845,"sortIndex":126,"researcher":28,"roles":1846,"affiliations":1847,"properties":1856},"15f5b8c8-f4cc-4f13-a3d0-44f490ecdd85",[947],[1848],{"id":1849,"sortIndex":32,"affiliation":1850,"properties":28},"3ab17c84-67ff-417d-84a6-96efd64d23ab",{"id":1849,"createTime":28,"updateTime":28,"relativeEntities":1851,"slug":28,"properties":1852,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1855,"statistic":28},[],{"title":1853},{"VI":1854},"Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, 44106, USA",[],{"title":1857},{"VI":1858},"William P. Schiemann",{"id":1860,"sortIndex":146,"researcher":28,"roles":1861,"affiliations":1862,"properties":1880},"2b8cd665-5c53-484a-b896-b6c468e76e0e",[947],[1863,1871],{"id":1864,"sortIndex":32,"affiliation":1865,"properties":28},"b13d8b79-ae61-43f4-bd45-9a195ba7e520",{"id":1864,"createTime":28,"updateTime":28,"relativeEntities":1866,"slug":28,"properties":1867,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1870,"statistic":28},[],{"title":1868},{"VI":1869},"Edward B. Singleton Department of Pediatric Radiology, Texas Children's Hospital, Houston, TX 77030, USA",[],{"id":1872,"sortIndex":40,"affiliation":1873,"properties":1879},"3bd53900-0460-46f8-85e0-7f62e5d9fae0",{"id":1872,"createTime":28,"updateTime":28,"relativeEntities":1874,"slug":28,"properties":1875,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1878,"statistic":28},[],{"title":1876},{"EN":1877},"Department of Radiology, Baylor College of Medicine, Houston, TX, 77030, USA",[],{},{"title":1881},{"VI":1882},"Ketan B. Ghaghada",{"id":1884,"sortIndex":323,"researcher":28,"roles":1885,"affiliations":1886,"properties":1900},"6a06eb91-8938-4cc3-820a-f88ffdd6305b",[947],[1887,1893],{"id":1594,"sortIndex":32,"affiliation":1888,"properties":28},{"id":1594,"createTime":28,"updateTime":28,"relativeEntities":1889,"slug":28,"properties":1890,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1892,"statistic":28},[],{"title":1891},{"VI":1599},[],{"id":1603,"sortIndex":40,"affiliation":1894,"properties":1899},{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1895,"slug":28,"properties":1896,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1898,"statistic":28},[],{"title":1897},{"VI":1608},[],{},{"title":1901},{"VI":1902},"Mark A. Griswold",{"id":1904,"sortIndex":51,"researcher":28,"roles":1905,"affiliations":1906,"properties":1934},"b828f08d-dd80-40ba-8abc-2ba0146f0687",[947],[1907,1913,1920,1927],{"id":1586,"sortIndex":32,"affiliation":1908,"properties":28},{"id":1586,"createTime":28,"updateTime":28,"relativeEntities":1909,"slug":28,"properties":1910,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1912,"statistic":28},[],{"title":1911},{"VI":1591},[],{"id":1594,"sortIndex":40,"affiliation":1914,"properties":1919},{"id":1594,"createTime":28,"updateTime":28,"relativeEntities":1915,"slug":28,"properties":1916,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1918,"statistic":28},[],{"title":1917},{"VI":1599},[],{},{"id":1603,"sortIndex":123,"affiliation":1921,"properties":1926},{"id":1603,"createTime":28,"updateTime":28,"relativeEntities":1922,"slug":28,"properties":1923,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1925,"statistic":28},[],{"title":1924},{"VI":1608},[],{},{"id":1849,"sortIndex":42,"affiliation":1928,"properties":1933},{"id":1849,"createTime":28,"updateTime":28,"relativeEntities":1929,"slug":28,"properties":1930,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1932,"statistic":28},[],{"title":1931},{"VI":1854},[],{},{"title":1935},{"VI":1936},"Efstathios Karathanasis",{"url":1579,"publisher":1938,"properties":1969},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":1939,"slug":872,"properties":1940,"entityType":25,"verifyStatus":878,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":1943,"manageAffiliations":1948,"indexDatabases":1954,"url":28,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":1941,"title":1942},{"VOID":875},{"EN":877},[1944],{"id":881,"createTime":28,"updateTime":28,"relativeEntities":1945,"label":1946,"description":1947,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":884},{},[1949],{"id":888,"createTime":28,"updateTime":28,"relativeEntities":1950,"slug":28,"properties":1951,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1953,"statistic":28},[],{"title":1952},{"EN":892},[],[1955,1962],{"id":896,"indexDatabase":1956,"url":902,"indexYears":903,"academicFieldIds":1961,"indexDatabaseRanking":906},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":1957,"label":1958,"description":1959,"key":781,"publicationTags":1960,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[905],{"id":908,"indexDatabase":1963,"url":920,"indexYears":28,"academicFieldIds":1968,"indexDatabaseRanking":28},{"id":910,"createTime":28,"updateTime":28,"relativeEntities":1964,"label":1965,"description":1966,"key":917,"publicationTags":1967,"standard":28},[],{"EN":913,"VI":913},{"EN":915,"VI":916},[919,813],[816,922],{"pages":1970,"volume":1972},{"VOID":1971},"51-58",{"VOID":1973},"173","2014-01-01",2014,[919,906],{"id":1978,"createTime":1979,"updateTime":1980,"relativeEntities":1981,"slug":1982,"properties":1983,"entityType":940,"verifyStatus":26,"verifyTime":1980,"verifyNote":941,"languages":28,"translateLanguages":28,"viewCount":32,"primaryUrl":1990,"fullTextUrl":28,"authors":1991,"publicationType":1025,"publisherRelationship":2091,"citationCount":28,"citationInfo":28,"publishDate":2128,"publishYear":2129,"citationAnalyzeStatus":878,"lastCitationAnalyze":28,"indexDatabases":2130,"openAccess":28,"references":28,"isForceReanalyzing":1066},"003cbac2-5df8-4b4d-946b-a40703ab4175","2023-12-07T13:27:37.606+00:00","2025-01-02T21:33:19.668+00:00",[],"Lectin-mediated-bioadhesion-Proteolytic-stability-and-binding-characteristics-of-wheat-germ-agglutinin-and-Solanum-tuberosum-lectin-on-Caco-2-HT-29-and-human-colonocytes",{"title":1984,"references":1986,"doi":1988},{"EN":1985},"Lectin-mediated bioadhesion: Proteolytic stability and binding-characteristics of wheat germ agglutinin and Solanum tuberosum lectin on Caco-2, HT-29 and human colonocytes",{"VOID":1987},"Lehr, 1991, An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop, Int. J. Pharm., 70, 235, 10.1016\u002F0378-5173(91)90287-X\nC. Marriott and D.R.L. Hughes, Mucus physiology and pathology. In: R. Gurny and H.E. Junginger (Eds.), Bioadhesion —Possibilities and Future Trends, Paperback APV, Vol. 25, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1990, pp. 29–43.\nBernkop-Schnürch, 1995, An adhesive drug delivery system based on K99-fimbriae, Eur. J. Pharm. Sci., 3, 293, 10.1016\u002F0928-0987(95)00018-9\nBernkop-Schnürch, 1997, Bacterial adhesins as a drug carrier: covalent attachment of K99-fimbriae to 6-methylprednisolone, Pharmazie, 52, 41\nI.E. Liener, N. Sharon and I.E. Goldstein, The Lectins: Properties, Functions and Applications in Biology and Medicine, Academic Press, Orlando, FL, 1986.\nNachbar, 1981, Lectins in the U.S. diet. Isolation and characterization of a lectin from the tomato (Lycopersicum esculentum), J. Biol. Chem., 5, 2056\nLehr, 1992, Bioadhesion by means of specific binding to tomato lectin, Pharm. Res., 9, 547, 10.1023\u002FA:1015804816582\nNaisbett, 1989, Uptake of tomato lectin by the adult rat small intestine in vitro, Biochem. Soc. Trans., 19, 879\nIrache, 1994, In vitro study of lectin–latex conjugates for specific bioadhesion, J. Control. Release, 31, 181, 10.1016\u002F0168-3659(94)00033-6\nIrache, 1994, Preparation and characterization of lectin–latex conjugates for specific bioadhesion, Biomaterials, 15, 899, 10.1016\u002F0142-9612(94)90114-7\nSchägger, 1987, Tricine–sodium dodecyl sulfate–polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa, Anal. Biochem., 166, 368, 10.1016\u002F0003-2697(87)90587-2\nCollett, 1996, Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption, Pharm. Res., 13, 216, 10.1023\u002FA:1016082829111\nHilgers, 1990, Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa, Pharm. Res., 7, 902, 10.1023\u002FA:1015937605100\nAllen, 1973, The purification, composition and specificity of wheat germ agglutinin, Biochem. J., 131, 155, 10.1042\u002Fbj1310155\nAllen, 1973, The purification and properties of the lectin from potato tubers, a hydroxyproline-containing glycoprotein, Biochem. J., 135, 307, 10.1042\u002Fbj1350307\nL.D. Powell, Inhibition of N-linked glycosylation. In: F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith and K. Struhl (Eds.), Current Protocols in Molecular Biology, Vol. 1, Wiley, 1995.\nTkacz, 1975, Tunicamycin inhibition of polyisoprenyl N-acetylglucosaminyl pyrophosphate formation in calf liver microsomes, Biochem. Biophys. Res. Commun., 65, 248, 10.1016\u002FS0006-291X(75)80086-6\nBurchard, 1993, Interaction between trophozoites of Entamoeba histolytica and the human intestinal cell line HT-29 in the presence or absence of leukocytes, Parasitol. Res., 79, 140, 10.1007\u002FBF00932260\nGebert, 1993, Differential binding of lectins to M cells and enterocytes in the rabbit cecum, Gastroenterology, 105, 1350, 10.1016\u002F0016-5085(93)90139-4\nNaisbett, 1995, The potential use of tomato lectin for oral drug delivery: 3. Bioadhesion in vivo, Int. J. Pharm., 114, 227, 10.1016\u002F0378-5173(94)00242-W\nNagata, 1974, Wheat germ agglutinin: Molecular characteristics and specificity for sugar binding, J. Biol. Chem., 249, 3116, 10.1016\u002FS0021-9258(19)42646-X\nKronis, 1985, Wheat germ agglutinin dimers bind sialooligosaccharides at four sites in solution: proton nuclear magnetic resonance temperature studies at 360 MHz, Biochemistry, 24, 826, 10.1021\u002Fbi00325a003\nGoldstein, 1975, Precipitation and carbohydrate-binding specificity studies of wheat germ agglutinin, Biochim. Biophys. Acta, 405, 63, 10.1016\u002F0005-2795(75)90313-X\nGabius, 1990, Tumorlektinologie—Status und Perspektiven klinischer Anwendung, Naturwissenschaften, 77, 505, 10.1007\u002FBF01139261\nGabius, 1987, Characterization of membrane lectins in human colon carcinoma cells by flow cytometry, drug targeting and affinity chromatography, Anticancer Res., 7, 109\nPancino, 1991, Purification and characterisation of a breast-cancer associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4, Br. J. Cancer, 63, 390, 10.1038\u002Fbjc.1991.91",{"VOID":1989},"10.1016\u002Fs0168-3659(97)00057-6","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0168365997000576",[1992,2007,2020,2033,2048,2063,2078],{"id":1993,"sortIndex":32,"researcher":28,"roles":1994,"affiliations":1995,"properties":2004},"2fc5a31e-2079-4b34-be73-23776b7f6c72",[947],[1996],{"id":1997,"sortIndex":32,"affiliation":1998,"properties":28},"ca5a2ff6-2471-4092-a65d-f3d402501d41",{"id":1997,"createTime":28,"updateTime":28,"relativeEntities":1999,"slug":28,"properties":2000,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2003,"statistic":28},[],{"title":2001},{"VI":2002},"Institute of Pharmaceutical Technology, The University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria",[],{"title":2005},{"VI":2006},"Franz Gabor",{"id":2008,"sortIndex":40,"researcher":28,"roles":2009,"affiliations":2010,"properties":2017},"0d8bfdfc-6314-4210-9ab7-4b6c0261fb55",[947],[2011],{"id":1997,"sortIndex":32,"affiliation":2012,"properties":28},{"id":1997,"createTime":28,"updateTime":28,"relativeEntities":2013,"slug":28,"properties":2014,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2016,"statistic":28},[],{"title":2015},{"VI":2002},[],{"title":2018},{"VI":2019},"Michael Wirth",{"id":2021,"sortIndex":123,"researcher":28,"roles":2022,"affiliations":2023,"properties":2030},"b32ffc02-1a4f-4a6c-8abe-89d766e45ec7",[947],[2024],{"id":1997,"sortIndex":32,"affiliation":2025,"properties":28},{"id":1997,"createTime":28,"updateTime":28,"relativeEntities":2026,"slug":28,"properties":2027,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2029,"statistic":28},[],{"title":2028},{"VI":2002},[],{"title":2031},{"VI":2032},"Barbara Jurkovich",{"id":2034,"sortIndex":42,"researcher":28,"roles":2035,"affiliations":2036,"properties":2045},"0888756c-7d9c-46d8-bf27-e72e4e84d1f1",[947],[2037],{"id":2038,"sortIndex":32,"affiliation":2039,"properties":28},"3345db81-cf63-4197-8fd7-15c13fe77467",{"id":2038,"createTime":28,"updateTime":28,"relativeEntities":2040,"slug":28,"properties":2041,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2044,"statistic":28},[],{"title":2042},{"VI":2043},"University Clinic of Surgery, AKH, Währinger Gürtel 18-20, A-1090 Vienna, Austria",[],{"title":2046},{"VI":2047},"Ines Haberl",{"id":2049,"sortIndex":45,"researcher":28,"roles":2050,"affiliations":2051,"properties":2060},"70406965-d3b3-4aaf-8f84-28bfeaa12f1b",[947],[2052],{"id":2053,"sortIndex":32,"affiliation":2054,"properties":28},"c75cfeab-6271-4319-a0fc-833f380dc609",{"id":2053,"createTime":28,"updateTime":28,"relativeEntities":2055,"slug":28,"properties":2056,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2059,"statistic":28},[],{"title":2057},{"VI":2058},"Ludwig Boltzmann Institute of Clinical Oncology, KH Lainz, Vienna, Austria",[],{"title":2061},{"VI":2062},"Gerhard Theyer",{"id":2064,"sortIndex":46,"researcher":28,"roles":2065,"affiliations":2066,"properties":2075},"c92fe788-dbdc-41b7-81e8-525c90383cea",[947],[2067],{"id":2068,"sortIndex":32,"affiliation":2069,"properties":28},"122a53d0-7c84-4fb8-a419-85d5928de678",{"id":2068,"createTime":28,"updateTime":28,"relativeEntities":2070,"slug":28,"properties":2071,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2074,"statistic":28},[],{"title":2072},{"VI":2073},"Department of Internal Medicine, KH Baumgartner Höhe, Vienna, Austria",[],{"title":2076},{"VI":2077},"Gerhard Walcher",{"id":2079,"sortIndex":48,"researcher":28,"roles":2080,"affiliations":2081,"properties":2088},"f9271460-9af3-4948-882c-6cdbf9dc510c",[947],[2082],{"id":2038,"sortIndex":32,"affiliation":2083,"properties":28},{"id":2038,"createTime":28,"updateTime":28,"relativeEntities":2084,"slug":28,"properties":2085,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2087,"statistic":28},[],{"title":2086},{"VI":2043},[],{"title":2089},{"VI":2090},"Gerhard Hamilton",{"url":1990,"publisher":2092,"properties":2123},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":2093,"slug":872,"properties":2094,"entityType":25,"verifyStatus":878,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":2097,"manageAffiliations":2102,"indexDatabases":2108,"url":28,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":2095,"title":2096},{"VOID":875},{"EN":877},[2098],{"id":881,"createTime":28,"updateTime":28,"relativeEntities":2099,"label":2100,"description":2101,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":884},{},[2103],{"id":888,"createTime":28,"updateTime":28,"relativeEntities":2104,"slug":28,"properties":2105,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2107,"statistic":28},[],{"title":2106},{"EN":892},[],[2109,2116],{"id":896,"indexDatabase":2110,"url":902,"indexYears":903,"academicFieldIds":2115,"indexDatabaseRanking":906},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":2111,"label":2112,"description":2113,"key":781,"publicationTags":2114,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[905],{"id":908,"indexDatabase":2117,"url":920,"indexYears":28,"academicFieldIds":2122,"indexDatabaseRanking":28},{"id":910,"createTime":28,"updateTime":28,"relativeEntities":2118,"label":2119,"description":2120,"key":917,"publicationTags":2121,"standard":28},[],{"EN":913,"VI":913},{"EN":915,"VI":916},[919,813],[816,922],{"pages":2124,"volume":2126},{"VOID":2125},"27-37",{"VOID":2127},"49","1997-11-01",1997,[919,906],{"id":2132,"createTime":2133,"updateTime":2134,"relativeEntities":2135,"slug":2136,"properties":2137,"entityType":940,"verifyStatus":26,"verifyTime":2134,"verifyNote":941,"languages":28,"translateLanguages":28,"viewCount":32,"primaryUrl":2144,"fullTextUrl":28,"authors":2145,"publicationType":1025,"publisherRelationship":2243,"citationCount":28,"citationInfo":28,"publishDate":2280,"publishYear":2281,"citationAnalyzeStatus":878,"lastCitationAnalyze":28,"indexDatabases":2282,"openAccess":28,"references":28,"isForceReanalyzing":1066},"003ce226-b927-424e-aa6b-a0399346c050","2024-02-14T07:58:39.375+00:00","2025-02-08T22:21:09.914+00:00",[],"Experimental-study-on-cell-self-sealing-during-sonoporation",{"title":2138,"references":2140,"doi":2142},{"EN":2139},"Experimental study on cell self-sealing during sonoporation",{"VOID":2141},"Bao, 1997, Transfection of a reporter plasmid into cultured cells by sonoporation in vitro, Ultrasound Med. Biol., 23, 953, 10.1016\u002FS0301-5629(97)00025-2\nMiller, 1999, Sonoporation of cultured cells in the rotating tube exposure system, Ultrasound Med. Biol., 25, 143, 10.1016\u002FS0301-5629(98)00137-9\nMiller, 2001, Lysis and sonoporation of epidermoid and phagocytic monolayer cells by diagnostic ultrasound activation of contrast agent gas bodies, Ultrasound Med. Biol., 27, 1107, 10.1016\u002FS0301-5629(01)00404-5\nMiller, 2003, DNA transfer and cell killing in epidermoid cells by diagnostic ultrasound activation of contrast agent gas bodies in vitro, Ultrasound Med. Biol., 29, 601, 10.1016\u002FS0301-5629(02)00783-4\nWard, 1999, Ultrasound-induced cell lysis and sonoporation enhanced by contrast agents, J. Acoust. Soc. Am., 105, 2951, 10.1121\u002F1.426908\nWard, 2000, Experimental study of the effects of Optison concentration on sonoporation in vitro, Ultrasound Med. Biol., 26, 1169, 10.1016\u002FS0301-5629(00)00260-X\nWu, 2002, Theoretical study on shear stress generated by microstreaming surrounding contrast agents attached to living cells, Ultrasound Med. Biol., 28, 125, 10.1016\u002FS0301-5629(01)00497-5\nWu, 2006, Sonoporation, anticancer drug and antibody delivery using Ultrasound, Ultrasonics, 44, e21, 10.1016\u002Fj.ultras.2006.06.033\nWu, 2006, Application of liposomes to sonoporation, Ultrasound Med. Biol., 32, 429, 10.1016\u002Fj.ultrasmedbio.2005.11.019\nWu, 2008, Ultrasound, cavitation bubbles and their interaction with cells, Adv. Drug Deliv. Rev., 60, 1103, 10.1016\u002Fj.addr.2008.03.009\nWu, 2007, Sonoporation, gene transfection, anticancer drug and antibody drug delivery in emerging therapeutic ultrasound, 219\nGreenleaf, 1998, Artificial cavitation nuclei significantly enhance acoustically induced cell transfection, Ultrasound Med. Biol., 24, 587, 10.1016\u002FS0301-5629(98)00003-9\nLawrie, 2000, Microbubble-enhanced ultrasound for vascular gene delivery, Gene Ther., 7, 2023, 10.1038\u002Fsj.gt.3301339\nWamel, 2006, Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation, J. Control. Release, 112, 149, 10.1016\u002Fj.jconrel.2006.02.007\nHallow, 2007, Ultrasonically targeted delivery into endothelial and smooth muscle cells in ex vivo arteries, J. Control. Release, 118, 285, 10.1016\u002Fj.jconrel.2006.12.029\nEshet, 2006, The effects of albumin-coated microbubbles in DNA delivery mediated by therapeutic ultrasound, J. Control. Release, 112, 156, 10.1016\u002Fj.jconrel.2006.02.013\nWu, 2007, Shear stress in cells generated by ultrasound, Prog. Biophys. Mol. Biol., 93, 363, 10.1016\u002Fj.pbiomolbio.2006.07.016\nPrentice, 2005, Membrane disruption by optically controlled microbubble cavitation, Nat. Phys., 1, 107, 10.1038\u002Fnphys148\nHusseini, 2008, Miscelles and nanoparticles for ultrasonic drug and gene delivery, Adv. Drug Deliv. Rev., 60, 1137, 10.1016\u002Fj.addr.2008.03.008\nTran, 2005, Mechamisms of cell membrane permeabilization with ultrasound and contrast microbubbles, IEEE Ultrason. Symp., 5\nReddy, 2001, Plasma membrane repair is mediated by Ca2+-regulated exocytosis of lysosomes, Cell, 106, 157, 10.1016\u002FS0092-8674(01)00421-4\nMcNeil, 2002, Repairing a torn cell surface: make way, lysosomes to the rescue, J. Cell Sci., 115, 873, 10.1242\u002Fjcs.115.5.873\nMcNeil, 2005, An emergency response team for membrane repair, Nat. Rev., Mol. Cell Biol., 6, 499, 10.1038\u002Fnrm1665\nKumon, 2007, Ultrasound-induced calcium oscillations and waves in Chinese hamster ovary cells in the presence of microbubbles, Biophys. J., 93, L29, 10.1529\u002Fbiophysj.107.113365\n1993, 127",{"VOID":2143},"10.1016\u002Fj.jconrel.2008.07.038","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0168365908004227",[2146,2161,2174,2189,2204,2217,2230],{"id":2147,"sortIndex":32,"researcher":28,"roles":2148,"affiliations":2149,"properties":2158},"24973ceb-de69-470b-8fbe-e22962c4e043",[947],[2150],{"id":2151,"sortIndex":32,"affiliation":2152,"properties":28},"ac78353e-7dec-49ce-bab1-7288f85a1f1b",{"id":2151,"createTime":28,"updateTime":28,"relativeEntities":2153,"slug":28,"properties":2154,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2157,"statistic":28},[],{"title":2155},{"VI":2156},"Jiangsu Laboratory for Biomaterials and Devices, State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China",[],{"title":2159},{"VI":2160},"Fang Yang",{"id":2162,"sortIndex":40,"researcher":28,"roles":2163,"affiliations":2164,"properties":2171},"750e6e4e-ca6c-4098-8875-c09fc07dc99d",[947],[2165],{"id":2151,"sortIndex":32,"affiliation":2166,"properties":28},{"id":2151,"createTime":28,"updateTime":28,"relativeEntities":2167,"slug":28,"properties":2168,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2170,"statistic":28},[],{"title":2169},{"VI":2156},[],{"title":2172},{"VI":2173},"Ning Gu",{"id":2175,"sortIndex":123,"researcher":28,"roles":2176,"affiliations":2177,"properties":2186},"20b129fd-be44-4281-8189-755d413b4ab8",[947],[2178],{"id":2179,"sortIndex":32,"affiliation":2180,"properties":28},"d6fd18a4-2943-492e-ad2e-377987ac8e7d",{"id":2179,"createTime":28,"updateTime":28,"relativeEntities":2181,"slug":28,"properties":2182,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2185,"statistic":28},[],{"title":2183},{"VI":2184},"Department of Physics, University of Vermont, Burlington, VT 05405 USA",[],{"title":2187},{"VI":2188},"Di Chen",{"id":2190,"sortIndex":42,"researcher":28,"roles":2191,"affiliations":2192,"properties":2201},"47960a1b-abf2-48ff-81d3-4f07bdaa71f6",[947],[2193],{"id":2194,"sortIndex":32,"affiliation":2195,"properties":28},"2f2a15b8-4ca6-40e3-9f70-d12c5e109c04",{"id":2194,"createTime":28,"updateTime":28,"relativeEntities":2196,"slug":28,"properties":2197,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2200,"statistic":28},[],{"title":2198},{"EN":2199},"Institute of Acoustics, Nanjing University, Nanjing, 210093, China",[],{"title":2202},{"VI":2203},"Xiaoyu Xi",{"id":2205,"sortIndex":45,"researcher":28,"roles":2206,"affiliations":2207,"properties":2214},"fa9b0d85-4440-4cb7-b618-c35901a98244",[947],[2208],{"id":2194,"sortIndex":32,"affiliation":2209,"properties":28},{"id":2194,"createTime":28,"updateTime":28,"relativeEntities":2210,"slug":28,"properties":2211,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2213,"statistic":28},[],{"title":2212},{"EN":2199},[],{"title":2215},{"VI":2216},"Dong Zhang",{"id":2218,"sortIndex":46,"researcher":28,"roles":2219,"affiliations":2220,"properties":2227},"68181409-f124-47cb-824d-1a9a510c03db",[947],[2221],{"id":2151,"sortIndex":32,"affiliation":2222,"properties":28},{"id":2151,"createTime":28,"updateTime":28,"relativeEntities":2223,"slug":28,"properties":2224,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2226,"statistic":28},[],{"title":2225},{"VI":2156},[],{"title":2228},{"VI":2229},"Yixin Li",{"id":2231,"sortIndex":48,"researcher":28,"roles":2232,"affiliations":2233,"properties":2240},"09d9f575-2421-47b9-b818-209c9d9bdd79",[947],[2234],{"id":2179,"sortIndex":32,"affiliation":2235,"properties":28},{"id":2179,"createTime":28,"updateTime":28,"relativeEntities":2236,"slug":28,"properties":2237,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2239,"statistic":28},[],{"title":2238},{"VI":2184},[],{"title":2241},{"VI":2242},"Junru Wu",{"url":2144,"publisher":2244,"properties":2275},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":2245,"slug":872,"properties":2246,"entityType":25,"verifyStatus":878,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":2249,"manageAffiliations":2254,"indexDatabases":2260,"url":28,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":2247,"title":2248},{"VOID":875},{"EN":877},[2250],{"id":881,"createTime":28,"updateTime":28,"relativeEntities":2251,"label":2252,"description":2253,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":884},{},[2255],{"id":888,"createTime":28,"updateTime":28,"relativeEntities":2256,"slug":28,"properties":2257,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2259,"statistic":28},[],{"title":2258},{"EN":892},[],[2261,2268],{"id":896,"indexDatabase":2262,"url":902,"indexYears":903,"academicFieldIds":2267,"indexDatabaseRanking":906},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":2263,"label":2264,"description":2265,"key":781,"publicationTags":2266,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[905],{"id":908,"indexDatabase":2269,"url":920,"indexYears":28,"academicFieldIds":2274,"indexDatabaseRanking":28},{"id":910,"createTime":28,"updateTime":28,"relativeEntities":2270,"label":2271,"description":2272,"key":917,"publicationTags":2273,"standard":28},[],{"EN":913,"VI":913},{"EN":915,"VI":916},[919,813],[816,922],{"pages":2276,"volume":2278},{"VOID":2277},"205-210",{"VOID":2279},"131","2008-11-01",2008,[919,906],{"id":2284,"createTime":2285,"updateTime":2286,"relativeEntities":2287,"slug":2288,"properties":2289,"entityType":940,"verifyStatus":26,"verifyTime":2286,"verifyNote":941,"languages":28,"translateLanguages":28,"viewCount":32,"primaryUrl":2296,"fullTextUrl":28,"authors":2297,"publicationType":1025,"publisherRelationship":2370,"citationCount":28,"citationInfo":28,"publishDate":2407,"publishYear":2408,"citationAnalyzeStatus":878,"lastCitationAnalyze":28,"indexDatabases":2409,"openAccess":28,"references":28,"isForceReanalyzing":1066},"004cab5e-b42d-4e5e-a81c-52b0487351fe","2024-01-13T18:08:14.071+00:00","2025-02-05T07:00:27.351+00:00",[],"PEGylated-poly-ethylene-imine-copolymer-delivered-siRNA-inhibits-HIV-replication-in-vitro",{"title":2290,"references":2292,"doi":2294},{"EN":2291},"PEGylated poly(ethylene imine) copolymer-delivered siRNA inhibits HIV replication in vitro",{"VOID":2293},"Dykxhoorn, 2005, The silent revolution: RNA interference as basic biology, research tool, and therapeutic, Annu. Rev. Med., 56, 401, 10.1146\u002Fannurev.med.56.082103.104606\nKurreck, 2009, RNA interference: from basic research to therapeutic applications, Angew. Chem. Int. Ed Engl., 48, 1378, 10.1002\u002Fanie.200802092\nPeer, 2009, Systemic siRNA delivery to leukocyte-implicated diseases, Cell Cycle, 8, 853, 10.4161\u002Fcc.8.6.7936\nWhitehead, 2009, Knocking down barriers: advances in siRNA delivery, Nat. Rev. Drug Discov., 8, 129, 10.1038\u002Fnrd2742\nHan, 2004, Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site, Virology, 330, 221, 10.1016\u002Fj.virol.2004.09.027\nKumar, 2008, T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice, Cell, 134, 577, 10.1016\u002Fj.cell.2008.06.034\nLee, 2003, Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector, J. Virol., 77, 11964, 10.1128\u002FJVI.77.22.11964-11972.2003\nNovina, 2002, siRNA-directed inhibition of HIV-1 infection, Nat. Med., 8, 681, 10.1038\u002Fnm725\nBanerjea, 2003, Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages, Mol. Ther., 8, 62, 10.1016\u002FS1525-0016(03)00140-0\nKim, 2010, RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice, Mol. Ther., 18, 370, 10.1038\u002Fmt.2009.271\nNeff, 2011, An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice, Sci. Transl. Med., 3, 66ra66, 10.1126\u002Fscitranslmed.3001581\nCron, 1997, Consistent transient transfection of DNA into non-transformed human and murine T-lymphocytes, J. Immunol. Methods, 205, 145, 10.1016\u002FS0022-1759(97)00065-3\nKeller, 1999, Transgene expression, but not gene delivery, is improved by adhesion-assisted lipofection of hematopoietic cells, Gene Ther., 6, 931, 10.1038\u002Fsj.gt.3300896\nHacein-Bey-Abina, 2003, LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1, Science, 302, 415, 10.1126\u002Fscience.1088547\nWeber, 2008, Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes, J. Control. Release, 132, 55, 10.1016\u002Fj.jconrel.2008.07.035\nJimenez, 2010, Carbosilane dendrimers to transfect human astrocytes with small interfering RNA targeting human immunodeficiency virus, BioDrugs, 24, 331, 10.2165\u002F11538400-000000000-00000\nBehr, 1997, The proton sponge: a trick to enter cells the viruses did not exploit, CHIMIA Int. J. Chem., 51, 34, 10.2533\u002Fchimia.1997.34\nKichler, 2002, Intranasal gene delivery with a polyethylenimine-PEG conjugate, J. Control. Release, 81, 379, 10.1016\u002FS0168-3659(02)00080-9\nMao, 2006, Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer\u002FSiRNA polyplexes, Bioconjug. Chem., 17, 1209, 10.1021\u002Fbc060129j\nPetersen, 2002, Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system, Bioconjug. Chem., 13, 845, 10.1021\u002Fbc025529v\nMerkel, 2009, J. Control. Release, 138, 148, 10.1016\u002Fj.jconrel.2009.05.016\nGarcia-Merino, 2009, The Spanish HIV BioBank: a model of cooperative HIV research, Retrovirology, 6, 27, 10.1186\u002F1742-4690-6-27\nAdachi, 1986, Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone, J. Virol., 59, 284, 10.1128\u002Fjvi.59.2.284-291.1986\nSharma, 2005, Mechanistic studies on aggregation of polyethylenimine-DNA complexes and its prevention, Biotechnol. Bioeng., 90, 614, 10.1002\u002Fbit.20444\nKrebs, 2002, Comparative in vitro sensitivities of human immune cell lines, vaginal and cervical epithelial cell lines, and primary cells to candidate microbicides nonoxynol 9, C31G, and sodium dodecyl sulfate, Antimicrob. Agents Chemother., 46, 2292, 10.1128\u002FAAC.46.7.2292-2298.2002\nBeyerle, 2010, PEGylation affects cytotoxicity and cell-compatibility of poly(ethylene imine) for lung application: structure-function relationships, Toxicol. Appl. Pharmacol., 242, 146, 10.1016\u002Fj.taap.2009.10.001\nRoesler, 2010, Amphiphilic, low molecular weight poly(ethylene imine) derivatives with enhanced stability for efficient pulmonary gene delivery, J. Gene Med., 13, 123, 10.1002\u002Fjgm.1538\nHong, 2006, Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability, Bioconjug. Chem., 17, 728, 10.1021\u002Fbc060077y\nTang, 1997, The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes, Gene Ther., 4, 823, 10.1038\u002Fsj.gt.3300454\nNeu, 2007, Bioreversibly crosslinked polyplexes of PEI and high molecular weight PEG show extended circulation times in vivo, J. Control. Release, 124, 69, 10.1016\u002Fj.jconrel.2007.08.009\nMerkel, 2011, Polymer-related off-target effects in non-viral siRNA delivery, Biomaterials, 32, 2388, 10.1016\u002Fj.biomaterials.2010.11.081\nZintchenko, 2008, Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity, Bioconjug. Chem., 19, 1448, 10.1021\u002Fbc800065f\nLedergerber, 2000, Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement, J. Infect. Dis., 181, 1280, 10.1086\u002F315366",{"VOID":2295},"10.1016\u002Fj.jconrel.2011.09.059","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0168365911008443",[2298,2322,2337,2350],{"id":2299,"sortIndex":32,"researcher":28,"roles":2300,"affiliations":2301,"properties":2319},"d737ef40-9420-4659-8fa9-bcf3dacfd437",[947],[2302,2310],{"id":2303,"sortIndex":32,"affiliation":2304,"properties":28},"448ff8d2-cc35-4101-8295-86ebb3367999",{"id":2303,"createTime":28,"updateTime":28,"relativeEntities":2305,"slug":28,"properties":2306,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2309,"statistic":28},[],{"title":2307},{"VI":2308},"Laboratorio Inmunobiología Molecular, Hospital General Universitario Gregorio Marañón, C\u002FDoctor Esquerdo 46, 28007 Madrid, Spain",[],{"id":2311,"sortIndex":40,"affiliation":2312,"properties":2318},"a1eb74d2-7a79-4bc9-9982-cfb7326d6322",{"id":2311,"createTime":28,"updateTime":28,"relativeEntities":2313,"slug":28,"properties":2314,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2317,"statistic":28},[],{"title":2315},{"VI":2316},"Centro de Investigacíon Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain",[],{},{"title":2320},{"VI":2321},"Nick D. Weber",{"id":2323,"sortIndex":40,"researcher":28,"roles":2324,"affiliations":2325,"properties":2334},"66300388-6d94-49a5-9686-488dbc322b40",[947],[2326],{"id":2327,"sortIndex":32,"affiliation":2328,"properties":28},"ef4cc050-1fc7-413d-a1b2-5def81b6af9b",{"id":2327,"createTime":28,"updateTime":28,"relativeEntities":2329,"slug":28,"properties":2330,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2333,"statistic":28},[],{"title":2331},{"VI":2332},"Department of Pharmaceutics and Biopharmacy, Philipps Universität Marburg, Ketzerbach 63, 35037 Marburg, Germany",[],{"title":2335},{"VI":2336},"Olivia M. Merkel",{"id":2338,"sortIndex":123,"researcher":28,"roles":2339,"affiliations":2340,"properties":2347},"50a3b071-0713-4414-8f3d-6d1a90db9226",[947],[2341],{"id":2327,"sortIndex":32,"affiliation":2342,"properties":28},{"id":2327,"createTime":28,"updateTime":28,"relativeEntities":2343,"slug":28,"properties":2344,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2346,"statistic":28},[],{"title":2345},{"VI":2332},[],{"title":2348},{"VI":2349},"Thomas Kissel",{"id":2351,"sortIndex":42,"researcher":28,"roles":2352,"affiliations":2353,"properties":2367},"c3eb3524-7c53-42f0-b723-5843a7473c42",[947],[2354,2360],{"id":2303,"sortIndex":32,"affiliation":2355,"properties":28},{"id":2303,"createTime":28,"updateTime":28,"relativeEntities":2356,"slug":28,"properties":2357,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2359,"statistic":28},[],{"title":2358},{"VI":2308},[],{"id":2311,"sortIndex":40,"affiliation":2361,"properties":2366},{"id":2311,"createTime":28,"updateTime":28,"relativeEntities":2362,"slug":28,"properties":2363,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2365,"statistic":28},[],{"title":2364},{"VI":2316},[],{},{"title":2368},{"VI":2369},"María Ángeles Muñoz-Fernández",{"url":2296,"publisher":2371,"properties":2402},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":2372,"slug":872,"properties":2373,"entityType":25,"verifyStatus":878,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":2376,"manageAffiliations":2381,"indexDatabases":2387,"url":28,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":2374,"title":2375},{"VOID":875},{"EN":877},[2377],{"id":881,"createTime":28,"updateTime":28,"relativeEntities":2378,"label":2379,"description":2380,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":884},{},[2382],{"id":888,"createTime":28,"updateTime":28,"relativeEntities":2383,"slug":28,"properties":2384,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2386,"statistic":28},[],{"title":2385},{"EN":892},[],[2388,2395],{"id":896,"indexDatabase":2389,"url":902,"indexYears":903,"academicFieldIds":2394,"indexDatabaseRanking":906},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":2390,"label":2391,"description":2392,"key":781,"publicationTags":2393,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[905],{"id":908,"indexDatabase":2396,"url":920,"indexYears":28,"academicFieldIds":2401,"indexDatabaseRanking":28},{"id":910,"createTime":28,"updateTime":28,"relativeEntities":2397,"label":2398,"description":2399,"key":917,"publicationTags":2400,"standard":28},[],{"EN":913,"VI":913},{"EN":915,"VI":916},[919,813],[816,922],{"pages":2403,"volume":2405},{"VOID":2404},"55-63",{"VOID":2406},"157","2012-01-01",2012,[919,906],{"id":2411,"createTime":2412,"updateTime":2413,"relativeEntities":2414,"slug":2415,"properties":2416,"entityType":940,"verifyStatus":26,"verifyTime":2413,"verifyNote":941,"languages":28,"translateLanguages":28,"viewCount":32,"primaryUrl":2423,"fullTextUrl":28,"authors":2424,"publicationType":1025,"publisherRelationship":2521,"citationCount":28,"citationInfo":28,"publishDate":2558,"publishYear":2559,"citationAnalyzeStatus":878,"lastCitationAnalyze":28,"indexDatabases":2560,"openAccess":28,"references":28,"isForceReanalyzing":1066},"006f4f05-8ceb-4cd2-93fa-17aae73d0ef2","2023-12-01T10:01:09.053+00:00","2025-01-02T09:52:27.151+00:00",[],"Nanoparticles-for-oral-delivery-Design-evaluation-and-state-of-the-art",{"title":2417,"references":2419,"doi":2421},{"EN":2418},"Nanoparticles for oral delivery: Design, evaluation and state-of-the-art",{"VOID":2420},"Ensign, 2012, Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers, Adv. Drug Deliv. Rev., 64, 557, 10.1016\u002Fj.addr.2011.12.009\nPridgen, 2015, Polymeric nanoparticle drug delivery technologies for oral delivery applications, Expert Opin. Drug Deliv., 12, 1459, 10.1517\u002F17425247.2015.1018175\nHunter, 2012, Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective, Nanomedicine, 8, S5, 10.1016\u002Fj.nano.2012.07.005\nPawar, 2014, Targeting of gastrointestinal tract for amended delivery of protein\u002Fpeptide therapeutics: strategies and industrial perspectives, J. Control. Release, 196, 168, 10.1016\u002Fj.jconrel.2014.09.031\nMalingré, 2001, Oral delivery of taxanes, Investig. New Drugs, 19, 155, 10.1023\u002FA:1010635000879\nThornton, 2009, The reformulation of amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis, Expert Opin. Drug Deliv., 6, 271, 10.1517\u002F17425240902802861\nDe Leo, 2010, Fasting increases tobramycin oral absorption in mice, Antimicrob. Agents Chemother., 54, 1644, 10.1128\u002FAAC.01172-09\nGao, 2013, Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs, Pharm. Res., 30, 307, 10.1007\u002Fs11095-012-0889-z\nSmart, 2014, Oral peptide and protein delivery: intestinal obstacles and commercial prospects, Expert Opin. Drug Deliv., 11, 1323, 10.1517\u002F17425247.2014.917077\nRenukuntla, 2013, Approaches for enhancing oral bioavailability of peptides and proteins, Int. J. Pharm., 447, 75, 10.1016\u002Fj.ijpharm.2013.02.030\nChoonara, 2014, A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules, Biotechnol. Adv., 32, 1269, 10.1016\u002Fj.biotechadv.2014.07.006\nRoger, 2010, Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery, Nanomedicine, 5, 287, 10.2217\u002Fnnm.09.110\nYun, 2013, Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery, Adv. Drug Deliv. Rev., 65, 822, 10.1016\u002Fj.addr.2012.10.007\nRieux, 2006, Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach, J. Control. Release, 116, 1, 10.1016\u002Fj.jconrel.2006.08.013\nBardonnet, 2006, Gastroretentive dosage forms: overview and special case of Helicobacter pylori, J. Control. Release, 111, 1, 10.1016\u002Fj.jconrel.2005.10.031\nAdebisi, 2015, Modification of drug delivery to improve antibiotic targeting to the stomach, Ther. Deliv., 6, 741, 10.4155\u002Ftde.15.35\nCone, 2009, Barrier properties of mucus, Adv. Drug Deliv. Rev., 61, 75, 10.1016\u002Fj.addr.2008.09.008\nAdebisi, 2011, Gastroretentive microparticles for drug delivery applications, J. Microencapsul., 28, 689, 10.3109\u002F02652048.2011.590613\nSoybel, 2005, Anatomy and physiology of the stomach, Surg. Clin. North Am., 85, 875, 10.1016\u002Fj.suc.2005.05.009\nGelberg, 2014, Comparative anatomy, physiology, and mechanisms of disease production of the esophagus, stomach, and small intestine, Toxicol. Pathol., 42, 54, 10.1177\u002F0192623313518113\nKong, 2008, Disintegration of solid foods in human stomach, J. Food Sci., 73, R67, 10.1111\u002Fj.1750-3841.2008.00766.x\nYoshida, 2013, pH- and ion-sensitive polymers for drug delivery, Expert Opin. Drug Deliv., 10, 1497, 10.1517\u002F17425247.2013.821978\nErah, 1997, The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection, J. Antimicrob. Chemother., 39, 5, 10.1093\u002Fjac\u002F39.1.5\nLai, 2009, Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues, Adv. Drug Deliv. Rev., 61, 158, 10.1016\u002Fj.addr.2008.11.002\nLai, 2009, Micro- and macrorheology of mucus, Adv. Drug Deliv. Rev., 61, 86, 10.1016\u002Fj.addr.2008.09.012\nCone, 2009, Barrier properties of mucus, Adv. Drug Deliv. Rev., 61, 75, 10.1016\u002Fj.addr.2008.09.008\nGarg, 2014, Gastroretentive drug delivery systems for therapeutic management of peptic ulcer, Crit. Rev. Ther. Drug Carrier Syst., 31, 531, 10.1615\u002FCritRevTherDrugCarrierSyst.2014011104\nPrajapati, 2013, Raft forming system-an upcoming approach of gastroretentive drug delivery system, J. Control. Release, 168, 151, 10.1016\u002Fj.jconrel.2013.02.028\nNakamura, 2003, Gastric juice, gastric tissue and blood antibiotic concentrations following omeprazole, amoxicillin and clarithromycin triple therapy, Helicobacter, 8, 294, 10.1046\u002Fj.1523-5378.2003.00156.x\nGisbert, 2006, Clinical trial evaluating amoxicillin and clarithromycin hydrogels (Chitosan-polyacrylic acid polyionic complex) for H. pylori eradication, J. Clin. Gastroenterol., 40, 618, 10.1097\u002F00004836-200608000-00011\nWang, 2012, pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide\u002Fprotein drugs and poorly water-soluble drugs, Eur. J. Pharm. Biopharm., 82, 219, 10.1016\u002Fj.ejpb.2012.07.014\nThakral, 2013, Eudragit: a technology evaluation, Expert Opin. Drug Deliv., 10, 131, 10.1517\u002F17425247.2013.736962\nBakhru, 2013, Oral delivery of proteins by biodegradable nanoparticles, Adv. Drug Deliv. Rev., 65, 811, 10.1016\u002Fj.addr.2013.04.006\nMaisel, 2015, Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse, J. Control. Release, 197, 48, 10.1016\u002Fj.jconrel.2014.10.026\nMüller, 2014, Development and in vivo evaluation of papain-functionalized nanoparticles, Eur. J. Pharm. Biopharm., 87, 125, 10.1016\u002Fj.ejpb.2013.12.012\nWilcox, 2015, The effect of nanoparticle permeation on the bulk rheological properties of mucus from the small intestine, Eur. J. Pharm. Biopharm., 96, 484, 10.1016\u002Fj.ejpb.2015.02.029\nPereira de Sousa, 2015, Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier, Eur. J. Pharm. Biopharm., 97, 257, 10.1016\u002Fj.ejpb.2015.01.008\nKöllner, 2015, Mucus permeating thiomer nanoparticles, Eur. J. Pharm. Biopharm., 97, 265, 10.1016\u002Fj.ejpb.2015.01.004\nDawson, 2004, Transport of polymeric nanoparticle gene carriers in gastric mucus, Biotechnol. Prog., 20, 851, 10.1021\u002Fbp0342553\nLai, 2007, Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus, Proc. Natl. Acad. Sci. U. S. A., 104, 1482, 10.1073\u002Fpnas.0608611104\nEnsign, 2013, Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues, Mol. Pharm., 10, 2176, 10.1021\u002Fmp400087y\nYildiz, 2015, Size selectivity of intestinal mucus to diffusing particulates is dependent on surface chemistry and exposure to lipids, J. Drug Target., 23, 768, 10.3109\u002F1061186X.2015.1086359\nAbdulkarim, 2015, Nanoparticle diffusion within intestinal mucus: three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles, Eur. J. Pharm. Biopharm., 97, 230, 10.1016\u002Fj.ejpb.2015.01.023\nPereira de Sousa, 2016, Insulin loaded mucus permeating nanoparticles: addressing the surface characteristics as feature to improve mucus permeation, Int. J. Pharm., 500, 236, 10.1016\u002Fj.ijpharm.2016.01.022\nClardy, 2011, Vitamin B12 in drug delivery: breaking through the barriers to a B12 bioconjugate pharmaceutical, Expert Opin. Drug Deliv., 8, 127, 10.1517\u002F17425247.2011.539200\nRussell-Jones, 2011, Intestinal receptor targeting for peptide delivery: an expert's personal perspective on reasons for failure and new opportunities, Ther. Deliv., 2, 1575, 10.4155\u002Ftde.11.129\nFowler, 2013, Nanoparticle transport in epithelial cells: pathway switching through bioconjugation, Small, 9, 3282\nPridgen, 2013, Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery, Sci. Transl. Med., 5, 213ra167, 10.1126\u002Fscitranslmed.3007049\nDevriendt, 2012, Crossing the barrier: targeting epithelial receptors for enhanced oral vaccine delivery, J. Control. Release, 160, 431, 10.1016\u002Fj.jconrel.2012.02.006\nWang, 2014, Roles of M cells in infection and mucosal vaccines, Hum. Vaccin. Immunother., 10, 3544, 10.4161\u002Fhv.36174\nRieux, 2006, Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach, J. Control. Release, 116, 1, 10.1016\u002Fj.jconrel.2006.08.013\nJepson, 2004, M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery, Adv. Drug Deliv. Rev., 56, 511, 10.1016\u002Fj.addr.2003.10.018\nGabor, 2004, The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery, Adv. Drug Deliv. Rev., 56, 459, 10.1016\u002Fj.addr.2003.10.015\nPusztai, 1990, Relationship between survival and binding of plant lectins during small intestinal passage and their effectiveness as growth factors, Digestion, 46, 308, 10.1159\u002F000200402\nLavelle, 2001, Targeted delivery of drugs to the gastrointestinal tract, Crit. Rev. Ther. Drug Carrier Syst., 18, 341, 10.1615\u002FCritRevTherDrugCarrierSyst.v18.i4.10\nLambkin, 2003, Toward targeted oral vaccine delivery systems: selection of lectin mimetics from combinatorial libraries, Pharm. Res., 20, 1258, 10.1023\u002FA:1025061317400\nCrouzier, 2012, Mucin multilayers assembled through sugar-lectin interactions, Biomacromolecules, 13, 3401, 10.1021\u002Fbm301222f\nAdebisi, 2014, Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus, Int. J. Pharm., 470, 28, 10.1016\u002Fj.ijpharm.2014.04.070\nFievez, 2009, Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination, Eur. J. Pharm. Biopharm., 73, 16, 10.1016\u002Fj.ejpb.2009.04.009\nTamagawa, 2003, Characteristics of claudin expression in follicle-associated epithelium of Peyer's patches: preferential localization of claudin-4 at the apex of the dome region, Lab. Investig., 83, 1045, 10.1097\u002F01.LAB.0000078741.55670.6E\nRajapaksa, 2010, Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery, J. Control. Release, 142, 196, 10.1016\u002Fj.jconrel.2009.10.033\nKang, 2008, Identification of a peptide sequence that improves transport of macromolecules across the intestinal mucosal barrier targeting goblet cells, J. Biotechnol., 135, 210, 10.1016\u002Fj.jbiotec.2008.01.021\nPorter, 2001, Intestinal lymphatic drug transport: an update, Adv. Drug Deliv. Rev., 50, 61, 10.1016\u002FS0169-409X(01)00151-X\nTrevaskis, 2008, Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update, Adv. Drug Deliv. Rev., 60, 702, 10.1016\u002Fj.addr.2007.09.007\nCai, 2011, Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles, Adv. Drug Deliv. Rev., 63, 901, 10.1016\u002Fj.addr.2011.05.017\nChaudhary, 2014, Recent approaches of lipid-based delivery system for lymphatic targeting via oral route, J. Drug Target., 22, 871, 10.3109\u002F1061186X.2014.950664\nSingh, 2014, Lymphatic system: a prospective area for advanced targeting of particulate drug carriers, Expert Opin. Drug Deliv., 11, 211, 10.1517\u002F17425247.2014.866088\nKhan, 2013, Advanced drug delivery to the lymphatic system: lipid-based nanoformulations, Int. J. Nanomedicine, 8, 2733\nTrevaskis, 2015, From sewer to saviour-targeting the lymphatic system to promote drug exposure and activity, Nat. Rev. Drug Discov., 14, 781, 10.1038\u002Fnrd4608\nvan Marle, 2007, Compartmentalization of the gut viral reservoir in HIV-1 infected patients, Retrovirology, 4, 87, 10.1186\u002F1742-4690-4-87\nHan, 2014, Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies, J. Control. Release, 177, 1, 10.1016\u002Fj.jconrel.2013.12.031\nCollnot, 2012, Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa, J. Control. Release, 161, 235, 10.1016\u002Fj.jconrel.2012.01.028\nWolk, 2013, New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities, Expert Opin. Drug Deliv., 10, 1275, 10.1517\u002F17425247.2013.800480\nEsseku, 2011, Bacteria and pH-sensitive polysaccharide-polymer films for colon targeted delivery, Crit. Rev. Ther. Drug Carrier Syst., 28, 395, 10.1615\u002FCritRevTherDrugCarrierSyst.v28.i5.10\nPatel, 2007, Therapeutic opportunities in colon-specific drug-delivery systems, Crit. Rev. Ther. Drug Carrier Syst., 24, 147, 10.1615\u002FCritRevTherDrugCarrierSyst.v24.i2.20\nSinha, 2003, Microbially triggered drug delivery to the colon, Eur. J. Pharm. Sci., 18, 3, 10.1016\u002FS0928-0987(02)00221-X\nHua, 2015, Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue, Nanomedicine, 11, 1117, 10.1016\u002Fj.nano.2015.02.018\nJohansson, 2011, The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions, Proc. Natl. Acad. Sci. U. S. A., 108, 4659, 10.1073\u002Fpnas.1006451107\nJohansson, 2014, Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis, Gut, 63, 281, 10.1136\u002Fgutjnl-2012-303207\nJakobsson, 2015, The composition of the gut microbiota shapes the colon mucus barrier, EMBO Rep., 16, 164, 10.15252\u002Fembr.201439263\nJubeh, 2004, Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes, Pharm. Res., 21, 447, 10.1023\u002FB:PHAM.0000019298.29561.cd\nLamprecht, 2001, Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa, Pharm. Res., 18, 788, 10.1023\u002FA:1011032328064\nYoushia, 2016, Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases, Expert Opin. Drug Deliv., 13, 281, 10.1517\u002F17425247.2016.1114604\nLih-Brody, 1996, Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease, Dig. Dis. Sci., 41, 2078, 10.1007\u002FBF02093613\nSedghi, 1993, Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis, Gut, 34, 1191, 10.1136\u002Fgut.34.9.1191\nZhang, 2016, Polysaccharide-based micro\u002Fnanocarriers for oral colon-targeted drug delivery, J. Drug Target., 1-11\nVan den Mooter, 1997, Use of azo polymers for colon-specific drug delivery, J. Pharm. Sci., 86, 1321, 10.1021\u002Fjs9702630\nSchippa, 2014, Dysbiotic events in gut microbiota: impact on human health, Nutrients, 6, 5786, 10.3390\u002Fnu6125786\nNguyen, 2015, How informative is the mouse for human gut microbiota research?, Dis. Model. Mech., 8, 1, 10.1242\u002Fdmm.017400\nCanevari, 2009, Poly(ethylene glycol)-mesalazine conjugate for colon specific delivery, Int. J. Pharm., 368, 171, 10.1016\u002Fj.ijpharm.2008.09.058\nRuiz, 2011, Investigation into drug release from colon-specific azoreductase-activated steroid prodrugs using in-vitro models, J. Pharm. Pharmacol., 63, 806, 10.1111\u002Fj.2042-7158.2011.01289.x\nde Moreno de LeBlanc, 2005, Reduction of beta-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model, Biocell, 29, 15\nCardon, 2006, β-Glucuronidase activity in germ-free, monoassociated and conventional mice, Microb. Ecol. Health Dis., 18, 38, 10.1080\u002F08910600600733264\nMinko, 2004, Drug targeting to the colon with lectins and neoglycoconjugates, Adv. Drug Deliv. Rev., 56, 491, 10.1016\u002Fj.addr.2003.10.017\nMoulari, 2014, Lectin-decorated nanoparticles enhance binding to the inflamed tissue in experimental colitis, J. Control. Release, 188, 9, 10.1016\u002Fj.jconrel.2014.05.046\nGamboa, 2013, In vitro and in vivo models for the study of oral delivery of nanoparticles, Adv. Drug Deliv. Rev., 65, 800, 10.1016\u002Fj.addr.2013.01.003\nShahbazi, 2013, Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication, Curr. Drug Metab., 14, 28, 10.2174\u002F138920013804545133\nLefebvre, 2015, Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices, Nanotoxicology, 9, 523, 10.3109\u002F17435390.2014.948091\nKura, 2014, Nanotechnology in drug delivery: the need for more cell culture based studies in screening, Chem. Cent. J., 8, 46, 10.1186\u002F1752-153X-8-46\nHidalgo, 1989, Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability, Gastroenterology, 96, 736, 10.1016\u002FS0016-5085(89)80072-1\nUngell, 2004, Cell cultures in drug discovery: an industrial perspective, 90\nVolpe, 2010, Application of method suitability for drug permeability classification, AAPS J., 12, 670, 10.1208\u002Fs12248-010-9227-8\nPowell, 2010, Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract, J. Autoimmun., 34, 226, 10.1016\u002Fj.jaut.2009.11.006\nKauffman, 2013, Alternative functional in vitro models of human intestinal epithelia, Front. Pharmacol., 4, 79, 10.3389\u002Ffphar.2013.00079\nWikman-Larhed, 1995, Co-cultures of human intestinal goblet (HT29-H) and absorptive (Caco-2) cells for studies of drug and peptide absorption, Eur. J. Pharm. Sci., 3, 171, 10.1016\u002F0928-0987(95)00007-Z\nWalter, 1996, HT29-MTX\u002FCaco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans, J. Pharm. Sci., 85, 1070, 10.1021\u002Fjs960110x\nMahler, 2009, Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion\u002Fcell culture model used to predict iron bioavailability, J. Nutr. Biochem., 20, 494, 10.1016\u002Fj.jnutbio.2008.05.006\nRieux, 2007, An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells, Eur. J. Pharm. Sci., 30, 380, 10.1016\u002Fj.ejps.2006.12.006\nSchimpel, 2014, Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles, Mol. Pharm., 11, 808, 10.1021\u002Fmp400507g\nWijtten, 2011, Intestinal barrier function and absorption in pigs after weaning: a review, Br. J. Nutr., 105, 967, 10.1017\u002FS0007114510005660\nLindberg, 2014, Fiber effects in nutrition and gut health in pigs, J. Anim. Sci. Biotechnol., 5, 15, 10.1186\u002F2049-1891-5-15\nLeonard, 2010, A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro, Mol. Pharm., 7, 2103, 10.1021\u002Fmp1000795\nLeonard, 2012, Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model, ALTEX, 29, 275, 10.14573\u002Faltex.2012.3.275\nHuang, 2014, A 3-D artificial colon tissue mimic for the evaluation of nanoparticle-based drug delivery system, Mol. Pharm., 11, 2051, 10.1021\u002Fmp400723j\nChen, 2015, Robust bioengineered 3D functional human intestinal epithelium, Sci. Rep., 5, 13708, 10.1038\u002Fsrep13708\nBermudez-Brito, 2013, In vitro cell and tissue models for studying host-microbe interactions: a review, Br. J. Nutr., 109, S27, 10.1017\u002FS0007114512004023\nFang, 2013, Human intestinal in vitro organ culture as a model for investigation of bacteria-host interactions, J. Exp. Clin. Med., 5, 43e50, 10.1016\u002Fj.jecm.2013.02.006\nFoulke-Abel, 2014, Human enteroids as an ex-vivo model of host-pathogen interactions in the gastrointestinal tract, Exp. Biol. Med. (Maywood), 239, 1124, 10.1177\u002F1535370214529398\nHartman, 2014, Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems, Exp. Biol. Med. (Maywood), 239, 1108, 10.1177\u002F1535370214529388\nVu, 2014, The promise of organotypic hepatic and gastrointestinal models, Trends Biotechnol., 32, 406, 10.1016\u002Fj.tibtech.2014.04.006\nGrabinger, 2014, Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy, Cell Death Dis., 5, 10.1038\u002Fcddis.2014.183\nMcCracken, 2014, Modelling human development and disease in pluripotent stem-cell-derived gastric organoids, Nature, 516, 400, 10.1038\u002Fnature13863\nPastuła, 2016, Three-dimensional gastrointestinal organoid culture in combination with nerves or fibroblasts: a method to characterize the gastrointestinal stem cell niche, Stem Cells Int., 2016, 3710836, 10.1155\u002F2016\u002F3710836\nChia, 2015, Biomimicry 3D gastrointestinal spheroid platform for the assessment of toxicity and inflammatory effects of zinc oxide nanoparticles, Small, 11, 702, 10.1002\u002Fsmll.201401915\nHuh, 2011, From 3D cell culture to organs-on-chips, Trends Cell Biol., 21, 745, 10.1016\u002Fj.tcb.2011.09.005\nEsch, 2012, On chip porous polymer membranes for integration of gastrointestinal tract epithelium with microfluidic ‘body-on-a-chip’ devices, Biomed. Microdevices, 14, 895, 10.1007\u002Fs10544-012-9669-0\nEsch, 2014, Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury, Lab Chip, 14, 3081, 10.1039\u002FC4LC00371C\nKim, 2012, Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow, Lab Chip, 12, 2165, 10.1039\u002Fc2lc40074j\nKim, 2013, Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation, Integr. Biol. (Camb), 5, 1130, 10.1039\u002Fc3ib40126j\nKim, 2016, Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip, Proc. Natl. Acad. Sci. U. S. A., 113, E7, 10.1073\u002Fpnas.1522193112\nShen, 2015, In vitro-in vivo correlation for complex non-oral drug products: where do we stand?, J. Control. Release, 219, 644, 10.1016\u002Fj.jconrel.2015.09.052\nKostewicz, 2014, In vitro models for the prediction of in vivo performance of oral dosage forms, Eur. J. Pharm. Sci., 57, 342, 10.1016\u002Fj.ejps.2013.08.024\nBarzegar-Jalali, 2012, A correlative model to predict in vivo AUC for nanosystem drug delivery with release rate-limited absorption, J. Pharm. Sci., 15, 583\nMusther, 2014, Animal versus human oral drug bioavailability: do they correlate?, Eur. J. Pharm. Sci., 57, 280, 10.1016\u002Fj.ejps.2013.08.018\nAkabane, 2010, A comparison of pharmacokinetics between humans and monkeys, Drug Metab. Dispos., 38, 308, 10.1124\u002Fdmd.109.028829\nKararli, 1995, Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals, Biopharm. Drug Dispos., 16, 351, 10.1002\u002Fbdd.2510160502\nZou, 2013, TPGS emulsified zein nanoparticles enhanced oral bioavailability of daidzin: in vitro characteristics and in vivo performance, Mol. Pharm., 10, 2062, 10.1021\u002Fmp400086n\nYuan, 2013, Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles, Mol. Pharm., 10, 1865, 10.1021\u002Fmp300649z\nTariq, 2015, Biodegradable polymeric nanoparticles for oral delivery of epirubicin: in vitro, ex vivo, and in vivo investigations, Colloids Surf., B, 128, 448, 10.1016\u002Fj.colsurfb.2015.02.043\nZhu, 2014, Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery, Mol. Pharm., 11, 317, 10.1021\u002Fmp400493b\nBraakhuis, 2015, Progress and future of in vitro models to study translocation of nanoparticles, Arch. Toxicol., 89, 1469, 10.1007\u002Fs00204-015-1518-5\nReineke, 2013, Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheres, Proc. Natl. Acad. Sci. U. S. A., 110, 13803, 10.1073\u002Fpnas.1305882110\nGardner, 1988, Gastrointestinal absorption of intact proteins, Annu. Rev. Nutr., 8, 329, 10.1146\u002Fannurev.nu.08.070188.001553\nBellmann, 2015, Mammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food-relevant nanomaterials, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 7, 609, 10.1002\u002Fwnan.1333\nCho, 2013, Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration, Part. Fibre Toxicol., 10, 9, 10.1186\u002F1743-8977-10-9\nHinkley, 2015, Oral absorption of PEG-coated versus uncoated gold nanospheres: does agglomeration matter?, Part. Fibre Toxicol., 12, 9, 10.1186\u002Fs12989-015-0085-5\nSinnecker, 2014, The gut wall provides an effective barrier against nanoparticle uptake, Beilstein J. Nanotechnol., 5, 2092, 10.3762\u002Fbjnano.5.218\nHu, 2016, Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery, Nanoscale\nHolmgren, 2003, Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges, Vaccine, 21, S89, 10.1016\u002FS0264-410X(03)00206-8\nJepson, 1996, Targeting to intestinal M cells, J. Anat., 189, 507\nPappo, 1989, Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: a quantitative model for M cell uptake, Clin. Exp. Immunol., 76, 144\nThomas, 1996, Particle uptake and translocation across epithelial membranes, J. Anat., 189, 487\nMeynell, 1999, Up-regulation of microsphere transport across the follicle-associated epithelium of Peyer's patch by exposure to Streptococcus pneumoniae R36a, FASEB J., 13, 611, 10.1096\u002Ffasebj.13.6.611\nDe, 1953, An experimental study of the mechanism of action of Vibriod cholerae on the intestinal mucous membrane, J. Pathol. Bacteriol., 66, 559, 10.1002\u002Fpath.1700660228\nSchanker, 1958, Absorption of drugs from the rat small intestine, J. Pharmacol. Exp. Ther., 123, 81\nMan, 2004, Improving M cell mediated transport across mucosal barriers: do certain bacteria hold the keys?, Immunology, 113, 15, 10.1111\u002Fj.1365-2567.2004.01964.x\nFox, 2015, Micro\u002Fnanofabricated platforms for oral drug delivery, J. Control. Release, 219, 431, 10.1016\u002Fj.jconrel.2015.07.033\nGeorge, 2006, Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan–a review, J. Control. Release, 114, 1, 10.1016\u002Fj.jconrel.2006.04.017\nChang, 2010, Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori, Biomacromolecules, 11, 133, 10.1021\u002Fbm900985h\nLin, 2013, Genipin-cross-linked fucose-chitosan\u002Fheparin nanoparticles for the eradication of Helicobacter pylori, Biomaterials, 34, 4466, 10.1016\u002Fj.biomaterials.2013.02.028\nLin, 2015, Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study, Nanomedicine, 10, 57, 10.2217\u002Fnnm.14.76\nLin, 2015, Active targeted nanoparticles for oral administration of gastric cancer therapy, Biomacromolecules, 16, 3021, 10.1021\u002Facs.biomac.5b00907\nDeng, 2015, A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity, Eur. J. Pharm. Biopharm., 97, 107, 10.1016\u002Fj.ejpb.2015.10.010\nSuwannateep, 2011, Mucoadhesive curcumin nanospheres: biological activity, adhesion to stomach mucosa and release of curcumin into the circulation, J. Control. Release, 151, 176, 10.1016\u002Fj.jconrel.2011.01.011\nPan-In, 2014, Ethyl cellulose nanoparticles: clarithomycin encapsulation and eradication of H. pylori, Carbohydr. Polym., 109, 22, 10.1016\u002Fj.carbpol.2014.03.025\nPan-in, 2014, Combating Helicobacter pylori infections with mucoadhesive nanoparticles loaded with Garcinia mangostana extract, Nanomedicine, 9, 457, 10.2217\u002Fnnm.13.30\nTachaprutinun, 2014, Acrylate-tethering drug carrier: covalently linking carrier to biological surface and application in the treatment of Helicobacter pylori infection, Biomacromolecules, 15, 4239, 10.1021\u002Fbm5012618\nNavabi, 2013, Helicobacter pylori infection impairs the mucin production rate and turnover in the murine gastric mucosa, Infect. Immun., 81, 829, 10.1128\u002FIAI.01000-12\nHe, 2015, VB12-coated Gel-Core-SLN containing insulin: another way to improve oral absorption, Int. J. Pharm., 493, 451, 10.1016\u002Fj.ijpharm.2015.08.004\nVerma, 2016, Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: a mucoadhesive and pH responsive carrier for improved oral delivery of insulin, Acta Biomater., 31, 288, 10.1016\u002Fj.actbio.2015.12.017\nMa, 2014, M-cell targeted polymeric lipid nanoparticles containing a Toll-like receptor agonist to boost oral immunity, Int. J. Pharm., 473, 296, 10.1016\u002Fj.ijpharm.2014.06.052\nXia, 2015, Enhanced transport of nanocage stabilized pure nanodrug across intestinal epithelial barrier mimicking Listeria monocytogenes, Biomaterials, 37, 320, 10.1016\u002Fj.biomaterials.2014.10.038\nLiu, 2015, A novel ligand conjugated nanoparticles for oral insulin delivery, Drug Deliv., 27, 1, 10.3109\u002F10717544.2015.1031295\nXu, 2016, The transport mechanism of integrin αvβ3 receptor targeting nanoparticles in Caco-2 cells, Int. J. Pharm., 500, 42, 10.1016\u002Fj.ijpharm.2016.01.028\nJin, 2012, Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport, Biomaterials, 33, 1573, 10.1016\u002Fj.biomaterials.2011.10.075\nLi, 2015, The glucose-lowering potential of exenatide delivered orally via goblet cell-targeting nanoparticles, Pharm. Res., 32, 1017, 10.1007\u002Fs11095-014-1513-1\nZhang, 2014, Mechanism study of cellular uptake and tight junction opening mediated by goblet cell-specific trimethyl chitosan nanoparticles, Mol. Pharm., 11, 1520, 10.1021\u002Fmp400685v\nMuchow, 2008, Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery, Drug Dev. Ind. Pharm., 34, 1394, 10.1080\u002F03639040802130061\nDate, 2007, Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles, Adv. Drug Deliv. Rev., 59, 505, 10.1016\u002Fj.addr.2007.04.009\nPuglia, 2012, Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals, Expert Opin. Drug Deliv., 9, 429, 10.1517\u002F17425247.2012.666967\nBeloqui, 2016, Nanostructured lipid carriers: promising drug delivery systems for future clinics, Nanomedicine, 12, 143, 10.1016\u002Fj.nano.2015.09.004\nAji, 2011, Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting, Eur. J. Pharm. Sci., 42, 11, 10.1016\u002Fj.ejps.2010.10.002\nZhang, 2012, Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats, Nanomedicine, 8, 740, 10.1016\u002Fj.nano.2011.08.016\nChaudhary, 2015, Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway, Int. J. Pharm., 485, 108, 10.1016\u002Fj.ijpharm.2015.02.070\nElKasabgy, 2014, Design of lipotomes as a novel dual functioning nanocarrier for bioavailability enhancement of lacidipine: in-vitro and in-vivo characterization, Int. J. Pharm., 472, 369, 10.1016\u002Fj.ijpharm.2014.06.048\nSiram, 2014, Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation, Expert Opin. Drug Deliv., 11, 1351, 10.1517\u002F17425247.2014.915310\nZhang, 2014, Enhancement of oral bioavailability of tripterine through lipid nanospheres: preparation, characterization, and absorption evaluation, J. Pharm. Sci., 103, 1711, 10.1002\u002Fjps.23967\nCho, 2014, Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake, Int. J. Nanomedicine, 9, 495\nRavi, 2014, Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism, Eur. J. Pharm. Biopharm., 87, 114, 10.1016\u002Fj.ejpb.2013.12.015\nNassar, 2011, High plasma levels and effective lymphatic uptake of docetaxel in an orally available nanotransporter formulation, Cancer Res., 71, 3018, 10.1158\u002F0008-5472.CAN-10-3118\nAttili-Qadri, 2013, Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption, Proc. Natl. Acad. Sci. U. S. A., 110, 17498, 10.1073\u002Fpnas.1313839110\nGugulothu, 2014, pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model, J. Pharm. Sci., 103, 687, 10.1002\u002Fjps.23828\nNaeem, 2015, Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy, Drug Des. Devel. Ther., 9, 3789\nNaeem, 2014, Enzyme\u002FpH dual sensitive polymeric nanoparticles for targeted drug delivery to the inflamed colon, Colloids Surf. B: Biointerfaces, 123, 271, 10.1016\u002Fj.colsurfb.2014.09.026\nAli, 2014, Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases, J. Control. Release, 183, 167, 10.1016\u002Fj.jconrel.2014.03.039\nBeloqui, 2014, pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease, Int. J. Pharm., 473, 203, 10.1016\u002Fj.ijpharm.2014.07.009\nVong, 2012, An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice, Gastroenterology, 143, 1027, 10.1053\u002Fj.gastro.2012.06.043\nVong, 2015, Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose-response efficacy, J. Control. Release, 210, 19, 10.1016\u002Fj.jconrel.2015.05.275\nVong, 2014, Oral nanotherapeutics: effect of redox nanoparticle on microflora in mice with dextran sodium sulfate-induced colitis, J. Gastroenterol., 49, 806, 10.1007\u002Fs00535-013-0836-8\nVong, 2015, Development of an oral nanotherapeutics using redox nanoparticles for treatment of colitis-associated colon cancer, Biomaterials, 55, 54, 10.1016\u002Fj.biomaterials.2015.03.037\nVong, 2016, Combination treatment of murine colon cancer with doxorubicin and redox nanoparticles, Mol. Pharm., 10.1021\u002Facs.molpharmaceut.5b00676\nCoco, 2013, Drug delivery to inflamed colon by nanoparticles: comparison of different strategies, Int. J. Pharm., 440, 3, 10.1016\u002Fj.ijpharm.2012.07.017\nArora, 2015, Biological therapy for ulcerative colitis, Gastroenterol. Rep., 3, 103, 10.1093\u002Fgastro\u002Fgou070\nLaroui, 2014, Merlin, Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis, J. Control. Release, 186, 41, 10.1016\u002Fj.jconrel.2014.04.046",{"VOID":2422},"10.1016\u002Fj.jconrel.2016.06.016","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0168365916303819",[2425,2451,2491],{"id":2426,"sortIndex":32,"researcher":28,"roles":2427,"affiliations":2428,"properties":2448},"7ff79ab3-e3ed-4274-acba-e4995d443d47",[947],[2429,2437],{"id":2430,"sortIndex":32,"affiliation":2431,"properties":28},"d31f3cf7-2f56-47a5-8709-94780d0a96a7",{"id":2430,"createTime":28,"updateTime":28,"relativeEntities":2432,"slug":28,"properties":2433,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2436,"statistic":28},[],{"title":2434},{"VI":2435},"The Center for Nanomedicine, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, 400 N Broadway, Baltimore, MD 21231, USA",[],{"id":2438,"sortIndex":40,"affiliation":2439,"properties":2445},"b067fc68-62c0-4245-9b1f-a195d2d5d1fb",{"id":2438,"createTime":28,"updateTime":28,"relativeEntities":2440,"slug":28,"properties":2441,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2444,"statistic":28},[],{"title":2442},{"VI":2443},"Department of Ophthalmology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, 400 N. Broadway, Baltimore, MD 21231, United States",[],{"title":2446},{"VI":2447},"Department of Ophthalmology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, 400 N. Broadway, Baltimore, MD 21231, USA",{"title":2449},{"VI":2450},"Abhijit A. Date",{"id":2452,"sortIndex":40,"researcher":28,"roles":2453,"affiliations":2454,"properties":2488},"2c94d4e2-97f9-4617-85e6-87a5acf77e85",[947],[2455,2461,2469,2479],{"id":2430,"sortIndex":32,"affiliation":2456,"properties":28},{"id":2430,"createTime":28,"updateTime":28,"relativeEntities":2457,"slug":28,"properties":2458,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2460,"statistic":28},[],{"title":2459},{"VI":2435},[],{"id":2438,"sortIndex":40,"affiliation":2462,"properties":2467},{"id":2438,"createTime":28,"updateTime":28,"relativeEntities":2463,"slug":28,"properties":2464,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2466,"statistic":28},[],{"title":2465},{"VI":2443},[],{"title":2468},{"VI":2447},{"id":2470,"sortIndex":123,"affiliation":2471,"properties":2477},"a1610321-c8c6-41af-9864-57cff02cee66",{"id":2470,"createTime":28,"updateTime":28,"relativeEntities":2472,"slug":28,"properties":2473,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2476,"statistic":28},[],{"title":2474},{"EN":2475},"Department of Chemical and Biomolecular Engineering, Johns Hopkins University, 3400 N. Charles Street, Baltimore, MD 21218, USA",[],{"title":2478},{"VI":2475},{"id":2480,"sortIndex":42,"affiliation":2481,"properties":2487},"c54a52a5-21f5-4997-9daa-36654ede6989",{"id":2480,"createTime":28,"updateTime":28,"relativeEntities":2482,"slug":28,"properties":2483,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2486,"statistic":28},[],{"title":2484},{"VI":2485},"Departments of Biomedical Engineering, Environmental and Health Sciences, Oncology, Neurosurgery, Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, MD 21205, USA",[],{},{"title":2489},{"VI":2490},"Justin Hanes",{"id":2492,"sortIndex":123,"researcher":28,"roles":2493,"affiliations":2494,"properties":2518},"4ead48eb-73bf-4221-acc4-7b086e1a4b07",[947],[2495,2501,2509],{"id":2430,"sortIndex":32,"affiliation":2496,"properties":28},{"id":2430,"createTime":28,"updateTime":28,"relativeEntities":2497,"slug":28,"properties":2498,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2500,"statistic":28},[],{"title":2499},{"VI":2435},[],{"id":2438,"sortIndex":40,"affiliation":2502,"properties":2507},{"id":2438,"createTime":28,"updateTime":28,"relativeEntities":2503,"slug":28,"properties":2504,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2506,"statistic":28},[],{"title":2505},{"VI":2443},[],{"title":2508},{"VI":2447},{"id":2470,"sortIndex":123,"affiliation":2510,"properties":2515},{"id":2470,"createTime":28,"updateTime":28,"relativeEntities":2511,"slug":28,"properties":2512,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2514,"statistic":28},[],{"title":2513},{"EN":2475},[],{"title":2516},{"VI":2517},"Department of Chemical and Biomolecular Engineering, Johns Hopkins University, 3400 N Charles Street, Baltimore, MD 21218, USA",{"title":2519},{"VI":2520},"Laura M. Ensign",{"url":2423,"publisher":2522,"properties":2553},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":2523,"slug":872,"properties":2524,"entityType":25,"verifyStatus":878,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":2527,"manageAffiliations":2532,"indexDatabases":2538,"url":28,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":2525,"title":2526},{"VOID":875},{"EN":877},[2528],{"id":881,"createTime":28,"updateTime":28,"relativeEntities":2529,"label":2530,"description":2531,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":884},{},[2533],{"id":888,"createTime":28,"updateTime":28,"relativeEntities":2534,"slug":28,"properties":2535,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2537,"statistic":28},[],{"title":2536},{"EN":892},[],[2539,2546],{"id":896,"indexDatabase":2540,"url":902,"indexYears":903,"academicFieldIds":2545,"indexDatabaseRanking":906},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":2541,"label":2542,"description":2543,"key":781,"publicationTags":2544,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[905],{"id":908,"indexDatabase":2547,"url":920,"indexYears":28,"academicFieldIds":2552,"indexDatabaseRanking":28},{"id":910,"createTime":28,"updateTime":28,"relativeEntities":2548,"label":2549,"description":2550,"key":917,"publicationTags":2551,"standard":28},[],{"EN":913,"VI":913},{"EN":915,"VI":916},[919,813],[816,922],{"pages":2554,"volume":2556},{"VOID":2555},"504-526",{"VOID":2557},"240","2016-10-01",2016,[919,906]]